Content-Type: text/html
Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . .] 181
batch____ bits E-value N 100.0% 1:181 MSEAPKKRWYVVQAFSGFEGRVATSLREHIKLHNMEDLFGEVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGTSDRPAPISDKEVDAIMNRLQQVGDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRATPVELDFSQVEKA
1 UniRef50_P0AA01 Transcription antiterminati... 190 1e-47 1 99.4% 1:181 1:181 MSEAPKKRWYVVQAFSGFEGRVATSLREHIKLHNMEELFGEVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGTSDRPAPISDKEVDAIMNRLQQVGDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRATPVELDFSQVEKA
2 UniRef50_Q01SW9 Transcription antiterminati... 189 4e-47 1 50.0% 2:181 61:239 -DESSAKKWYIIHTYSGFENKVQESLRTRADAFGFADKIGQILIPTEEVVELRNGKKVTSKRLVYPGYVLVEMEMNDALWHEVKNTPRVTGFVGG-GNSPVPLSADEVNSILYRQASSAERPRPKMTFEKNDSVRIIDGPFANFSGKVDEVNPERGTLRVMVTIFGRATPVELEFLQVEKV
3 UniRef50_Q9CK84 Transcription antiterminati... 185 6e-46 1 77.9% 1:181 1:182 MTETtkKRWYVLQAFSGFEGRVATTLREYIKLHQMEDQFGEVLVPTEEVVENVAGKRRKSERKFFPGYVLVQMEMNDETWHLVRSVPRVMGFIGGTADKPAPISQREADRILNRLQESSEKPRHRKEFQPGEEVRVTEGPFADFNGTVEEVDYEKGRLKVSVSIFGRATPVELEFSQVEKT
4 UniRef50_C7M2W0 Transcription antiterminati... 183 3e-45 1 46.6% 8:181 67:243 -------EWYVVHCYSGYENRVRQNLATRIRSLGLEDRIFEVEIPMEDVTELKNGRRVKVQRKVFPGYVLVRAEMDDEVWSAIRNTPGITSFVGS-GSKPVPLSRKEVEAMFSFATPEELRPQPqqEFEIGETVRVKEGPLADFVGEVAEVNADQLKLKVLFNIFGRETPVELDFTQVSKA
5 UniRef50_A5D5K3 Transcription antiterminati... 182 7e-45 1 48.0% 6:180 2:173 -----EKKWYVVHTYSGYENKVKANLEKRIDSMNMEDKIFRILVPMEDEVEIKDGKKKVSKRKIFPGYVLVEMIMTDDSWYVVRNTPGVTGFVGS-GSRPIPLNDAEARQIIRQM--GVEEPRTRVDFTVGENIRVISGPFENFIGQIEEINMEKSKVKVMISMFGRETPVELDFTQVEK-
6 UniRef50_D0LJE5 Transcription antiterminati... 181 1e-44 1 48.0% 3:181 13:189 --QNDKFKWYVVHTHAGYEQRVRETLQQRAVALGFKDNIGEILVPTLNVMEVVKGKRKTSTKKFFPGYIFVQMEFTDSVYHLIRNTPKVTGFVG--GNTPQPVPESEISVIHNTMSDNHSKPRPKVMFEQGDNVRVTDGPFASFTATVEEVKPDKQKLRVLVTIFGRATPVELDFTQVEKA
7 UniRef50_P57151 Transcription antiterminati... 180 1e-44 1 80.6% 1:180 1:180 MHESQKKRWYVLQAFSGFESRVAQSIREHVKLNQMEDLFGEVMVPSQEVVEIRGGQRRKSEYKFFPGYVLIQMKMTDSTWHLIRNVPKVLGFIGGKSDKPSPISDKEVEIIINRLRKIGNKPRPKTLFEPGEMIRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRSTPVELDFRQVEK-
8 UniRef50_D1CD65 Transcription antiterminati... 176 3e-43 1 46.6% 5:180 26:198 ----DGFQWYVIHTYSGYEDKVKRDLQHRVETMGMSDRIRDIIVPTVEEIEIREGKRHKVQKKVFPGYVLVRMRMDDAAWNVVRYTPGVTGFVGS-GTKPTPLDEKEVEKILQRM--SEEPPKVKMSLRLGEAVRIVDGPFTDFEGTVDEINEEKGKVKVLISIFGRPTPVELDFLQVEK-
9 UniRef50_Q9KGE7 Transcription antiterminati... 175 4e-43 1 44.6% 6:180 2:177 -----EKNWYVVHTYSGYENKVKTNLEKRVESMDMTDKIFRVMVPVEEETEVKNGKSKQVSRKVFPGYVLVEMVMTDDSWYVVRNTPGVTGFVggAGSKPTPLLPEEVDAILRQMG-MQEERQVEIDFQLKESVKVKEGPFANFIGTIEEIQLDKRKLKVHVNMFGRETPVELEFTQIEK-
10 UniRef50_C8XBG0 Transcription antiterminati... 175 5e-43 1 46.2% 8:180 123:305 -------EWYVVHSYAGYENKVKTNLETRIKSLDMEDYIFQIEVPTEEVTEIKNGQRKQVQRKVYPGYILVRMDLTDQSWSAVRNTPGVTGFVGATAQKPSALTIDEVVKILTPTapGSAPVRTEVDFSIGESVTVMDGPFATLPATINEVNADAQKLKVLVSIFGRETPVELSFSQVAK-
11 UniRef50_Q5HRL6 Transcription antiterminati... 175 5e-43 1 38.9% 1:180 1:181 MSEegAKRWYAVHTYSGYENKVKKNLEKRVESMNMTEQIFRVVIPEEEETQVKDGKAKKLVKKTFPGYVLVELIMTDESWYVVRNTPGVTGFVggAGSKPNPLLPEEVRFILKQMGLKEKTID--VELDVGEQVRIQSGPFANQIGEVQEIEADKFKLTVLVDMFGRETPVEVEFDQIEK-
12 UniRef50_A6W3A4 Transcription antiterminati... 174 1e-42 1 69.3% 6:181 2:177 -----TKRWYVVQAYSGYEKHVMRSLIERVQVMGQEENFGDILVPTEEVVEIRDGKKRKSERKFYPGYVLVQMDMNDASWHLVKGTSRVLGFIGGTADKPSPITSREADAILQRVSDGVDKPRPKTLFEVGEVVRVNEGPFADFNGVVEEVDYDKSRIKVAVLIFGRSTPVDLEFSQVEKA
13 UniRef50_Q6A6K1 Transcription antiterminati... 174 1e-42 1 41.6% 8:180 117:302 -------EWYVLHTYSGMENKVKQNLDARVQNFNMEDYIFETVVPTEEVVEIRNGARRTITRVYLPGYVLVRMDLTDDSWGIVRHTPSVTGFVGQSTT-PIPLTFDEVVKMlkTSSPKAKPKVEVADYEVGESVQITDGPFAGVPAQITEINTNNQRIKALVEILGRSTPVDLEFNQIEK-
14 UniRef50_Q1WST1 Transcription antiterminati... 174 1e-42 1 38.8% 3:180 6:184 --ESVEKKWYVLHTYAGYENKVKENLESRATSMGMEDYIFRVVVPEEEKHEtkTGKEKVEKLKTFPGYVLVEMVMTDQSWYVVRNTPGVTGFVggSGSKPAPLLDEEINHILHELGISSR--HSNFDAEVGDAVTIIDGAFSGLVGKITEIDTEKMKLKVDIDMFGRETAAELNYDQVDK-
15 UniRef50_B4R8J9 Transcription antiterminati... 172 3e-42 1 54.2% 4:180 12:187 ---NPRHKWYIVHAYSNFEKKVAESIREQARTQGLEENFSEILVPTEDVVEIRRGRKVNSERKFFPGYVLVKMEMTDEAYHLIKNTPKVTGFLGS-GSKPIPVSEKEVERIVGAIEEGVERPKPTITFEIGEQVRVTDGPFASFNGSVEQVDEERARLRVTVSIFGRATPVELEYGQVEK-
16 UniRef50_A3EVT3 Transcription antiterminati... 172 4e-42 1 43.6% 2:180 6:183 -DSDSKKNWYVIHTYAGFENRVKTSIEERVVLKDLADIVGQVVVPIQNVTELKEGKKKVSSRKVFPGYVLVEMEPTEEAIQFILATPKVTGFLGN-GTTPIPMSSREVSELFDRIESGTAMPSPSQHFSESETVRITDGPFQGFSGMISEVDNDHGKLKVLVSIFGRQTPVELDFLQVER-
17 UniRef50_B9KYX2 Transcription antiterminati... 172 7e-42 1 45.8% 4:180 23:196 ---DQQGEWYVLHTYSGYENKVRQNLLHRVETMDVADKVFEVVIPMQEEIEIRGGQRHTVQRKVFPGYVLVRMILDDESWHVVRNTPGVTGFVG-VGNRPVPLDRAEAEAIIR--GAKAEQPKVRMTLLPGDVVRIIDGPFTDFRGVVDEVDNEKGKVRVLVSFFGRETPVTLDFLQVER-
18 UniRef50_P65591 Transcription antiterminati... 171 8e-42 1 61.5% 7:180 3:176 ------KKWYVVQAYSGFEKNVQRILEERIAREEMGDYFGQILVPVEKVVDIRNGRKTISERKSYPGYVLVEMEMTDDSWHLVKSTPRVSGFIGGRANRPTPISQREAEIILQQVQTGIEKPKPKVEFEVGQQVRVNEGPFADFNGVVEEVNYERNKLRVSVQIFGRETPVELEFSQVEK-
19 UniRef50_D1BP79 Transcription antiterminati... 171 1e-41 1 42.1% 4:181 2:177 ---EADKKWYVIHTYSGYENKVKTTLELKVQSMGLQDVISRILVPLEDEIDEKDGVKKVVKRKIFPGYVLVEMEVNDRSWYVVRNTPGVTGFVGSAT-KPVPLSDSEVEHILKSQGL-DKKPTINVDVEVGETVRITSGAFEDKLGVITELNPEKGTLKLSVEMFNRDTEVELEFSQVEKA
20 UniRef50_Q2LQ92 Transcription antiterminati... 171 1e-41 1 50.3% 8:178 4:173 -------KWYVVHTYSGFESKVKQSLQERIEAAGMQARFSDILIPEEDVVELVSGEKKTSKRKFFPGYILVKMELDDDTWHLVKDTPKVTGFIGSRE-KPSPIPDKDVELLKTRIDEGTLKPKPKFKFEVGDHVTIIDGPFTNFDGVIDEVKAEKGKLRVIVSIFGRPTPVELDFIQV---
21 UniRef50_B1I1L1 Transcription antiterminati... 170 2e-41 1 41.7% 7:181 3:177 ------KQWFVVHTYSGYENKVKANLEKRIESMSMEDKIFRIVVPVEDEIEVKGGKRKISKRKIFPGYVMVEMILDDDSYRVVRNTPGVTGFVggIGSKPIPLTDAEANQIISQMEGDE--PRIRIDLVPGEKVRVMAGPFENFIGTVDDVNYEKAKIRVMISMFGRETPIELEYFQIEKV
22 UniRef50_Q1AU17 Transcription antiterminati... 170 2e-41 1 40.8% 7:180 2:175 ------KKWYVVNTYSGHENKVRATLERRIESLGLQRYFGEIRIPTEQVIEIKNGKKVPTTHRQFPGYILVNVEMNDDTWRVIRQTPGVTQIVGS-GDKPTPLSRAEVERLLHPEeeKREKVKATVDFDIGETVRVVAGPLSDFTGTISDINVDQSKVKVLVSIFGRETPVELSFNQVAK-
23 UniRef50_Q0AUG6 Transcription antiterminati... 168 6e-41 1 42.4% 9:180 33:202 --------WYVVHTYSGYENKIKVDLSKRVESMNMQDKIFEVIIPEEQEVEYKNGKRKVTNKRIFPGYVIVNMIMDDDSWYVVRHTPGVTGFVGS-GSKPIPLHQEEIDKIRRQMGLM-EKKTMIIDIEIGESIRVKTGPFANFEGVVRELLPEKGKIRVNISMFGRETPVELDYEQIEK-
24 UniRef50_C4Z2Q9 Transcription antiterminati... 168 9e-41 1 36.6% 5:179 2:176 ----DDAKWYVVHTYSGYENKVKANIEKTVENRNLHDQILEVIVPLETVVEIKDGSKKAAQKKMFPGYVLVKMVMNDDSWYVVRNTRGVTGFVG-PGSKPVPLTPTEIKNliSLEEEQEVKPVIQFAGKVGDKVMILSGAWEDTVGEITNINEGKQCLTINVEMFGRETPVEIDFTDVK--
25 UniRef50_P35872 Transcription antiterminati... 167 2e-40 1 42.5% 8:181 4:184 -------EWYAVHTLVGQEEKAKANLEKRIKAFGLQDKIFQVLIPTEEVVerEGGKKEVVRKKLFPGYLFIQMDlpNEAWEVVRGTPGITGFVG-AGMRPVPLSPDEVRHILEvlLGKKEAPKAQVAFREGDQVRVVSGPFADFTGTVTEINPERGKVKVMVTIFGRETPVELDFSQVVKA
26 UniRef50_C4XIP4 Transcription antiterminati... 167 2e-40 1 52.8% 1:180 8:186 VDEQSNARWYIVHTYSGFENRVELTLREMMRTGQDGGSIKEVVVPTEKIIELVKGEKKTSTRKFYPGYVMVKMAMDDNSWHLVQSIPRVTGFIGGK-NQPTPMRDSEAQKILSLMVSRQEQPRPKYHFERGDDVRVIDGPFGGFNGVVEDVNYDKGKLRVSVSIFGRQTPVELDFVQVSK-
27 UniRef50_D1B6U2 Transcription antiterminati... 167 2e-40 1 41.3% 3:181 2:180 --KDDKRRWYIVQTYSGYENKVKANLEQRIATMGMEDRIFNVLVPVEEKVFVKEGRAKRVRRKVFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGS-GNHPIPLTDREVAEVMGKIgpADRKPKVELDIEVGDTVRVKSGPFEGCVGPVVEVDPDKGRVRFSVTVFGRETVAEAGHEDLEKV
28 UniRef50_B0SAG6 Transcription antiterminati... 166 2e-40 1 39.1% 1:179 1:181 MGDSLDKKWYVLQTYSGHENKVKTNIEKMVQQQKLEDQIFSVKIPSMEVAEMKNGKKKVTKKKLMPGYVLVEMNMTDDLRFKIQNLPSVSTFVGGKGKGPEPLSLDEIKNLFSDVgeSEEVSRPRFLFKVGETLKIIDGPFANFTGLVDEIFPDKGRLRVRVEIFGRSTPVELDYLQVK--
29 UniRef50_D0WPF7 Transcription antiterminati... 166 3e-40 1 38.3% 6:180 86:272 -----DGRWYVLHTYSGYEKRVKQDLEVRMHSMNMEDYIFQIEVPMEEVFEIRRGQRKLVSRVRMPGYVLIRMDLTDDSWRVVQSTNGVTGFVGN-GRTPVALSENEVVSMLTPvkAASPTPATLSPYAVGDAVTLTSEPWAGMPATVSEVDAANQRLTVLMTLVGQETPVELSFNQVRK-
30 UniRef50_Q9CBK0 Transcription antiterminati... 166 3e-40 1 43.0% 9:180 39:227 --------WYVIHSYAGYENKVKANLETRVQNLDVGDCIFQVEVPTEEVTEIKNGQRRLVNRKVLPGYILVRMDLTDDSWAAVRNTPGVTGFVG-ATSRPSALALDDVVKFLLPSGSAKKDAkiEVDYEVGESVTVMDGPFATLPATISEVNAEQQKLKVLVSIFGRETPVELTFSQVSK-
31 UniRef50_B2KEU4 Transcription antiterminati... 166 4e-40 1 42.2% 1:180 1:176 MSEN--KAWYIVHTQTGHEDKVREKILLQVETQNFGDRIFQVLVPTEDVVEVKQNKKVQRKRKFFPSYVLVEMDLTSEAYWFIRNVSGVTGFLGDPN--PVPLPEEEIAAILDLTQPGSGKPKHVIEFEAGENVRITEGPFKHFIGVVQEVNNQKTKLKIMVNVFDRSTPVELDFLQVEK-
32 UniRef50_C1Z9H7 Transcription antiterminati... 165 6e-40 1 35.2% 2:180 24:203 -STENAMLWYVLKITSNREKSIRDNLLRRIRQEGLEQFFGEILIPTEKVVENKNGKKKVVEHKLYPGYLMVQMILNDDTWYIVRTTGGVGDFTGSAG-KPTPMQDHEIARMLQKQEQKQeaPAMKIEFAVGDIVKIKEGTFEGFEGPIDSIDEANGKINVLVEIFGRSTPVELEYWQAER-
33 UniRef50_P27309 Transcription antiterminati... 165 7e-40 1 36.4% 8:180 111:298 -------EWYVIHTYAGYEKRVKANLEQRAVSLNVEEFIYQAEVPEEEIVQIKNGERKNVRQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYD-PYPLTLDEIVKMLAPEapAVKRTIEVLDFEVGDSVTVTDGPFATLQATINEINPDSKKVKGLVEIFGRETPVELSFDQIQK-
34 UniRef50_A6LPP9 Transcription antiterminati... 164 1e-39 1 39.5% 4:180 10:179 ---SDRARWYVVHTYSGYENKVKANLEKAIENRNLEALIHDIQVPMEEVVEEKDGKQKVSLKKKFPGYVLVKMLMGDEAWYVVRNTRGVTGFVG-PGSKPVPLSDEEVESM------GVLEVPVEIDLEVGESIRIISGPLRDSVATIQEIIPDKRKVKALVEMFGRETLAELDFNQVEK-
35 UniRef50_B3T6R2 Putative transcription term... 164 1e-39 1 38.9% 2:181 91:270 -PQNPNVKWYILQAYSGYEGRVEQTIREKLRIKGIEHLVDEIFIPSEDIIRTKEGKKRKVNQKYFPGYVLIHMELTPELWHLLMNVNRVSGFIGGTQKKPLPLDEKELEEIRSQVNEGFQQKATEDEYSVGQKVTITEGSFGNFSGTIDEVNLERRKLKVLVSIFGRPTPVEVEFENVKHV
36 UniRef50_D1NBR2 Transcription antiterminati... 164 1e-39 1 39.8% 1:181 1:192 MNESAEtqWFVIHTLSGHENKVRDKILRQLQT-GDQVPVYEAFIPTEKVAEVRQGKKTTTTRKLFPGYIWVRMDlnEKAWYFIRSVQGVLGFLGGD-NKPTALTESEVEDIMRPAQAGAPEVKPKIAFEVGEVVRIKDGAFENFEGAIQEIDNERGKLKLMVSIFGRSTPVELEFWQVERT
37 UniRef50_B8DVU5 Transcription antiterminati... 164 1e-39 1 37.1% 6:180 142:327 -----EGKWYVLHTYSGYEKRVKSNIESRVQSFGLEDTIFQVEVPMEEVEKHTEKGKKVVTRVRVPGYVLIRMYPDENARRIVRETEGVTGFVG-PSREPAPLSRKEVVSMMAPmpAAAKKRTLEVSYKVGDQVTVTDGPFTSMSAVVSDVEPATQKLTVLVSIFGRDTPVELGFDQVQR-
38 UniRef50_Q6MJ02 Transcription antiterminati... 163 2e-39 1 49.7% 6:180 2:176 -----EKKWYIVNVQTSCENTAKKAIEEKIKSSKMEEFFGEILIPAESVVELVKGQKQTKSRKFFPGYIFVQMFLNDETWHLVRNSSKVTGFVGGTKTRPPEVPEAEVLRVTQQMAGVAEKPRPKVKFAVGENVTVIDGPFSNFQGTVEEINEDKAKLKVLVSIFGRPTPVELDYIQVEK-
39 UniRef50_D2MPP9 Transcription termination/a... 163 3e-39 1 30.7% 2:180 13:192 -DDENEVRWYVVNTYAGHENRVKDNLEKRLETMGIQESLFRIFVAEEEEIVIKKNNKSEVKknMFPGYIFVQMKMTDQAWYVVRNTPGVTGFIGSSGgkPFPVSEDEMESILRRMGHGDQKV--VVDFQVGDNVKILTGPFANMIGRISAMNDQTQIATVMTLLFGRETPNEISYGDLQK-
40 UniRef50_B3QYK9 Transcription antiterminati... 162 3e-39 1 38.4% 8:179 29:199 -------RWYTVRTYSGHERKVKEHLDKKIDDAGIRDKIPQVYIPYERFVEVKDGKKKSRVKNAFPGYVLIEAVLDKQTRYLVLDAPSVIGFLG-VGDEPTPLRPDEVKRLLEPEQEIERKMVTKAPFEVGGAVKIIDGPFNSLTGVIQEVNAEKMKVKVLINFFGRSTPTEVDFSQVK--
41 UniRef50_A4QBE9 Transcription antiterminati... 162 4e-39 1 39.1% 3:181 118:317 --KKQPGVWYIIQCYSGYENKVKANLDMRAQTLEVEDDIFEVVVPIEQVTEIRDGKRKLVKRKLLPGYVLVRMDMNDRVWSVVRDTPGVTSFVGNEGNA-TPVKHRDVAKFLMpmPTDTKKPQVAVDFTVGEAVTILTGAFASVSATISSIDPELQKLEVLVSIFGRETPVDLSFDQVEKV
42 UniRef50_C9M8Z2 Transcription antiterminati... 162 4e-39 1 36.9% 3:181 7:185 --EQANVQWFAVQTYSGYENKVKNNLEQRIASMNAEDKIFRVLVPMEDVVVVKDGKSKQMSRKLFPSYVLVEMIMDDQSWYVVRHTPGVTGFVG-AGAHPLPLSDEEVRDVLVKVGeeAETPQIVVECQVGDSVRVKSGPFVGAVGVVSDVNTSTGKVKFVLSVFGRETEAEVNHTELERV
43 UniRef50_A4XLK3 Transcription antiterminati... 161 1e-38 1 37.2% 1:180 1:174 MSDK-RAKWYVVHTYCGYENKVKANLEKIIENRNLSDKILDIRIPTELVTEIKDGKKIVKEKKKFPSYVLIKAVMDNDIWYTIRNVRGVTGFVGPE-SKPTPLTDEEIEAM----GIKEEEVVEVFDIEVGDNVKIVAGPFADFYGPVIDINKERKKVKVMLNLFGRETPVEFDYHQVEK-
44 UniRef50_D2R5P4 NusG antitermination factor... 161 1e-38 1 35.0% 2:181 85:267 -DKDLKFEWYILKVQVNREDSIKASLLRRINMNGLERFFKDVVVPTEDVAetKTGKRRVVKKKIYPGYILVNMVFNDETWFIVRETSGIGDF-TGAMGKPTPMDPKDVERIlkMLEEDTNQVRTAIPFKVGDRVRVKEGYFQNFEGDIDGIDQANGRVTVMINIFGRSTPVELEHWQIEAV
45 UniRef50_Q1UZH8 Transcription antiterminati... 160 2e-38 1 45.7% 7:181 2:175 ------KNWYIVQSHSNFENKVAGLIKEEAEKAKISDKIEEIVVPTHDVTEVKRGKRIQRKKKYFPGYVLIKSEMDNDLYHLIKNLKRVSGFLGSKG-IPVPVSDKEIEKILGQIKDGVAQPKSGIEYSIGEKVQVVDGPFASFSGMVEDIDEEKSRLKVSVSIFGRPTPVDLEYNQVEKA
46 UniRef50_B3E158 Transcription antiterminati... 160 2e-38 1 42.2% 2:181 16:200 -AKSQNMQWYALHVLSGQEEKVKKNLEKRIKTEEMQDLVGEVVIPVERVSEVRKGKRIEINRKLYPGYVFLQIQLRdrAWYFVRETSGVIGF--ADGDNPLPMPREQVEGMLRQIQERTSSALPKTVFSVGDRVKVGDGPFLNSEGVIEEVDLERGKLRVSVNIFGRSTPVELEYWQVEKA
47 UniRef50_Q87A27 Transcription antiterminati... 160 2e-38 1 63.4% 7:181 2:185 ------KRWYVVHAYSGFEKSVAQALRDRISRIEIQDRFGDVLVPAEEVVEMRSGQKRRSEHKFFPGYVLIQIeiDNECWHLVKETPKVMGFIGGTADRPLPISSDEADVILRRVQDGAEKPRPKVLFEPGQMVRVIDGPFNDFDGLVEEVNYEKNRLRVAVLIFGRPTPVDLDFGQVQKS
48 UniRef50_Q1RHC5 Transcription antiterminati... 160 2e-38 1 44.1% 2:180 13:188 -SEKDTKKWYVIHTASGAENRIKRIMLERISKQKMSDFFDDILVPVFGVSEVKRSKNVKVEKKLMPSYILIKMNMTDKSWHLVKNIPGVTGFLGSKTT-PKALTESEIQNIR--LETEAKEAKDAKLYEVGEIVTVTEGPFETFTGTVEEVDQEKARLKVSVSIFGKATPIELSFTQVKK-
49 UniRef50_Q14PQ9 Transcription antiterminati... 160 2e-38 1 34.1% 8:180 32:215 -------KWYVINCYSGHEDRVRDDLIQRVESLNMKDVVFDIRVIKETVSAKKGGKLIEKEKNLYPGYIFINMIMNDEAWYIVRNTTGVTGFIGSSGrkPFPLTDQEARTMLSKtqGKKVKKVFVANFEVNDYVRILSGTFTEMEGQVTKIDTSKGIAIVNLEMFGRLTPTEVEFDQCEK-
50 UniRef50_B2UQY7 Transcription antiterminati... 160 2e-38 1 38.1% 1:181 1:189 MPSTPEPhwYVLHVLSGQENSVRDRIIRKAKDAELSDFIYRVEVPTELISEVRNGKKTERHSKLFPGYVYANmtLNKDLWYFIQQIDGVISIAGSR-NAPLPMRKREVEDLLPLLDAEAVAARPKVEFAVGDPVRVCEGPFQSQEGTIEEIDPEKGKLRVSVSIFGRATPVDLEYWQVEKA
51 UniRef50_C8WBL1 Transcription antiterminati... 160 2e-38 1 48.0% 7:181 2:178 ------SRWYIIHAYSGFENKVKEAVAAEAERLGLQPLVEAIEVPTEQAVEVRRGKKVAVERKCFPGYVLAKLNMNEDVYHLVKNTPKVTGFLGFSG-KPQPISDAEAEHILNHKAEAekKAQIKVDFEIGDQVKVLEGPFASFNGVVEDLDFDRARVKVSVSIFGRATPVELEFEQVERA
52 UniRef50_D0MHN6 Transcription antiterminati... 160 3e-38 1 43.3% 1:180 1:184 MTEEKkrKWYVLRTFSGHEKKVKQYLEREIERLGLQDRVGQILIPTETVFELRGGKKRTRERTFFPGYILIEAVLDRELQHLIANMPSVVGFLGS-GDQPTPLRPDEVRRILGKVDEAREmeQPEIPFKPGDVVRIIEGPFNNFTGVVEEVYPDKLKLKVMVSIFGRKTPLEVDYLQVER-
53 UniRef50_Q6AP83 Transcription antiterminati... 159 4e-38 1 51.2% 7:178 3:174 ------KQWYILQAHSGFEEKVKLTLEDRIKKDGLEDFFGDILVPTEQVVEMVKGSRKTSSKKFFPGYMLINMELTDETWhvHENMPRVVGFVG-DDRNPMPLSDEEAAKIIGRIQEGSERPRPKVIFDVGENVRVIDGPFSNFQGVVDEVFPDKGRVRVMVSIFGRETPVELEFVQV---
54 UniRef50_D2RNN9 NusG antitermination factor... 159 4e-38 1 36.2% 4:180 2:189 ---ENQKHWYVIHTYSGYENKVKMNLESKIHSLGMEEQIFQVLVPMQNEVDAKDDKQKVVARKVFPGYVLIEMIVDDRTWYAVRNTPGVTGFVG-TGTKPIPLSDREVERILGAQPKEgeEPVVRMECPVgdTVRIKAPGFTDMVGTVAEINDEQQKIKVMVEMFGRETPIEVKFTQVEA-
55 UniRef50_A6CA55 Transcription antiterminati... 159 4e-38 1 37.1% 4:181 17:194 ---SEKRLWYVLKVQSNREKSIRDALLRGIKRDGLEEYFGEIIIPTEKVVETKGGKKRVFERKLYPGYLMIQVELNDDSWYLVRSTNGVGDFTGAAG-KPIPMQEHEIARMLGREESKEETpkIKLDFQVGDVVKVKDATFEGFEGTIDAVDEASGKVTVLIEIFSRPTPTELEYWQIEKV
56 UniRef50_B0RIR6 Transcription antiterminati... 159 4e-38 1 39.0% 4:180 153:344 ---SKPGKWYVIHSYAGFERRVKSNIENRMVSLNMEDDIYQIEVPMEDVVEIKNGQRKMVNRVRIPGYVLVRMALNEDSWSVVRHTPGVTGFVGNA-HNPTPLRFEEAFSMLKSlgQAQRVVAAEVDFEIGETITIKEGSFAGLPGSISEIKPESGKLTVLVSLFERETPVELSFDQVTK-
57 UniRef50_B1ZPC3 Transcription antiterminati... 158 6e-38 1 39.5% 4:180 8:189 ---PADAQWFALHTLSGQENKVKAYIDKFKKAEELDDSIFEVLLPTEIVSEVKGGKKSTKVRKLYPGYVFIQMRLynKPWYFVKEVAGVIGFVG--GDRPAALRQSEIDEIRARIEAANGKEVPKVQYSVGEEVKITDGAFASLTGRIDEIDPERGKLKVSVSIFGRFTPVELEYWQVQR-
58 UniRef50_B0S060 Transcription antiterminati... 158 8e-38 1 38.6% 5:180 21:192 ----KEGKWYVVHTYSGHEGKVKVNIEKMVENRGYIDDIFEVVVPTEEYVSEVGGAKKLKERKIFPGYVFVKMTITDVSWYLVRNTRGVTGFVGPE-SKPVAVSEKEIQKFALKNQSYSKK---EIDVNVGDNVNIVSGAFSDQVGIIEEINTEKAICKVLISLFGRDTSVEISFDDIEK-
59 UniRef50_B6G0A9 Transcription antiterminati... 158 9e-38 1 37.8% 1:180 1:179 MSELQEAKWYVVHTYSGHENKVKATIERAVITRGMENIITHVVVPTENVVEkpKGNEKIRQRKVYPSYVLIKMIITDESWYVVRNTKGVTGFVG-PGSKPVPLSEEEVIAM-GIELPAQEVVGGDVDFEPGDVVKIINGSFAGNVGTVEEVNAEKKEVKLLTEIFGRKSPVTIGIQSIEK-
60 UniRef50_A0Q872 Transcription antiterminati... 158 9e-38 1 54.7% 9:180 3:175 --------WYVVQVHSGYEKRVKAQLEENIEIAGLKNNFGRILVPTENVVEMKGGQKRKSERKYFPGYVLIEADLSTDAWNLVKSVPRVLTVVGSKG-KPIPLSKAEVDRILGFVekSTVEPRLRKSYHVGEVVRVLEGPFNDFTGVIEEVNYEKSRLRVAVSIFGRSTPVELEFSQVEK-
61 UniRef50_C0QWX1 Transcription antiterminati... 157 1e-37 1 39.4% 1:180 1:194 MSEekDYKWYIVHTQHGYENKVRERIEKRAKENGMTDLIVDIYIPSETVTSTKNGKKVSKEEFFYPGYVLVKMVMNDATQSMVRRTPGVAGFIGsgNIIPTPLSESDVARIFENREDKSKTGINEieFDIGEKVQVIDGPFNGLNGIIENINSDKGRVTVKIEIFGRSTPTELEFSKVKK-
62 UniRef50_P68893 Transcription antiterminati... 157 1e-37 1 33.7% 1:178 1:176 MLDSFDKGWFVLQTYSGYENKVKENLLQRAQTYNMLDNILRVEIPTQTVNVEKNGQTKEIEENRFPGYVLVEMVMTDEAWFVVRNTPNVTGFVGSHGnkPTPLLEEEIRAILLSM--GQTIDVFDTNIKEGDVVQIIDGAFMGQEGRVVEI--ENNKVKLMLNMFGSETVAEVELYQI---
63 UniRef50_Q9CDV7 Transcription antiterminati... 157 1e-37 1 35.8% 1:179 1:181 MEDNndQGWFVIQTYAGYERKVKEDLLERAELYNMADKILRVEIPTETIRTEVNGKMKEVEENLFPGYVLVEMNMTDEAWFIVRNTPNVTGFVGSHGnkPTPLFEQEIQDILVGM--GKVVREIDFDVFVGKRVRIVDGAFSGFEAPITEINGDK--LTLTVDMFGRATPVELDMHQIE--
64 UniRef50_C4LL90 Transcription antiterminati... 157 2e-37 1 40.6% 1:180 145:351 MRELKkgEWYIVQCYSGYENKVKTDLEVRSQTLGVDEQIHEVVVPIEEEVEVKDGKRKVVKHKLLPGYVLMRIELDDASWSVIRDTPGITSFVGNEGH-PTPVKIREVAKFLLPPETATQKAEQevDYEVGEAVTVLSGPFASVSATISEIDAENSKLKALVSIFGRETPVELDFDQVEK-
65 UniRef50_C8NX40 Transcription antiterminati... 157 2e-37 1 36.6% 9:180 146:340 --------WYIIQSYSGYENKVKTNLDMRIQTLEVEESIYDVVVPIEQVFEkkNGKKKIVKRKLLPGYVLVRMDLNDAAWSVVRETPGVTSFVGNEGNA-TPVKHRDVAKFLMpmPEQEEKPNVAHDFQVGEAVTILSGALASVSATINEIDPETGKIQALVSIFGRETPVELTADQIER-
66 UniRef50_P52852 Transcription antiterminati... 157 2e-37 1 37.6% 8:180 126:308 -------EWYVIHTYAGYENRVKTNLEPRAVSLNVEDYIFQAEVPQEEVVQIKNGDRKTIKQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYD-PYPLTLDEIVKMLAPEapQRKVEVQVLDFEVGASVTVTDGPFATLQ-TINEIKSDSKKVKGLVEIFGWETPVELSFDQIQK-
67 UniRef50_B9CLA2 Transcription antiterminati... 156 4e-37 1 39.0% 7:178 3:180 ------KRWYVLHTYSGYENKVMNDLEHRVEAYGLQDAVVDVQAPGEMVTEVKKRGEKDveVKFYPGYVLVRMELDDNTWSVVRNTPGVTGFLGVDG-KPSPLRREEFNKMMRRSgdATTLKRVTTDVEVGQSVHVLSGPLADFDGIVSEVNAESGKIKVMLTIFGRETPVELTLDQI---
68 UniRef50_C2KN14 Transcription antiterminati... 155 5e-37 1 39.9% 8:180 90:278 -------RWYVVHTYSSYEKRVKQNIEQRVANngMEEWIYQVEIPMEEHIEVKAKSRRKVLRPRIPGYVLVRMDMEENSWRLVKDTPAVTGFVGNQQD-PVPLTLQEVIDMLAPTAAQavSTQIVTDFEVGQGVTITSGPFETMTATIAEIYPDTSKLKVLVTIFERETPVELNFDQVEK-
69 UniRef50_B3EL56 Transcription antiterminati... 153 2e-36 1 37.7% 5:179 16:189 ----SRPRWYALRIYSGHERKVKEGIELEVERQALEDKILQVYVPYEKFVEVRNGKKRSLTKNAFPGYVLIEAILDKQTKNLIMDIPSVMGFLG-VNDIPTPLRPDEVEKILEPESTVEQRSVVEAPFRVGDTVKVIDGPFSSLTGVVHDVCVERMKVKVMISFFGRSTPTELDFSQVK--
70 UniRef50_C9LQP9 Transcription antiterminati... 153 2e-36 1 34.9% 3:177 30:200 --SEKDIRWYVIHTYSGYENKVKDTLTRKVHSMGMDDTIIQILLPMHDEEEVKDGEKKVVSRKVFPGYLLIQMEVNDRSWYVVRNTPGVTGFVG-TTTKPIPLSDEEAKRII---EGKDKKQTAKTDAKVGDTIKITRGPFADRSAVVLDVSDDRSKIKADISNFGTTTTIELEVGY----
71 UniRef50_A3ZLI3 Transcription antiterminati... 153 2e-36 1 35.8% 9:181 120:294 --------WYILKVQSNREKSICANLWRRVKMAGLEAYFDEVMVPTEDIVEFKNGKKKITKRKLYPGYIVVHMAINDDTWFLVRETGGIGDFTGAAG-RPTPMLAHEVERITKKVEdgEEPVKTNIRFKLGDHVRITEGTFENFEGDVEGIDETNGRVTVMINIFGRTTPVEMEHWQMEPV
72 UniRef50_C7GYQ7 Transcription antiterminati... 153 2e-36 1 36.2% 4:180 28:197 ---DNVARWYVVHTYSGHEQKVKDNILKIVESRGMGDLILKINIPTEEKVEIKNGQRKSRKVKQFIGYILIKMKVTNESWYVVRNTQGVTGFVG-QGKKPVPLTAEEVRRL------GIEKVIVNLKIKPGDTIKVINGPFEGHNGEVIEVDEEHETLRAKIFMFGRETPVDLEYEQIDK-
73 UniRef50_B8E0K4 Transcription antiterminati... 152 4e-36 1 35.6% 5:181 2:175 ----AEPKWFVVHTLAGHEHKVKAILERQVKLNHLEDKVFEIVVPEEKVMTVKGGKKRIQVKKVFPGYLFIRMIEDEDVIRMIRNTTGVTGFVGTPG-RPSTLNPQEEHWIRRFLEQKEIRPELKV--KKGDRVYIKSGPFMGYEGFVDEVYPEKGTVRVLLSIFGRETPTEIDHTQVEKT
74 UniRef50_Q83MQ7 Transcription antiterminati... 152 5e-36 1 40.5% 8:180 36:215 -------KWYVVHSPAGFERRAKANLETRVVSMNADQAIYQVEVPMEDVVGIRNGQRKMITRVRIPGYVLVRMDLNESSWAVVRNTPWITGFVGN-MHQPVPLSFEEVFDMLKTtrQKRSVTVSDVDLEVGETVVIKTGSFAGLPGTISEIKPENGRLTVLISLFERETPVELAFDQVEK-
75 UniRef50_C7RDB1 Transcription antiterminati... 152 5e-36 1 35.8% 4:179 36:205 ---KENARWYVVHTYTGYENRVNDKIQMMIDNEQNPD-ILEVTVPTEEYVEVKNDTKKVKTRKLFPGYVMVKMNITNKSWYIIRNTQGVTGFVGPDG-KPVALTPAEVRKF----GVKDEAPILNINVNVGDDVNIISGPFEGFVAKVEEVDKEKGSIKAFVDMFGRDTLIDLDFTDIE--
76 UniRef50_P36265 Transcription antiterminati... 152 6e-36 1 39.9% 3:180 17:203 --TPSEGHWFAVQVASGCEKRVKLNLEQRIHTLDVADRILQVEIPKTPIVkrKDGARVQGEEKIFPGYVLIRMIMDDDAWQVVKNTPHVINFVGSEQKrpMPLSHGEVERIFRHVDE--QEPVVKIDMEIGDHIMVLSGPFKDFEGDVIEVSPERSKLKALLSIFGRETPVELEFTQVEK-
77 UniRef50_C1A6N2 Transcription antiterminati... 151 1e-35 1 37.9% 6:179 3:179 -----EHRWYAIQTTSGHENKVQRLIQRKipAQPEDRLIRQALVPTQQVVEIKNGKKVTVERKIFPGYVLVEMVASQDTLHEINAIQGVIKFVG-KDKDPMPLRDDEVRRLLGQADPADETprEEIPFLVGQAVAITEGPFADFNGTVEEILPDKGKVRVSVSLFGRPTSVELDYLQLR--
78 UniRef50_Q2JTQ7 Transcription antiterminati... 151 1e-35 1 38.7% 8:180 40:221 -------RWYAVQVASGCENKVKSTLMQRAAALDVADQIVEVVIPKRTGFKlrSGKRQEQEEKIFPGYVLVRMDLNDDTWMVVKTTPNVINFVGTEERrpRPLSPSEVQRIFSSVE--VEEVPLKIDMAPGDRIEVLSGPFQGFYGEVVDVSPERGKLKALISIFGRDTPVELEFGQVRK-
79 UniRef50_B1VAN1 Transcription antiterminati... 148 7e-35 1 30.9% 2:179 24:201 -TEAPQFRWYIAQTYLGYENTVKQDLLRRVESLGIGELISNVLSPRETYYETrdGKKTSKERNLYPGYVFIEMIITDHSWFVVKNTPRITGFLGSSgsKPIPLSEKEINPVLFKMGIMS---KPNYDHLIGKKVEIISGSLANQQAKVSIIDNDREKIIVEVDLFGRTVPVEISFSDFK--
80 UniRef50_A6GCJ0 Transcription antiterminati... 148 1e-34 1 43.5% 12:179 1:171 -----------MNTFSGYENTVKKSLEDRIKKNELEECFEDILVPSEQVIEQRGKRQVKQTRKFFPGYIFVRMRLTKPAWHLVKNTPKVSGFL-SSGKTPKPVSQREMDRMLGKTEpeEEVVVPDIDYSVGDQVRVKSGAFANFSGEVEEVNTEKRKIKLSVSIFGRPTRVEVDFSEVE--
81 UniRef50_Q2S1Q0 Transcription antiterminati... 147 2e-34 1 39.1% 1:179 1:182 MAEDTETdwYVLRTFSNHEKKVRRYLESEIERIGLEDQVEEILIPTETVFEMKGGEKKTKEKTFFPGYILLNCTLTSDLRDLAEDLPSVIGFltGTGDEPTQLREEEIKRILGKMDRAEEmeQPEMPFKVGDPVKVVDGPFDSFNGIVEDVYPDQMKVKVMVSIFGRKTPVELDYLQVE--
82 UniRef50_A7BC06 Transcription antiterminati... 147 2e-34 1 40.7% 9:180 73:253 --------WYVIHTYSGHERKVKANLEQRITTQNMEDYIFAVEVPDEYVMEYRGNAKKRVRHVRIPGYAIVCMDFNEASYRVVKETPAVTGFVGDQ-HNPVPLSIDEVVMLLTPndQPAPVQAVQTQFEVGEIVTVTDGPFETMSATISEIMPEAQKLKVLVTIFERETPLELGFDQVEK-
83 UniRef50_Q9ZK20 Transcription antiterminati... 147 2e-34 1 40.7% 9:180 4:174 --------WYAIQTYSGSEQSVKKAIENLANDHDIRDRIQEIIVPTEDIIEvkKSKTKVMERSLYPGYVFIKVDLDTVLWHKIQSLPRVSRFIG-ENKKPTPLSEADIGHILEKM-NNRAAPKPKIFFEQGEVVRVVEGPFANFTATVEEYDVEHRKLKLNVSIFGRTTPIEILYSQVEK-
84 UniRef50_A5TS63 Transcription antiterminati... 145 8e-34 1 35.4% 1:181 1:193 MSVENVRKWFMIHTYSGYEKKVKTDLEQKMETLGFREVVTNILVPEEELTEIVRGKPKKIYRKLFPAYVMLEMEATRevWYEVRNTNGVTGFVG-VGSDPIPMEEEEVKNIFNIIGVKTPKETIKIDFAEGDYVKILKGSFKDQEGQVAEIDNEHGRVKVMVDIFGRMTPVEIEVDGVLKV
85 UniRef50_Q1Q133 Transcription antiterminati... 143 2e-33 1 40.5% 7:179 3:180 ------KEWFVLRVQSNREDKVRDNLVERIRAQGMESLITNVLVPSEKISEVKGGKKRVSDRKIYPGYIMVEIEVDeeVWFTIRETSGTGEFIGGQ-SKPVPMTKYEVEKLLSDLDQKEERPRAKIEFNEGEKVRIKEGPFENYDGIVEEVLPASGRVKVMLTVFGRATPVELEYWQVE--
86 UniRef50_C9RQP0 Transcription antiterminati... 142 4e-33 1 36.8% 8:181 4:177 -------QWYAVHTFTGQENNIKKRLEQMIEREGVQDKFGRIIVPTREVVSNVRGKRRISVQNLFPAYIIIEMELDELTQHLVSTINGVTHfmTRASRVPIPLRQSEVDRLLGVDPENSIEGEIQIPYTIGENVCIKEGPFKGFVGVVDEIMEAK--IKVMVSVFGRSTPVELAFNQVESA
87 UniRef50_C7NC81 Transcription antiterminati... 142 5e-33 1 33.7% 6:180 15:204 -----EKKWYIIHTYSGYEKKVAADLEKRIESLDLTDKVFRILVPEEEVLEEKRGKQVKVSRKLFPSYVMIEmrVDSDAWYVIRNTNGVTGFVG-VGSDPIPLSDEEASNLLAKIgeGETSPRIDIDFKVGEVVEVKGGSFDGQQGEIAEIDYEHGKVKVMLEVLGRLTPVEVEHTEIAK-
88 UniRef50_B9KHV6 Transcription antiterminati... 141 9e-33 1 34.4% 2:181 5:186 -HDDSGHEWYIVQVSSGSEEKVAQMILERSQQLGMSGVFSEVFIPYEEVTKVKYNKKVAMRRKLSPGYVFLYMRLSDDAINFVRRVPKVSNFLLDDAGLPKVIPASEMETMRSSMCrsSEAASEVCSFEVGDEVVINDGLFQDFNGRVEYVNEDKKVAGVSVMIFGRLTKIEFKLSSIQKV
89 UniRef50_O83264 Transcription antiterminati... 141 1e-32 1 39.7% 7:180 3:184 ------KEWYILHTFSGREARVERAVRMLVEHARIpnVIFDIKIPEELLTEVKDGKKRVVRRKFFPGYLLVEMDLPEVDWreVRRIPGVSGFLGSSGnkPQAVSADEARRILQKAGegDRTPRIAQTFLVGQQVRIVEGPFATFSGEVEEVMSERNKVRVAVTIFGRATPVELELVQVEA-
90 UniRef50_C7PUF8 Transcription antiterminati... 141 1e-32 1 35.2% 5:180 17:194 ----QDTKWYVLRVVSGKEKKVKEYLDIEVRRSDWGNVITQIFLPVEKVYKVQAGKKVMREKNFYPGYVMIEakMTDEVIQSIRNVSGVIHFLGKD--KPIALRKAEVNKMLGKVDesDNGLTMSEPFIVGETIKIIDGPFNDFNGIIEEVIEDKKKLKVTVKIFGRATPVELNFMQVEK-
91 UniRef50_Q7UMY8 Transcription antiterminati... 140 2e-32 1 34.6% 1:179 42:223 VDDESPMDWYILKVAFNREDSIAEALRKKVRMEDMGEYFGDIVVPSEDvtFTRDGKRRVSKRKLLPGYIMVYMSINDDTWFLVREVGGISDFTGSAG-KPQPMEPEDVERFINRpdEDETPIKTAIPFKVGDRVRVKEGNFENQEGEVDVVDEANGRVTVIINIFGRSVPMELDHWQVE--
92 UniRef50_B3ETZ5 Transcription antiterminati... 140 3e-32 1 33.9% 4:180 2:184 ---KTDPKWYVLKVVSGQEKFVKYHLDSELERRKLQDYVAQILIPSEKIYEMRAGKRQTRERNFFPGYLILHADLSdrVLHTIKDIPNALGFLGVRgsQPIPLREKEINKILGRVDEIAEDDNgeKPFIVGETVKIVDGPFSGFTGNIQEVFEERKKLNVIVKIFERNTPIELTYTQVEK-
93 UniRef50_B0A697 Transcription antiterminati... 139 3e-32 1 37.4% 1:179 1:177 MSEIQEAKWYVVHTYSGHENKVKATIENSVKNRGMEDYIKQVIVPTEDVIetKTGKEKVRQRKIYPSYVLIQMIITDESWYIVRNTKGVTGFVG-PGSKPVPLSEEEVKSMGIDLDKIGEK---RTEIEVGEVVNVRDGVFKGQSGVVKELDLKNEKVKISvnGTSGELSLELDLKSIE--
94 UniRef50_C0W699 Transcription antiterminati... 139 5e-32 1 35.0% 1:180 57:262 MSSLP-GEWYVLHTYSGYERRVAADIMARAENFELEDYVFDAVVPMETVIEVkaGKKKEVSRVRIPGYVFVRMDlsDRVWRTIKDTPAVTGFVGDRYN-PVPLTFDEAVSQLGPTPEEVAAKqyEVAFEVGESVIVTDGPFESLPATISEIHPETQKLQVLISLFGRDTPAELSFTQVAK-
95 UniRef50_C4V5M2 Transcription antiterminati... 138 9e-32 1 32.9% 9:178 18:182 --------WYVIHTYSGYENKVKANLERLMHSASMSEMIFDVVVPVENEIEVKDGKEKVVPRKVFPGYVLVDMIVDEHSWYVVRNTTGVTGFVGSE-KHPIPLTAEEAERILS--GSVGAEPKRRTKVNVGDTVRITSGAFEDYAGKITSIDMSSMGVKVDVD--GKSLDVEIDQVEL---
96 UniRef50_Q5GRY4 Transcription antiterminati... 137 2e-31 1 33.7% 3:180 95:275 --EFNKYKWYILRVASNYEEKVCQHVLENSMRLGVNDYFKEVFIPYEELSEVerSKKAAMRRKCFPGYVFLYVDLCDEVLNFVNNIPkvYGFLKN-GSVPKVISDDEIYSMCNALYNAQETKKLSHGYEKGEKVKINDGLFQNFTGKVDMINDEKKIINIEVSILGKPTIIELDLAQVEK-
97 UniRef50_B0VGC6 Transcription antiterminati... 135 7e-31 1 32.0% 8:179 2:173 -------KWYVIHTYSGHENKVKTAIEKGLAGTPLEKQVGRLLVPVRKTFVIREGKKIERDKKLFTSYVIMEADMTPELKTYILQIAGVTSFLgkEHKEPIPLSQEEVDRLLGITDPNRDIKVYS--YMPGDMVKVISGPFTDFEGIVQKTTENGTKLIIEVTVFGRRTPVELNASQVE--
98 UniRef50_A4WZX9 Transcription antiterminati... 135 9e-31 1 21.9% 4:181 8:173 ---PDTAPWYLVQTKPNAFRIAERNLLR---------QDFSVFSPTQNQTKKHGTRFRHTVQQLFPGYLFVRFNPEFPQWRAINATYGVSRLVTF-GNIPSPVPHALIAGLRQRCANDGTLLPPE-QLSLGDRVRIISGPFADYVATVEQIEPDK-RVWILLDILGGQTKTQIQIAALQKA
99 UniRef50_O51355 Transcription antiterminati... 134 1e-30 1 37.8% 9:180 5:183 --------WYVVQTYSQYEKKIEQDIRLLINEGVFGGVVLDVKAPIEKVEEIRNGKKRIRERKIWPGYILIELDLPEVGwaNIIKVQGVINFVgsKGQRPIPINDEEVKsmLTGEIKANKSIFMLYDFEEGERVRIKGGPFDSFEGLISSIDYERKKLKVAVQIFGRSTPVEVDFQHIEK-
100 UniRef50_A6FV14 Transcription antiterminati... 132 6e-30 1 26.4% 1:178 1:166 MTLEAQIRWYLVQFKPNSHKIAARNLQR---------QSFQTFLPMQDVTRRRAGKFHTAPQPLFPGYMFVSLDTIRGPWRQINATLGVSKLVSVAG-RPQPVPDTLVNALLERCDDDGKLLPPET-FSPGEQVTLRSGPFASFVATVEKMQPDR-RVWVLLEFMGQATRIQVDADIL---
101 UniRef50_A9ND88 Transcriptional activator R... 132 6e-30 1 21.3% 1:178 1:164 MSTDSD--WYLIYTKPRQERIAEENLER---------QGYRIYLPFIQVNRRRLGCYQLITEPLFPRYLFILLNIDKDNWGPIRSTRGVSALVRF-GGIPAKVPPDFVQ-FLKNNETSASVPPKVSLFQKGQRVQIIDGVMAGYEGVFEMYSGAK-RVTLLLDMVGKVTRVEVPLDSV---
102 UniRef50_C8WIE4 Transcription antiterminati... 132 7e-30 1 26.6% 9:181 2:169 --------WYVAQVQAGRESSTLEMCRRLVPPSVMED----CFMPEYEVMWKIRGEWRLVKRLLFPGYLFFVTDDPEALNRELSRVPMPIRLLGNEENSFFPLTGKERDWFLSFM-DGNHTVRMSEGYISGDKITVTRGPLMGFEGDIRKIDRHKRRAYIDVSLFGRTVPASVGLEIVRKS
103 UniRef50_Q4A951 Transcription antiterminati... 131 1e-29 1 27.0% 8:181 5:188 -------KWYMISTISSKEDTAISLLKNRIKYENLEEHFQEItvPYYEENPNKPGEKKLKYRNLYKGYFFIKMNMVDKAWFVVRNTQYVTGLVggRGTKPTPISPRQFERMRkqILNFQQTNDGTINWEIGDWVKVTHGPFSDDFGKIIEMNVTKTLITVELevFGRRTPATFEYKNLKKV
104 UniRef50_C7RAP1 Transcriptional acivator Rf... 130 2e-29 1 27.1% 1:181 1:167 MSEC-EKSWYLINSKPKQELRALEHLK---------NQEINCVLPVLEVERIIRGKRQKAIEPLFPGYLFVELQTNGQGWSKIRSTRGVRDFVRF-GGVPGRVPDSVLEHLL--ILDTSFTPIETNAPGAGDKVIITDGPFKDLEGVF-KISNGEKRSIVLLTILGKVTEMELENKQLRKA
105 UniRef50_A3WUF1 Transcriptional antitermina... 130 3e-29 1 26.5% 1:181 1:170 MTASGQ-QWYVVQTHPHAEGKAAAHLRR---------QGFEVYLPRYARRRRHARRVDITASPLFPRYLFVAIDLVHQRWRAIRSTVGVTNLV-YSGDEPAPVPDDVVRRLKQREdkGCVQLDLAPRFSAGDTVRVVDGAFSDCLGLFESMS-DGERVLVLLDLLGRKVRVTMDIDTIEAA
106 UniRef50_Q2LVW1 Transcription antiterminati... 129 3e-29 1 27.9% 9:180 3:166 --------WYAVHTRSRHEDKVFTGLVQKS---------ITTFLPKIEVWSKRKDRRKRIMTPLFPGYLFVDMplDNQAKLDVLKTFGVVRILGktGSAPIPVPDDKIDAIRRIV-DSRVEVQNLQYPHVGEAARIVDGPFKGIEGTVIKTDYDKDLFVVTIELLQRSVAIKLDSSQIEK-
107 UniRef50_A0LIY4 NusG antitermination factor... 129 4e-29 1 23.2% 5:181 37:202 ----DTKSWFALYVQVKHEKEVVRRLDQKS---------IDCFLPLMECWSKRLDRRKRITLPLFPGYVFVHTVLDNYTNVNILKTPGALSILKNSEG-PLPIPVYQIENLQTIL-NSSKSLDLHPYLKEGEWVRVIRGPLSGCVGILKRHAPKKGRLVVSVDCIRQSVSVELDVEDVEAT
108 UniRef50_C4XFX3 Putative uncharacterized pr... 129 4e-29 1 27.4% 1:179 1:200 MEddKNFQWYMISTVSGKEDKVVEALKNRIISEQVEDCffKIftPKELEKQKNGEEYKVKYVNMYSGYIFINMDMTDRAWFIVRNTQYVTGLIGSSGrkPTPVSQHQIDKSFKklQEDFDKGVTHTKFQIGEIVEIIDGPFKGEQGRVLECSEANKKVTVEIEYLGKKTPADFEYKEIK--
109 UniRef50_A1WZB7 Transcription antiterminati... 127 2e-28 1 23.7% 9:181 15:175 --------WYLVYSKPRQEERA---------WWNLDHQGFRCFLPMARFRRRRQRRYQTVIEPMFPRYLFIRLAAGLEDWSPIRSTTGVSGLVRF-GTWPARVPDGLVDTIRARIEDGHCDLAPE-PLQPGERVRVLDGPFQSYEGIF-RASRSDERVMILLDVAGQHTTLTVSQHQIERA
110 UniRef50_A6F1J5 Transcriptional activator R... 127 2e-28 1 22.7% 9:180 3:159 --------WYALQHKPSQGDRALTHL---------QNQDIACFYPKITVEKIKAGKRTKQLEPLFPGYLFVNLEQTDPMWAKLRSTRGILRIVSFA-NKPAAIPDDVIQHIK----DSLHTVAEQGGIKPGQAVELDEGPFKGIEAIFQAYDGE-ERAIVLISFMQKQQTVKVPLSTLHR-
111 UniRef50_B1I6V9 Transcription antiterminati... 127 2e-28 1 27.2% 8:180 4:167 -------QWCAVNTKPKKEDFAARQLEAK---------GLEVFLPRISVTRKRGASKFSLWEPLFPGYLFVKLLPEPVQVQRVNWTPGVRRLLC-AGDTPVPVPDEAIALIRQRVGPGGrtPKPQAEFPAGSRVAVRHGPFAGLLGVVEKPMSGRGRVRVLLELLQRQTAVEIDAVDLDR-
112 UniRef50_A5CC98 Transcription antiterminati... 127 2e-28 1 35.8% 8:180 10:180 -------QWYIIRT-SGSESSIKQTILEKAAKKGIAHCFEEIIIPGIQVVKMKRGKAINVNKKTMPGYILIKMDMIDQVKDFMQKVVKLNRFPGNE-SKIVQVTEKEVQEMMVQLENKAQDPSFLEKYQIGEEVRVNDGPFETFVGRIEEVDYAKKILKLSISIFQRSTELTVDFSQVEK-
113 UniRef50_Q2ST07 Transcription antiterminati... 127 3e-28 1 29.0% 4:179 15:209 ---EAKGQWFVISCQTGHEEKVLGDLQQKIKSASIEDEVFSIKISKANQVSKSG---KASIKNKFPGYIFINMIMSEKAWFLIRNTPGVTGFIGSSGrkPSPLTIEETLNMLVPNIEEIQQAhfTADFKIGDIVKVKSGIHENEEGTVKDMDYSKGVAFVAIEMFGRWTTLEVSFKNVE--
114 UniRef50_C8VZE8 Transcription antiterminati... 126 3e-28 1 29.3% 8:181 2:164 -------HWYVIHCLTGHEEDVRSRVKEK--------DIARAVVPRRLMVERRQGGWQYVERVVFPGYVFVQAHMTPAAYYAMRNLPGVIRVLG--TSRPVPLMGNEVTLFLKLCRDGDPLGLSEV-FVKGGSVKVISGPLMGLEGHIVKLDARRFRAKVNISLMGEPRIVELAVSVIKKT
115 UniRef50_C6PET8 Transcription antiterminati... 125 5e-28 1 26.0% 4:180 2:174 ---EDGEKWYVIYTRTGDELKVKRLIELLFSKLN--KKPIRVLIPKRAIIERKGKKRVEKIKFLFPGYVFIKTNMCFEIYYEISKLPHFLKFLKDEM-EPAEVRDDEIRIILSLVGDSD-IVGFSTGIKIGGKVKIIDGPLKGFEGLIEKIDKRKGRVKVRLNVSGNANLVDLGIHIVEK-
116 UniRef50_Q1QVL5 Transcription antiterminati... 125 5e-28 1 22.2% 2:181 12:181 -DTAARPRWYVVQCKGGESFRAGEHL---------TNQGYRVFHPVLEVQKKRRNKLVWIAEPLFPHYLFIHLDRVASNWRPIRSTRGVLKLVGF-GDEPLPVPDALIETLAArhLDEASRTSGNAYFRPGEIVEITEGPFQALQAVF-DTQQGDERAIVLLNMLHHQQRLELPVGHLRRS
117 UniRef50_O84322 Transcription antiterminati... 125 7e-28 1 39.1% 8:181 3:175 -------KWYVVQVFTAQEKKVKKSLEDFKEASGMSDFIQQIILPSENVMEVKKGEHKIVEKYIWPGYLLVKMHLTDESWSYVKKTQGVVEFLG--GGAPVALSEEEVKNILADLEEKKSGVVQKHKFEVGSQVKINDGVFVNFVGVVSEVFHDKGRLSVMVSIFGRETRvdLEFWQVEEV
118 UniRef50_Q8R8A2 Transcription antiterminati... 125 8e-28 1 27.5% 3:180 10:177 --TKEKPLWYVVFTYHNAEKRVEEHINSLAKTEKYDGLIIKAEVPVQKRTVSRRGKIKEIEEKIFPGYVFVKAVMTPEVMAAIRRINGVAHFVGG-GNEPVPITPEEVKR-------ARIQDDLSEEFKAGDTVMITDGPFENFIGKIIKI--EGRKINIALSLFDREMGIDFSPEQIMK-
119 UniRef50_Q82X31 Putative transcriptional ac... 125 9e-28 1 21.8% 8:181 2:164 -------HWYLVHTKPKQEKCAFQNLQQ---------QGYRCYLPMLPVEKLHLGNLTVVDEPLFPRYLFIQLedSAKSWVPIRSTRGVNRLVCF-GSEPARIDDILIDLLR--MQEASFQHKPERLFKPGERVRLTEGAFAGIEG-IYQMAEGERRVMVLIELLSKPVAMRVSPTSLRKT
120 UniRef50_C8WL22 NusG antitermination factor... 124 1e-27 1 23.8% 9:180 4:170 --------WYVVQTVGGQEKHVLDLINKLVD----EELIQESFIPQYEVKKRIQGVWKMRSEVLLPGYIFVITDQPGKLREALRSVPKFTRLLGNND-VFTPLDDQEVAFINAFTKPDHRVVEFSSGVMEGDEIVILNGPLMNQTGLIKKLDRHKRLAYLEIEILGRVKTVKVGLEIVRK-
121 UniRef50_B5Y935 Transcription antiterminati... 124 2e-27 1 32.8% 7:180 2:180 ------KKWYIVTTVHGKESAVAEAIKLRAENAG-NTAISDVLVPKEWRLEYRGKKPrrVQRVIYPGYVFVEVeiDPETWSLIRYTPGVRGFISTPDHTPIPVQDNEMEKVL---QKSREQEAVKVDLQTGDEVEVRDGALKGLTGVVVDVDHEKQKVFVKISMFGREVISDLDAVQVRK-
122 UniRef50_C3RLT4 NusG antitermination factor... 123 2e-27 1 19.0% 8:181 4:172 -------NWYVIQVRTGKEEKIKNTCEKLISRDILE----ECFIPKCIRLKKYQGTWKEVDEVLFKGYVFMISDHIDELFNKLKLIPDLTKVLGNDGEFICPI-LKEEAIFLLKFGKEKHIVDLSQGYIEGDKINIISGPLVGYEGMIKKIDRHKRVAYIEVKLFDQITMVQVGLEIIGKS
123 UniRef50_D1AXH4 NusG antitermination factor... 123 2e-27 1 28.7% 7:180 10:189 ------KKWYIIHTYSGYEKKVKTDLEKRIMSEDLNDKVFRILVPEEKIFEEKKGKMVPVFRKIFPSYVLVEmrVDSRAWYIIRNTNGVTGFVG-VGSDPLPMDEKEVEEIFSKMSNEDFQEK--LEYEVGDYVK----TLDGIEGTVEHIDYIAKQIKIVIQVGSRPTTLTLGLNEVTK-
124 UniRef50_B3PLY8 Transcription antiterminati... 123 2e-27 1 25.7% 1:179 3:194 MNNQDKakWYMISTVSGKEDNVVESLKNKISTQDMDECFKEIKIFkeLEKKSKGEEYKVKYLNIYKGYIFINMIMTDEAWYLVRNTQYVTGLIGSSGkkPTPISTRNFEKMVQklAEKFAAGDIETVFKEGVIVKITSGIFKGEMGEIVKNNDITQKAFVNIEQYGRKVPTEIDHADLE--
125 UniRef50_Q3J8A9 Transcriptional activator R... 123 2e-27 1 17.8% 1:180 1:171 MESSPSSkwYLIYCKPRQERLAQENLER---------QNFETYLPLVRQMRRRAYRRIATVEPLFPRYLFIHLDTEKDNWGSIRSTIGVISLVRF-GAQPAHVPDTLIRELQTHEGSDGIQDLASPDFRKGQQVLVEEGLLAGHEGIWL-TSNGKKRAHILLEIMGKQIKTEVNENWLKR-
126 UniRef50_Q3KCF2 Transcriptional activator R... 123 3e-27 1 21.3% 3:180 5:169 --SSDQPNWYLLQCKPRQDERAHLNLLQ---------QNYVVFHPQLVSERVIRGKRQRVQESLFPGYLFIQLSR-DDNWAPLRSTRGVSRFVEFNHG-PATVAEHVIEHLRARCLESTLSEPDEA-LKPGENLQIVSGPLAPLEGVFLGL-HGTDRVMILLQFLNREQPVCLPLSVIER-
127 UniRef50_Q48H23 Transcriptional activator R... 123 3e-27 1 22.9% 3:181 4:166 --SAQEARWYLIQTKPRQEARAEEHLRR---------QHFQCYRPLQVDVKKTA-ARVQADEPLFPGYLFIQMDQVQDNWYPIRSTRGVSRIVTF-GGHPVPVRDHLIEQIRQRLS----TPAPKARFIQGDPVMITTGSWSDVEAIFLSED-GTERAVILLNMLQRQQKMGLPISSLSRV
128 UniRef50_C1DDG1 RfaH n=1 Tax=Laribacter hon... 123 3e-27 1 24.6% 3:181 5:171 --SEEKMHWYLVHTKPRQEQCALQNLQQ---------QGYQCYLPMLATEKLRQGRLVVSEEALFPRYLFIRLGlsDKSWAPIRSTRGVNQLVRF-GTEPARIDDGLIERLRGH---DAARANPEPLFRTGERVRLTDGPFAGIEGIYQMTDGE-SRVMVLIEFLTRPVVARVAPGSLRKV
129 UniRef50_Q0ACI7 Transcription antiterminati... 122 4e-27 1 19.3% 1:181 6:177 VTEQQEHrwYLIYTKPRQEEAARDNLGR---------QGFHAWLPRVRVVKRRGTRRVPVVEPMFPRYLFVELDSAYQDWSPISSTLGVTSLVRF-GGVPAKVPGPLVAALQARADEDDidLSARQQPRAGDTVRVAHGAFAGYEAVFQA-RSGRERVLVLLEVAGKQSRVTLPADDIDPV
130 UniRef50_C2NS75 Transcription antiterminati... 121 9e-27 1 24.1% 9:178 6:173 --------WYALCVRSGYEDLVESLILR-----DLNETLVSVLVPKKTVPEKRKGHFKWVTRKLLPGYILINTSMDAKMYYKLKEIPNCYNFldDDDIYFLEIPDQEITPIIQLLNDRGTIECSEAYFE-GSKVIVKSGPLKGREGIIRRIDKRKKRAKLLLNFLGDTKMIDVGVEFL---
131 UniRef50_C4FB35 Putative uncharacterized pr... 121 1e-26 1 22.2% 19:180 13:169 ------------------EDRAAALIAKIA-----QGAVDDCFVPKREVTHRKSGQWHRILEKLFPGYVFVRTSAPKQIREALGRVPAFTRMLTSAGDTCLPLTADEVAWINAITNVDTHVMEMSEGVIEGDCVMVIRGPLKGHEARITRIDRHKRLAWVDMDMFGRHKAIRVGLEIVSK-
132 UniRef50_C8WIA3 NusG antitermination factor... 121 1e-26 1 23.3% 9:180 2:168 --------WYVVQTVAGREFAVCRLIESLVEDDVLQ----ECFVPRYEVQKQFRGQWRTCTATLFPGYLIVVTDRVDELESQLRRVPAFA-WVLSNDGGFVPLERDEVAWIDAFTEKGHRTVGVSEGVIEGDRIIVLKGPLVGREGWIRKINRRKRTAYLEIDMFGRTIQTKIGLGIVRK-
133 UniRef50_Q1Q029 Similar to transcription an... 121 1e-26 1 23.2% 3:179 2:166 --EKNVAYWFAVHTRSRHEKQVDSFLREKN---------ISSFLPLVKTISRRRDRKKFIDVPLFPGYLFVNITLDN--LYEIKSTRGVVRIIGNEDdiPSPIPDAEINNL-KTLINSNVAIDPYKYLQKGTKVRVVSGPLIGLEGLLVK-RKTNYRVVVSIDILQKSTSAEISIADIE--
134 UniRef50_Q4K6G2 Transcriptional activator R... 121 1e-26 1 20.3% 9:180 84:238 --------WYLVQCKPRQDLRAEENLRR---------QGFHCYRPQRGCERVVQGRRQSGTESLFPGYLFIALEH-DASWAPLRSTRGVNRLVAFNG-QPLAVPVSLIESLRQRVTDMDTSLPY-----KGTRVCITEGCFADLEAIFESSIGD-ERVVLLLTLLNQQRRIELPLSSIRK-
135 UniRef50_UPI0001692BF2 putative transcription anti... 120 1e-26 1 20.0% 9:178 3:173 --------WYVLFVTTGKEDVVGKYISNFCNHLSLQ-----CFIPKKVVPECHKGVRRDVIRVLFPGYIFIRTTMSSNLYYLLKEIPNLHYLVNSGDRkySAIPEEEMEWIRDLTGNRDTIEYSEVSI-INKKVKVISGPLKGKEAMIKKVDKRKRRAKIEVTLLNKTNLVDVGINIL---
136 UniRef50_Q0F316 Transcriptional activator R... 120 2e-26 1 22.2% 5:171 2:160 ----SDKQWFAIRVKPRQESLAAANLER---------QGFEVYLPMINTRISHAGKVSWQPRPFFAGYLFVHLSIDEQRWTTIRSTVGVLAPVAFGTFYP-PLSDQVIALLQARHDENgvSSTPESPFRAGEKVRMLDGAMKGLEGVFIEM-RGQDRALILLDWMKKSMRV----------
137 UniRef50_C8PLY0 Transcription antiterminati... 120 3e-26 1 23.3% 10:181 4:171 ---------YAVQVKTGKEPE----LLKKIRKLNEENHEIQAYFPRRVLYIKKKGIRQKVDAPVFPGYIFLEIDDLSLPLCWqrKTPNFYHFL-PNNQNPLPLVDNDLSLLHHFLSFGEVTAPSKVYFDANSRICVIDGALKGLEGKIIKVDRRKQRAKVLLDMYTDSFPIDLAFDVIEPA
138 UniRef50_A0KGQ9 Transcriptional activator R... 119 4e-26 1 21.3% 7:180 19:181 ------KKWYLAYCKPKEEARARAHLEA---------QGIESYYPMVEIEKLRRGKRVPVREPMFPNYLFIYVDLEEVTPVTLKSTRGISRIIHF-GREWTSISSQLVYQLMSRDDSDEARASYASLPTQGDKVLIESGPLAGFEAIYLEPDGDK-RAILLVSLLNQETSSSFDNQSFRR-
139 UniRef50_C5EKF0 Predicted protein n=1 Tax=C... 119 5e-26 1 24.3% 8:180 3:169 -------RWYAVQVRTGREEAVLQLSKKMIDGSVLK----ECFIPYYERMKRYQGEWHKEQYILFPGYIFLVTEQVDELFWELKKVPGLTKILG-DGMEFVPIKEEE-KVILQKMGGSDHIAEMSKGYVIGDIVTVISGPMKEMKGKIKFIDRHKRLAVIEIEMFGRKTEVRLGLEIVMK-
140 UniRef50_D2C1D2 NusG antitermination factor... 118 7e-26 1 17.9% 9:181 4:162 --------WYLLYCKRGQLLRAKEHLER---------QDVVCLSPMIALEKIVRGKRTEVSEPLFPNYLFVEFDPEHIHTTTISSTRGVSHFVRF-GNLPALVPQQVIEDLQHHQCTTHVDPETP---QPGDQVTITEGVFSGLEAIYTEPDGEA-RSMLLLNLLNKQVRQSIDNRQFRKV
141 UniRef50_Q982S4 Transcription antiterminati... 118 7e-26 1 28.1% 3:180 8:180 --DGPEARWYVLRV----EDRADIAVDKLLGEANVERVMLHTECEAKRRGRRKHQSLEPVRVPSFPGYIFVKVVSCAATWAGLRTVSGVLGPIGGCDG-PSPVSEQEILKFQARIENDPEAIAVLTnlKAGDKVSIDSGPFAGFEAVVL-MLGDKHKVHVEVDIFGRKTPIGFALAEVTK-
142 UniRef50_Q0FE68 Transcription antiterminati... 117 1e-25 1 19.1% 7:179 3:163 ------KEWFILQFKPNSHHQATKNLTR---------QGFETFLPLTDITSRKTSRFINTTRPLFPGYMFITFDRTKPEWHKINNTYGVSRLVTFNSN-LKSIPTTLVENLMVRCDLSSKILPVE-NLKKGDQVKILHGPFANFIATVETYETDQ-RIWVLMDLMSRKTKIQTPLDALE--
143 UniRef50_B8FH43 NusG antitermination factor... 117 1e-25 1 20.6% 5:179 8:169 ----NTKQWYALYTKSRHEACVNNYLAARS---------IESFYPQMRILSRRKDRRKMIDVPMFPGYLFVRAALRSRQHLSILKAPGAVTLIGNTRGAIA-IPEDTISSLRIVSQK--EALETGPCYHAGDLVLIVSGPFAGVTGVFMR-NKGGGKILVNIDALGQSVAVEMGGADVQ--
144 UniRef50_C0ZGR2 Transcription antiterminati... 116 3e-25 1 24.9% 8:180 2:175 -------KWYAIFVESGKEEVVQKYLR-----LYFNEQSLKSIVPKRLVPEKKSGIVYNVLKNFFPGYVLIQTEMTNEMFHKIKKIPRSLRLVNneGAYYSSIEEKEITPILQLMGNGEVVDYSKVYLE-NSKVIVESGPLKGLEGIIKKVDKHKNRAKIFLTFMGVEKTIDVGIEILSK-
145 UniRef50_Q7MMR1 Transcription antiterminato... 116 3e-25 1 23.1% 7:179 2:165 ------KKWYLLYCKRGEQIRAKQHLE---------NQGVECFYPTIEVEKILRGKRQIKSEPLFPSYIFVRFDFegPTFTTVRSTRGVVDFVKF-GAHPKELQGDLIYELKLLEQEGHQSALQGSNlkPGDSIKVKSGQFAGIEAIFQEQDGET-RSIMLVKMISQTVPVSIENSDLE--
146 UniRef50_A1T084 NusG antitermination factor... 116 3e-25 1 17.8% 8:181 4:167 -------QWFVVYCKSREELRAQRNLE---------NQGVYSFFPKICKEKILRSKKKVVEEPLFPSYLFVNISKNDEKFSAIRSTRGINNFVKF-GLSIATIPDQQIKKIEQLCHVNNKLAVNSEdyQNGDKIEILSGPFKGLTAIF-NIEDGLERSMLLLKILNQDNNISFKNSALKKV
147 UniRef50_C6LL07 Putative transcription anti... 116 4e-25 1 21.9% 3:180 11:182 --KEETEVWYVMQVQTGMEERICAQCRRKISETVLE----QCFIPRYEVKKHIQGEWKTQKQILFPGYVFVVTSDIQNLHEELKKVIGLTKLIG-TGREIVPISENEKEFLLGFGGE-EQVVQMSEGIITGSQVVIHSGPLKGKEGYIRKIDRHKRKAWLELPLLGGMQNVQVGLEIVCK-
148 UniRef50_A5IXI2 Transcription antiterminati... 115 5e-25 1 29.8% 9:179 6:195 --------WYMISTVSGKEDKVVESLKNRIVSEQVEECFNqvLTTKEAEKKALGEPYKVKMSNMYGGYIFINMDMTDKAWFVVRNTQYVTGLIGSAGkkPTPVTKKEIDLAfkQLIEDFNAGKIIDKFTVGEIVEIIDGPFKGTIGKVLEANESIHKVTVEVEHFGKKVPTDFDYSVVE--
149 UniRef50_UPI00016C58F1 transcription antiterminati... 115 5e-25 1 32.6% 4:181 21:223 ---ENKKKWYAIKVQSGREDTIKAAILRKIAIEGLEDVFGQIMVPVEKVIEKKaeRKVERKVKKFQGYIFAELEFNDRLLYLIRETSGVGDFLknDTPVPEPMSDAEVKQMleKVGPEKGPTKVKVDFEKGDRVRIKEGSFKDSEGDVKDVILPKdkVIVTVTFWGRPLDVELEYWQVTKA
150 UniRef50_Q5QWY1 Transcription antiterminato... 115 5e-25 1 21.2% 1:179 1:163 MNELESDVWYIVRTKPKQEERAILNLE---------NQGFGVFAPELTVKKVRRGVRTSVVERMFPGYVFVKPDDIIEQFYKLRSTYGVAGVLRFGDNIPK-VPQRWIDQMR-----GVDQLTDEQAPQIGDTVEIQQGPFRGFLAKIVKLDGE-SRCFVMLEWMQKEVKANFSYKELQ--
151 UniRef50_B4D2H1 Transcription antiterminati... 115 5e-25 1 23.5% 2:180 13:180 -AEIPEAKWYCLRAQPKHEHIAAARLRQCEE--------IQVFCPRVRIQRSTRRGLVWFTEALFPNYLFARFEWV-QSHALVRSCQGVSGIVRFGDHVP-EVPAGTLDDLRAYMEDA-ELKTVSFNIDEGDDVEIVEGPFRGQNGVVKQLLPARERVKVLLEVLGGATEVDLCLTSVFK-
152 UniRef50_Q2WBC3 Transcription antiterminati... 115 8e-25 1 19.2% 9:180 4:165 --------WFVVHTHANAEKIAAGHLQR---------QHFDVYLPQYSKRRSHARKVEWVKAPLFPRYLFLRMDPDLTPWFSIRSTVGVHSLVCR-GGMPVPLGQVIIDEIRGREDDSgvSLGEAMPFASGQRLEIVEGPLAEQLGLFQGLD-DMNRVVLLLDLLGRQVRVRVPLEAVRA-
153 UniRef50_B6GCE7 Putative uncharacterized pr... 115 8e-25 1 21.9% 4:181 32:204 ---SQEVPWYVVNVPTGRESALCKVIERIAP----EGVVRECFSPLYSTQIKRGGEWLDVEKTLLPGYVIVATEQIGRVKRLLREVPEYTRVL-NMGESFVPLADGERAWIDAFTRKGERCVPMSMGVMEGDHVVVVSGPLLGREACIKSVNRHRSIAYVELEICGRRVTTKVGLGIVSRA
154 UniRef50_A6GM36 NusG antitermination factor... 115 9e-25 1 21.1% 7:181 14:179 ------AQWYVMYTKPRQETVALENLQR---------QNYNVFFPQARVQKRKTGqtVQVVEPLFPRYMFIQLEVGVSDFSKLRSTKGCVDLVKF-GGKPSVVPIELIELIQHQLDSDSvdLLKLNELEVGGEVRVAEGPFEGMMGKIAARKSDQ-RVIVLLNVLGAERSVELAQSQLDKA
155 UniRef50_Q1YPV4 Transcriptional activator R... 115 1e-24 1 23.1% 9:181 4:167 --------WFLLQTKSKQEGRAVENLER---------QGVKSFCPMIKVEKLSRGSRVVKEEALFPGYLFVNFDQSSVSSTTVRSTRGVSHFVTSAGL-PVKVPESLINQLMLRTDAGNDETVSSLP-SKGERLQIIDGPFRGLNAVFSQPDGDR-RAIVLINLLNQQVSASLPFASleRV
156 UniRef50_A4EGG1 Transcriptional antitermina... 114 1e-24 1 21.1% 1:180 1:170 MNDRNEKlwFVLQLKPNGLSLARTHLAR---------QGFLTLMPLREVSQHARYGLRTVRQPLFPGYLFFSVTARQINWPAAANTRGVTRIVVGTDGQPARLPADIAAGLLAITTEDG-MLGDVADLQTGDQVGVVNGPFAGWMAKVVSADTP-DRIQLLVDVMGRETAVNIAGRDLEK-
157 UniRef50_C7PUS0 NusG antitermination factor... 113 2e-24 1 19.4% 6:180 12:172 -----DTKWYVAYTRANFERKVAKDIV---------DQQIEHYLPLRRETRKWSDRLKQIEVPLFPNYIFVKIKLQHKV--NILGIPGVLSLVSFSG-QPVSVSEREIQHIRK-IEERGQDIALEYYYCVGDRVRITQGIFTGMEGILLR-KSGQMRFVLKLPAISQAVSVEIEGDQLER-
158 UniRef50_Q2CAE9 Transcriptional antitermina... 113 3e-24 1 19.1% 29:180 10:161 ----------------------------RLATQNLARQGLAVFCPLQQASRRIRGQIRSVTKPVFPGYLFVSLAPAGGEMRAASYTRGVARLVTLDESGPKAVPDALIEELqrCTPEGILGPPEADQLDVGDRVWVTDGPLAGQVSRIIALAPEA-RIWLLLDLMGRQTRVAVKREAVRR-
159 UniRef50_B9XAW5 NusG antitermination factor... 112 5e-24 1 15.3% 2:178 27:192 -ATDGEPAWYCVRSKPKHEHIAAANLSKL--------QVVETFNPSLRSRKATRRGPVWMTESLFPNYIFARFPF-EQMFDEVKYTRGVSSLVHFGTGYP-EVPADVIEELRRNFPANELKLSSEVP-TAGDQVTITSRALFGLQGVVLRTMPAQRRVQVLLDMLGQTSAVELNLNSV---
160 UniRef50_B4S8Z4 NusG antitermination factor... 112 6e-24 1 23.6% 1:178 1:166 MDETGNLCWYAVYVRSRFEKKVHLLLQEK---------GIVSFLPLVDTWRQWSDRKKKVSMPLFRGYVFVRIHYRQD-HPFVLDTDGVVKFIG-IGRAASVIRDRDIEWIKILTGEPDVRKEVLPLLPPGKQVKVIAGPFVGLEGVVRK-DGRESKLVVYFESIMQGIEVTINAEYL---
161 UniRef50_A6DRM3 Putative transcriptional ac... 111 1e-23 1 18.2% 6:181 3:167 -----EGDWYCLYTKPRQENLTAQS---------ALDAGFPTFNPKIEVRKVRRGKATYVHAALFPSYVFIQA--NEGNLDKARYLRGVNRIIGFGRDGESLKIPAVILETLSTFLEDNVYKHDMHELKDGDKVQVLDGPLKGVEAIFKKGLKDGERAVVLFELFSNYQEAKVNIEDLIKS
162 UniRef50_C6XVK8 NGN domain protein n=1 Tax=... 111 1e-23 1 16.3% 3:180 7:171 --TSDIKKWYPVYTQSRAEKKAYQALLSK---------GIEAYLPLQRQLRQWSDRKKWVEEPLIKSYLFVHIARQQQTEVLM--TTGISRFIYFSG-KIAAMPDRQIEELKLLLASPYELEITEERLLPGEKIEIKAGPLKGIRGEIIEY-RSQKQLLLRLGDISHSIVVNVSASLIER-
163 UniRef50_Q01XJ6 NusG antitermination factor... 111 1e-23 1 22.3% 4:178 15:175 ---EPALPWFAVKVRSNFEKKSADILREK---------GYQEFAPSYPSRRYWSDRVKVIDQPLFPGYVFCRFHPN--HFLPVLQTAGVVQIVGF-GGKLAPVDEVELASLRTLM-NSSLPISQREFLHVGRKVLIRRGPLAGVEGILEEI-RKGYRIVVSISLLQRSVTAEIDANWV---
164 UniRef50_B9YBP8 Putative uncharacterized pr... 110 2e-23 1 18.5% 8:180 2:169 -------NWYVLFVRGGMEEKIRD---------FFLSQGLNAFIPKMKVVFRKQGISELVEKIMFPGYLFIESemDEQIKELRMQKTGIVKLLKFD-KEGTPALRSEEKDYLERLLGKNKVLEHSTGLIQGNQVIITEGPLQGFESQIVKIDRHKRRAVLELELCGQPRRVSVSLEIVQK-
165 UniRef50_P0AFW1 Transcriptional activator r... 110 2e-23 1 16.9% 9:180 4:161 --------WYLLYCKRGQLQRAQEHLERQA---------VNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRF-GASPAIVPSAVIHQLSVYKPKDIVDPATPY---PGDKVIITEGAFEGFQAIFTEPDGEA-RSMLLLNLINKEIKHSVKNTEFRK-
166 UniRef50_C5CGE4 Transcription antiterminati... 110 2e-23 1 36.9% 51:180 219:352 --------------------------------------------------RKEIKIFKITRTRLYPGYIFIEMIMTDETWNLVKSTPNVVNFV-SNGGQPIELKPKEIKALLRLveEKTRPIKVEVDFEVNEMVRINSGPFEDFVGKITEIDPERQEVKVVVSIFGRETPVMLNLSEIEK-
167 UniRef50_P29397 Transcription antiterminati... 110 2e-23 1 42.7% 50:180 217:351 -------------------------------------------------TRKEIRIYKTKRRKLFPGYVFVEMIMNDEAYNFVRSVPYVMGFV-SSGGQPVPVKDREMRPILRLaeEKKKPVKVELGFKVGDMVKIISGPFEDFAGVIKEIDPERQELKVNVTIFGRETPVVLHVSEVEK-
168 UniRef50_B0P702 Putative uncharacterized pr... 110 3e-23 1 21.1% 7:177 2:163 ------AKWYVLQVLAGQETAVRDAL---------HIMGIRAAVPQEERLLRKNGGWTSRIYTLFPGYVFLSLEYSAENYYRVKAVPHVLRFLGFSGLSPSCLTHLEAEWLRLLSNGGEPLKPSRVEELPDGSVRIMEGVLQNFPVRSIHFDRRARRARVGITLCGEPKILTLSMGS----
169 UniRef50_C7PGB9 NusG antitermination factor... 110 3e-23 1 22.2% 3:178 2:163 --EQKTHTWYAVYTKPRWEKKVADALVRK---------QIETYCPINRVTHQWSDRKKIVEEPLFKSYVFVRIPEDKKT--LVRETSGIVNFV-YWLGKPASIPDHEVELIKRFLREYQDVQVERFPIQEDDLIRITAGPLMHQHGRVVE--AGKNTVKAVLYSMGFSLIATVKTSDL---
170 UniRef50_C0QI35 Transcriptional antitermina... 110 3e-23 1 21.0% 4:179 2:167 ---SQEKSWYTLLTKSRFENVVFNDIQKKS---------IEVFLPKIKKRSQRKDRKLMIDVPLFPGYLFVNITLDPVTHLSVVKTTGAVRLLGYSSG-PVPVPSAHIESLKIVTGTGLDVVSGTInlQKGERVLVVRGPFSGVKGEFLR-HKGKDRVIIKIETLGQFAGVEIDREDLE--
171 UniRef50_B5YJ95 Transcription termination f... 110 3e-23 1 22.7% 8:179 7:167 -------NWYCIYVKSRHEFKVFDRLTK---------AGIEAFLPAVERLRRWKDRKKLIKFPLFPGYLFVCIEKSYELMLKVLKTPGVVTFIKTPSGEPEPIPEEEIVPLRKAIENGREIDPY-PYLKEGQRVKIKSGPLAGATGILKK-KEKQHFFIISIHILQRAVSVKIDASEVE--
172 UniRef50_B8KUX9 Transcription termination f... 109 6e-23 1 18.9% 7:170 21:170 ------RRWYVVASKPRSEGVAKSQLER---------QGFVTCAPRIKLRKRQRGKWQQVIEPLFPGYLFVALRLGVDDPAPIRSTLGCIGLVR-MGREFVPVPEAVMQPLLSI---GESPDASEAVFQPGQAVRFEAGPFEGLSGIF-KMPKGQDRAEVLITLLGSSAR-----------
173 UniRef50_B6TZG2 Transcription termination f... 108 6e-23 1 26.3% 7:181 103:327 ------PQWWLVRV-SMAPGTDYVDLLTKAISRRYSEVPFKIYNPSIQVKRrkSGAISVKSKPLHAGLVFLHCTLNKELHDFIRDTEGCYGFIGATVgkPKPIPVDEVESIIREEKEEQERVDREFefSPGATVHVLSGPFADFTGSILEVNRKNKKATVQLSLFGKESFVDLDFDQIEVV
174 UniRef50_C6Y0K9 NGN domain protein n=1 Tax=... 108 8e-23 1 18.5% 4:181 5:167 ---QQEKNWYVVVTYPNLERKALLNLLKNN---------FIAFLPLQKVQRKWSDRKKTIEIPLFPNYLFININEKDR--FEALDIYGVKRYVTF-GGRPAFISETDILNIKRIVESVDLYIEHS--LVKGDAVKIIGGPFKDMIGILFK-KSGQARFGIRVESMNQTLSIEICHTLIRKV
175 UniRef50_A1VS68 NusG antitermination factor... 108 8e-23 1 20.0% 2:181 16:184 -STDSESLWFLAHTRPRLETVALQNLQQ---------QGFDVYLPLYKRLKKIDAGMQAVFEPMFSRYVFFRTTSLAQSIAPVRSTRGVAQIVSF-GSEFATIRPDMLDAIRQLEqrNAADVAELSTLRPGHLVRFCNSALSGLEGVVKSVSS--CRVAVLLEIMGRQQLVRVDHHQLVAA
176 UniRef50_B1KMD8 Transcriptional acivator Rf... 108 9e-23 1 20.6% 7:181 4:179 ------KAWYLLYCKPRGEARAVHNL---------TLQNIDTYLPTIGEEKRVKGEVSIKRIPLFPGYLFINIDPQVTSVARIHSTRGVGRIVGcdDSIIHSIRLREHKLLSELLPASELSQksTVEINPGDQVKFTEGPFADLEGIFAEKSGDK-RCHVLFEIMGQKKRVSVPRDSIKPV
177 UniRef50_Q04WD1 Transcription antiterminato... 108 9e-23 1 19.6% 1:179 1:170 MIENSKVnwYALYTNPRAEKKLKRLLQER---------KIECFLPLISKKKKWSDRWKVVEEPMYPSYIFVKISFFQDR-VKILQLPGAHHFV-FYSGKPYVIPDEDLNLIRIFLepDRIQVEIQERLLPGKKILIQEGPFAGFKAEIIQRKNEKQ-IIVKFPGMNLMTSVTLDIKTLK--
178 UniRef50_A7Z6E4 Transcription antiterminati... 108 9e-23 1 23.7% 8:180 2:175 -------KWYALFVESGKEETVQKFLR-----LQFDEQALYSIIPKKKVTERKAGIKYEALKKMFPGYVLFKTKMTERTFHKIKELPISCRIVNNGatYFTTIKDEEILPIIRLIGEGDTVDYSKVYIE-NSKVTVASGPLKGMEGIIKKIDKRKRRAKICLSFMGLDKMVNVGIEVLSK-
179 UniRef50_O67757 Transcription antiterminati... 108 1e-22 1 40.0% 46:180 116:247 ---------------------------------------------KITCKENKTEAKIVLDNKIFPGYILIKAHMNDKLLMAIEKTPHVFRPVM-VGGKPVPLKEEEVQNILNQIKRG--VKPSKVEFEKGDQVRVIEGPFMNFTGTVEEVHPEKRKLTVMISIFGRMTPVELDFDQVEK-
180 UniRef50_C6QI43 NusG antitermination factor... 108 1e-22 1 23.7% 6:178 12:172 -----KPCWVVVNAQAHREFVAASNLKK---------QGYEIYAPVIRKTTRHARISRESLTPLFPGYLFARWTAPDMRWRPILSTVGIRSIVRN-GNEPSRLDGAIVDALKAREKDG-VIVRAESQREIGQIVRFARGPFDGIAAEIVELC-DKDRLVVLMTLLNRPTKVTVLEDQL---
181 UniRef50_B8I511 NusG antitermination factor... 108 1e-22 1 17.8% 8:181 16:187 -------HWYVLFVKSGREHRVEQYLKKIV-----GIDMINPFIPLHEFLFKISGTVKRELKPLFPGYVFIESDMarKLYNKIYLLSDIVRILKYSDTEIAVRDSE--KQMLLDLCNNEHCIESSRGVIKGDRIYITNGPLRGRESIIKKVNRHKRQALVEMEFMGDKRLVSVALEIVEKV
182 UniRef50_Q3AU98 Transcription antiterminati... 107 1e-22 1 22.9% 1:179 1:168 MAEIITPqwYAVYVRSRYEKKVYQALLER---------EVNSFLPLYETIRQWSDRKKKVSEPLFRGYVFVNIAMQQESI-KVLDTEGVVKFIG-IGRKPSVIAEREIEWLKKLVREPEAISRTVASLPAGQKVRVIAGPFKDMEGVVVK-EGRESQIVIYFDSIMQGVEVSIYPDLLQ--
183 UniRef50_B6GA74 Putative uncharacterized pr... 107 2e-22 1 19.4% 6:180 2:171 -----RVQWYVIQVMKGREDSMASLIGRVVPKSLLQ----EVFSPKYETEIKVRGRWVPVQKTLLPGYLIAVTNDPEGLEAVLRDLPEFARLLA-QGNEFVPLAPAEVEVIGSFTSPGKRVVPMSIGVKDGDRVVVTGGPLVGHEAMVKEIWRRKSIAILEVNMCGRVVTTRVGLGVLSK-
184 UniRef50_B8IAM8 Transcription antiterminati... 107 2e-22 1 29.8% 4:181 87:255 ---ERGRRWHVMVAKPRFARRAAKDLTKAGIPAVLTDERVE--------LVEESGRRRIVKRPLLRRVLFVGLPRCAAPEVVHRETYFVRDAVRDGCGRAIQVPADQLRRFVRALAD-TLTERDPNAFEPGDEIRIKSGPFASFHGIIEDADYATRRLKVAVEIFGRPSPVGLDFSEVERA
185 UniRef50_UPI000197AEF0 hypothetical protein BACCOP... 107 2e-22 1 26.0% 5:181 2:168 ----EKENWYAMYVRMHHEKKVAEKLGQ---------MGVEHYLPVQEVVRQWSDRRKKLQVVVIPMMIFIRAS-EQVRLSVMRNIPSVSglIDRCTHRPAVIRDEEMQRFRFMLDYSEEAVHfnTPLAPGQKIRVIKGPLAGLDGELTEID-GKSQVMVRIEQLGYA-SVEMPVGYVEAT
186 UniRef50_A6FES1 Putative transcriptional ac... 107 2e-22 1 19.0% 1:179 1:167 MAD-DKKDWYLLYCKGKEEPRALINLK---------NQGIESFYPTMTVEKKLRNKLICQEIAIFPNYLFVAIDKNTANFNSIRSTRGVIDFVKC-GANYTKVPAALVTELRATQRCRDKSANEVTVFSEGETVIIQDGAFKGIEA-IYQCKDGLERSMLLINLINHSTTMSVANGEIK--
187 UniRef50_A3V684 Transcriptional activator R... 106 3e-22 1 24.3% 4:180 5:168 ---DDTAAWHIAQLRPNGLLMALRNLER---------QSVAHFAPTELRTERRGAKFVTRDVPAFPGYVFVQPSAASGGVRAVNSTRGITKLVT-LGQGPAIVPAGLIAALRIRFAPPDITPAPQ--FDQGDWVRILDGPFAEFVAQV-EATPAAERVYLLIDLMGRATRVAVDARSLKR-
188 UniRef50_Q10BA7 Os03g0825500 protein n=3 Ta... 105 5e-22 1 25.1% 7:181 104:328 ------PQWWLVRV-SMAPGTDYVDLLTKAISRRYPELSFKIYNPSIQVKKrkNGSISTKSKPLHPGLVFLYCTLNKEVHDFIRDTEGCYGFIGATVgkPKPIPVEEVESIIREEKEEQERVDREFefTPGASVHVLSGPFEGFTGSLLEVNRKNKKATLQLTLFGKESFVDLDFDQIEAV
189 UniRef50_A0XZ39 Transcriptional activator R... 105 6e-22 1 15.8% 9:179 4:159 --------WYLVICKPRQEERAKANL---------NNQGIEAFYPILTTEKLVKSRRTVKQVALFPNYLFVCLDSKNGPFAAVKNTRGIGGFVTY-GANYQVVPLAIIEHLNNHTSNTVE----SQLPKQGDAVSVSNHSFKNIDAIYKEPDGD-MRSILLINLLNKQVEMSVDNTDIE--
190 UniRef50_A6TKC4 NusG antitermination factor... 105 6e-22 1 22.6% 12:179 1:159 -----------MHVKSNEEMKAKKLVEKEIED-------IKVIVPQRIIPEKRQGETRHVKKILFTGYLFLNVELDVDTYYKLKRIPSIHRFLGLE--KPEAIPLEEMQRVLRLCNQGELIGLSKVIVKEGNKVQVVSGPLLGMEGHIIKVDKRKGRAKVCLSVLGDAKTVDLGIEIIK--
191 UniRef50_A3XR75 NusG antitermination factor... 105 6e-22 1 25.3% 8:173 2:153 -------NWYVLYVKPQSEKKVASALEK---------LGVKVFCPTLEEVRVWSDRKKKIQVPLFKSYVFVCLPNTERQQVF--AVPGVVRYL-FWLGKPAVVRDEEIAAIQDWLSDEAVADVQVRTYTPGTEVKIAAGHFKGQKGIVQEV--GRKRLKMVIKSLGVIVEARL--------
192 UniRef50_Q01TC5 NusG antitermination factor... 105 7e-22 1 20.3% 8:179 18:175 -------QWFALSVTPK---------LTQLVLMALEHKGYECFTPLQSSTRKRRDQVADMQVPAFPGYVFARIDVRFRL--PVLVTPGVRGIVGY-GRQPAPVDDGEIFALRRVM-QSQLPAKSAPYLRTGDRVQLVEGPLSGLTGLLIQ-QKGANRVLVQVTLINQALAVDVESAWVR--
193 UniRef50_Q6MDM6 Transcription antiterminati... 105 1e-21 1 43.1% 64:179 1:115 ---------------------------------------------------------------MWPGYLLIKMNLSDESWQYVKNTNGVIDFLG--GDKPTPLTDFEVGEILKDLEDKKRKITQKHKFEVGDRVKITDGVFVNFIGTVTEVFHDKGRLSVLVSIFGRDTRvdLEFVQVE--
194 UniRef50_B3DWJ1 Transcriptional activator R... 104 1e-21 1 20.0% 9:178 11:168 --------WYCLSIQPKKEKLAVENLKKEN---------IEVFFPQFQYQKIRSRKTSLVLEPLFPGYLFAKFNLYSK-LTFVRSTKGVRKVVHFGSSYPV-IPDSFIEELRIQFGEEG-IKTIRERIDVGSTINIAEGPFQGYSCIVLGFIPAKERVRVLLEWLGRAVQIEVNLKEI---
195 UniRef50_C8QDS8 Transcriptional acivator Rf... 104 1e-21 1 21.6% 8:174 3:156 -------NWYVAQTKYAQEKRAQQQLL---------SQGVTCLFPVFSEVrqNGGIRRIAEQPLFPNYIFVRFDPEVVHTTAIKATRGVSSLISF-GGLPSVVPDSVIIRL---NQGWERAPLNTDAPVHGDRVVIRDGAFEGLEAVWYEPDGLK-RAMLLLTLMNREVRVPVE-------
196 UniRef50_C3MAS1 Putative uncharacterized pr... 104 2e-21 1 20.7% 8:181 3:168 -------HWYVVRTRAGQQQKA---------TREFEDNGVTVYCPMLRRETRHFQSKKwkECPLFTGYVFAYLRISD--FGTLREMRHVLSVLADAGGTPIPVAGNIVEDIRDAQERGDFDvpPVRRLKAGDTVQVKDGPLTGHYAAVTNI-VGRRAIKAFVEIFGSLREVEIGLESIRRV
197 UniRef50_C7PT75 NusG antitermination factor... 104 2e-21 1 20.0% 9:178 8:165 --------WYLLYTRPRQEARVAK---------EMADKNIQIYLPYTTVTRRWTDRIKVLEVPLFPSYVFVHLTNMHE-FYYGSNLESACSYVRF-GNEVARVSDAAVDAVRTIAKAGNNLEVSSERFTPGQQMMIKEGPLCGLNCEVIQY-KGKDKILVRVHMLQRSIMADMPASVL---
198 UniRef50_A6EBM5 Putative uncharacterized pr... 104 2e-21 1 15.1% 2:180 4:169 -TERDIKKWYPVCTQSRAEKKAYSELTRKN---------ITSYLPLQRQMKQWSDRKKWVEEPLIRSYLFVHISRQQQAEVLM--TSGIARFIYFSGH-IASMPEQQIEQLKLLTASPYELEITENNLLEGEKITIKAGPLQGMSGEVVAY-RSQKKLLVRMTELNHAILVHIPASLIGR-
199 UniRef50_Q3SSD1 Transcription antiterminati... 103 2e-21 1 25.1% 5:179 31:209 ----QPKYWFILRTHPGCERKVMREFERRN---------ISAYCpqQRVVRRVHgiKRLVQVPLFPQLVFV-----PDFERVPADIGGVSGWLRFGGWRARIPSERemADIHALVaaNTPQSKRAARFEIGALVRIVDGPFRDFSGRIERLD-SKGRLKVAIEIFGRLSPTEMSEAQIE--
200 UniRef50_D2QI92 NusG antitermination factor... 103 3e-21 1 21.5% 9:180 3:160 --------WYVLCTKPRKEKFLAKLLAEK---------QIEVYCPLIRRKRRWSDRIKTVEEPLFPCYCFVNVKESERADVFV--TPGIVRYL-YWLGKPAIVKDKEIDLIKLTLNQFDHDLIHLESFNPKDKVVINSGSFMGQGGTV--VNQQGIKVLIHLDSLQLCIRVDTSKTLIAK-
201 UniRef50_C7PTI0 NusG antitermination factor... 103 4e-21 1 17.9% 2:180 8:172 -TQQRESKWYVLYTYPLFEKKIGRQLAL---------IDIIHYLPVKTEVRKWSDRLKRMEVPLFPNYIFVKTNLLNKT--PILGIPGVVRFVSVEGRAIA-ISEDDINKIRQ-IEQSRQDVEIESVYNTGDKIRILNGVFSGLEGELYK-RSNRLRVLIKLPVIAQAVSVEISNCDIEK-
202 UniRef50_Q1QKQ8 Transcription antiterminati... 103 4e-21 1 27.2% 9:181 7:194 --------WYVLQTRPAHEDKAARGLVARGFDPYAPVVYRRV--PTGRRDDKGRKLTREIARPMFPGYIFVQFDAGDEKFAEVRIVPGITGYLKDEAGEPQAVPDVAMDLIAVSETEesKRKRGPPEFKAGDDVRVVRGEWKDWIMKVSKAD-DLGRVVLLFHIFGRETKIHADQADLEVA
203 UniRef50_Q73PT3 Transcription antiterminati... 102 5e-21 1 17.0% 10:180 4:171 ---------YVVQVSTGKE---KNFIEDAEFKNKFDELSYSIVFPQRILKIRKAGKVTEKQLPVFAGYLFIGTdiSKDLYQHLRKCKGFYRFL-PNNQEPKFLEGRDFEILNQFISFGGLAKISQVVFDENDRIKVIEGPLSGLEGYIVRVNKRKGRATVCLDMCQTAFSIDLGFEILNK-
204 UniRef50_C7PS65 NusG antitermination factor... 101 8e-21 1 19.4% 9:168 8:155 --------WYALYTMPRHEKKLHTRLSELNVTS---------FLPMTRMLRTWHDRKKYVEMPLFPSYIFVYLN-NIEHYYNVLNTNGALYYVK-TGNELSRISEQIIHYIRIVSEQSTGIELSADYFPPGKELLISSGPLAGFSCEVVSYKNS-EKILVRVSLLQRS-------------
205 UniRef50_Q98R28 TRANSCRIPTION ANTITERMINATI... 101 8e-21 1 20.0% 5:179 2:190 ----NKFNWYMISTIPNKEKEVIEAIKNKVVSENLEAYFSDFKiaKELEKKQAGDSYKTTKKNMYNGYIFIEMVITNETWFLVRNTENVSGLVGShgAWPTPISKLKFKKMIEEETKKEEEFQLSLnfREGLFVKIVDGPFKNDEIviKKTNHEKKYSILEIESLGKSVDTQIDHKHLK--
206 UniRef50_B8IIP1 Transcription antiterminati... 101 1e-20 1 32.4% 8:180 58:229 -------RWHLVDCRAGKARQFADALAAGA---------IPALRLSEEVVRVRSGRPIRTRMPLFGRLLFVGLdhSEDAHWLRDKYDREIKGVRFRDEKFMLVPGRELDQFTGVLGGDVPPAERRtdFEIGEAVRVADGPFASFSGLVEEIDAESQNLKVSVSIFGRSTPVTLEPTQVEK-
207 UniRef50_Q1ITB0 Transcription antiterminati... 101 1e-20 1 23.7% 5:181 10:172 ----DELHWFAVQTRHRHEKRVAERLRQ---------SEIETFLPIHrvHRWKNGINAEVNLPLFPGYLFTRLRGSQRI--PLLREPGVI-AIAASSNSPTPIGDNEIAQLR--LVAESVKAEPHPFLAIGQQVKVVAGPLFGMEGILIR-KKSEYRVVVSVKIIMRSVAVDVSELEIEPV
208 UniRef50_A3I2H8 NusG antitermination factor... 101 2e-20 1 21.7% 5:179 2:163 ----NELKWFVMYTASRSEKKVAKRLR---------ENGKEVYLPIIEEIRQWSDRKKKVEKPLFNGYVFVKTTRNQ--LWECLQVPGAVKFVHFSGQH-ATVRDEELETIERIISTGVAVESDGSVIEAGEKVEVIGGALQHMTGEVIE-KGNKDYFLIRIPSIYQNMLVSIPRKFLQ--
209 UniRef50_D2LJZ0 NusG antitermination factor... 100 3e-20 1 17.0% 1:176 1:164 MLLPVNSKWVVLTTHPHRENFAVENLAR---------QDFTAYCPMTVKHVRHARRAYDAPRPLFPGYVFVEHQSAFQYLRPILGTYGVRSILR-IGDSPAVLPVGFIESLKAREMDG-VISKPEAPLKAGQTVTISGGPFDGLVGQILEF-RERDRVLLLLDLLNQQTRVQVEAK-----
210 UniRef50_A4YU22 Transcription antiterminati... 100 3e-20 1 24.3% 9:181 31:199 --------WYILRTHPHCEAKVMKAFRLRNISAYLP-----VMTVSKEFRRMRRGFEWIERRDVVSPLIlvLIPDFEERWQCWRGVDGAVGLLRFGEWTP-RLTPKLFQDIRKIEDIANTPkkRARAFEVGQLVRVLSGPFRYFSARVERID-SRGRLSVGAEIFGRITPIDIDEGEIEAV
211 UniRef50_B1AJM2 Transcription termination/a... 100 3e-20 1 21.3% 6:179 23:247 -----RHQWYIVTVVSGNEQKVIENIKDKLNGYGYGDKLSDLKIIKEKIKEVkyRCTKIKEGNKFNGYIFLKAEMTDQIWFLIRNTQMVTGLVGSSGkkPIPVPEDKILKLIADNDAKrhEDENFTNFEVDQEVKIIADTFFGEIAKIAKIDQNKKIATVEFEFFGRINTLDLNFNDIQ--
212 UniRef50_Q1D5E3 NusG-like protein n=2 Tax=M... 100 4e-20 1 22.9% 5:179 7:164 ----AENDWVALLVRVNHEKVAAAQLGKH---------GYEFFLPTYTPPKSSGVKAKL---PLFPGYLFCRYQPLN-PYRIVRA-PGVIRLLGGDAG-PEAVPAQELEAIRR-VADSGVSSNPCDYLRVGQRVRIIEGPLTGLEGSLV-TSKSQLRFIVSVGLLQRSVSVEVSAEQLE--
213 UniRef50_Q7D1F8 Transcription antiterminati... 99 6e-20 1 26.4% 2:179 8:186 -NQPGKHEWFVVETKHKAEKAVEDALRK---------AGVKVFLPLETIGevRGRIIPAVSRPLLPGYVLVNIVYSPAAVCGIARLEGVAGFVGG-MVHPHRVSDEEMNRFKAFGDDETApvKHCEQFKRGDKVRFVLGPFASFGGNILKLRKDRAvaVVAVDVFGKVSTIEAPLALLE--
214 UniRef50_B0K4N5 Transcription antiterminati... 99 6e-20 1 25.7% 7:181 2:168 ------KKWYVIFTRSGYENKVRDIIENCFKEE------VKLLIPKRKIIERVKGQPVEKIKLLFPGYVFVNAEMSDDLYYKISEVLK-RGIFLKEGKRPAFVKEEEMKIILSLTKNSD-LIDLSKGIMEGERVKIIEGPLKGYEGLIKKIDKRKKRAKVIFSIAGELKSVDLAIEVMENV
215 UniRef50_UPI00016C34F5 transcription antiterminati... 99 6e-20 1 19.9% 1:181 1:173 MDEseVGRWAALRTAARWEKAVTEQLAA---------AGVPVFLPLLTRVSRTKSKTQTAQLPVFPGYVFCG---EREYRDSTRVPPSCRKLIAQLLRAPDPDQLKDELRSVADLLANRQLLQERVYGVIGDTVRIVGGPLAGSLGTILRLKPGTRRVLIEVSFLGARMEATVEERLLEKA
216 UniRef50_UPI0000E0F5F6 transcriptional activator R... 99 6e-20 1 19.6% 2:180 10:174 -SGPQGKVWYLLYCKAKEEGRAVMHLA---------NQGIDAFYPKANITKVLRGKRQTVEEALFPNYVFAQLDHDVHNFTSVRSTRGVIGFVK-QGKDYQKVSQALIDVFVQC---DTVDKLDSALPTKGDNVMLQHPQYQNIPAIYQEPKGEN-RAILLIHLLNKPVELVVDNSQFTK-
217 UniRef50_Q2GD85 Putative transcription term... 99 7e-20 1 22.9% 1:179 4:173 MSSSSDHTWCVLRVRSGSESKVCDLIKSRC-----SDEVVDLFSPALVKFDASASKR------FLPGYVFVKVVPGSAFLsvMRSLYGIPCRFLNQAGSPKFLSDKDIDEMRNFMLSPEVTPESG-KISVGSRVAILCEYFEACVGEVDEIDERTSKAKVKIVFCGQDVVVSFNLDQLK--
218 UniRef50_Q4A648 Transcription antiterminati... 98 8e-20 1 21.3% 3:180 2:198 --QNSKFRWYLISTITGKEAVIVEALKNRIKSENIedGPFKVfvPSITKTELNKKQkkVKWKNMFPGYIFVKADMQDLVWYIIRNTLQVtiGSGGGGEKPTPVSQNQIRKSLEKEEEAkeENKNLLNLKVGDLVLITDGNWVGNEAVIEKIIVEDNMAEISFEDFNKKVEFKINLDWLTR-
219 UniRef50_A9ECY4 Putative uncharacterized pr... 98 9e-20 1 19.8% 4:180 24:187 ---SKNRNWFVLYTAPRAEKKAKLELEYR---------GYEVFLPMTKSLRIwnRQKKLIDSVLFPSYIFVKTD--ERYLAEICRINKIATYIHC-GGKPCKVSPECIEAIKCML-SMDQEISVGNDFIEGESVRIVEGPLAGYNGVLVQ-QKSKTKFGIHLKEINQVASIEICTSALEK-
220 UniRef50_B5CXQ3 Putative uncharacterized pr... 98 9e-20 1 21.1% 1:180 1:170 MEAKKETHWYAFYVRMHHEKKTAEKLEMLKVVH---------FLPIQEVIRQWSDRKKKIKQVVIPMLIFICTD-EKGRIELLQNLPSLTglIDPATRRPAIIRNEEMEKFKFMLDFSDETIRFQSelAPGEKVEVIKGSLKGLQGELVEL-EDHSQVMIRIEHLGYAT-VEIPVGYVKK-
221 UniRef50_A6DPM2 Transcription antiterminati... 98 1e-19 1 35.6% 8:111 6:114 -------QWYTLQALSGKENKARQDLERRIEQDSMQDSVLEVLLPTEKVTTVRQGKKITQNRKFYPGYLFVNVdmKEDVWHFVKNTYGIINFLG--GDKPVPLSDDEIQIL----------------------------------------------------------------------
222 UniRef50_A7AFP3 Putative uncharacterized pr... 98 2e-19 1 21.8% 5:174 21:171 ----DKTSWYVLYTAPRAEKQVRDRINA---------LGVECWLPLHRAPRVWSDRVKIVELPLFNSYLFVRCTDPE--LRNLTRVYGVARIVYYNG-KPAVVRQKEIDAIQDFLDQASE-----HALCPGEEVEILCGAMKHVSGKVKKIK--KNHLVLYLEQLGATVCVKLD-------
223 UniRef50_A5FN19 Transcription antiterminati... 97 2e-19 1 22.7% 8:161 2:143 -------NWYVVYTKPKWEKKVAEKLTQ---------IGIECYCPLITQVKQWSDRKKKVEMPLFNSYVFIQIEDADR--NSVFEVAGIVRYL-FWLGKPAVVRDEEINVIKNSLKASNIADISVSQIQVGDKIKLETGAFSNQNAIVQEVSKTHYILVLE--------------------
224 UniRef50_Q1IKV1 Transcription antiterminati... 97 3e-19 1 19.4% 9:178 27:182 --------WSALFTYPRHEKKVAEQLLCR---------GVESFLPLYAEKRTWKNRQTVttLPLFPGYVFARFARRDRVR--VMSLPGVVSIVERAGAV-SSISDHYIEKLRAGIRLGRVRPFREAIL--GDRVQITSGPLSGLEGVLMHFRSE-FRVVVSIGMIGQSVSIEVLRDEI---
225 UniRef50_A8S2H9 Putative uncharacterized pr... 97 3e-19 1 25.7% 9:175 3:154 --------WYVVQVRTGEEKDIAAKL---------TDMGFQTLAPVENRPVRSGGAWGTKEYVLFPGYVFLQMDYNAGNYYRLKAVPGIVKLLSGT------LTYLEAEWIRLLAGQGGRPLEPTLMRETEEGLEIETGILQNFKSRIIRMDKRSLRATIELSICGEKKEVQLGI------
226 UniRef50_A6UA20 NusG antitermination factor... 96 4e-19 1 23.9% 5:180 48:218 ----GKAPWFALRVWTGREKTVEKSLDIMA---------VRSLVPMRkdLRRRGRVIEGQMMPVIHGYVLVQMMALSEYLAGLLGVEHVIDVLGGCE-RPMRLSDKEVNRFNGLARNGNFDWERPVDLVvgEPVLITAGPFCDRRATVITpkKGRGDVVVSIDFMGGEVPVTVPLALLKK-
227 UniRef50_B0UIZ3 NusG antitermination factor... 96 4e-19 1 25.9% 5:178 48:215 ----PDRVWLVARTRPRWAPRVVRDLAA---------LGLCAFEAREEVERvpDGARRRVAVPLLHRLVFLGLRDDADLARA-EAHPGVLRVLFREGRapAPILQAFADALAGRAGEGEDEAVEAVLLALGDAVRVTRGPLAALRGTIEAVDPARRRYRVALGLFGRATRVDLAAEEV---
228 UniRef50_B9HCH7 Predicted protein n=1 Tax=P... 95 8e-19 1 25.6% 7:178 109:337 ------PQWWIVRV-SRIRGDETSDVLARLLARNFPQMDFKVYAPSVKERRkkNGTYSVKPKPIFPGCVFLWCVLNKEIHDFVRECDGVGGFVgrQINKPRPVSDDDMEAVFQQAKEEQEKADIGFepKTGSTVRVVSGTFADFVGSLKKLNRKTGKATVVVTLFGKESLVELDLSEI---
229 UniRef50_A9DI26 NusG antitermination factor... 95 8e-19 1 18.5% 9:181 7:169 --------WHVLYVKSRWEKKVHNSLE---------NISIKSFLPKTKTVQQWSDRKKTILTPLFPSYVFVYIE-SPLDFHKALSVDGACCYIRF-GKEYARVTEKEINQilVDSKEIEEIELNPTFPKIGEMKKIEQGPLSGLDCEIIEA-ENYNKIIVRISSLRQNILATIPLNSFKKA
230 UniRef50_Q5LEP1 Putative LPS-related regula... 94 2e-18 1 16.7% 3:176 9:169 --KENTSCWYAVYTAPRAEKKVKEQLDK---------IGVENYLPLQPVVRLWNNRKKKIFIPVVPGCLFVHISSEEIAHVA--GIHGVA-FLLKEKGQYVSIPEVQMETFKTMIEHSCELVEfpNEFVPGTVVRVISGQLQGLEAELVEC-QGNNKLLLRVEGLG-CALVTVSTD-----
231 UniRef50_A6L3Q7 Putative transcriptional re... 94 2e-18 1 22.4% 7:180 2:164 ------KKWLVAYVRLHHEKKTAERL---------TAMNIENFLPVQEEIRQWTYRKKKIKRVVIPMMIFVHVDAAERSQVLTLSAIS-RYMVLHGEHTPAVIPDEQMERFKFMLDYSDEAVEMCtpLAPGELIRVVKGPLKGLEGELVEVD-GKAKVVVRLDLLG-CAGVDMPVGFVEK-
232 UniRef50_B9JXL7 Transcription antiterminati... 94 2e-18 1 18.3% 4:178 47:218 ---DTQARWVVARCKSGLEQVIRDALA---------EQGIDCWCPCERRRLPPRRRKpvVERPLFRGYLFVRVIPDNEAYAGLLLASRLQSLMGQDG-KPYLMPETLMRQLQLSAKAAERRHMDAGDVPpgKQVTIRSGPFADFVVTVRKVLSKRGQVVVDVPMFGGMSEVTVGVEAI---
233 UniRef50_A4E6I1 Putative uncharacterized pr... 93 3e-18 1 15.0% 26:178 1:152 -------------------------MRERIERMVPASAMQELFYPQYQTEIKVHGEWVSTTKPLFPGYLICDTADPRTVQQYLLRMDDFARVL-SQDGQFVPLAKEETQLIGSFTNRGDRVVPMSEALKDGDQVVVTAGPLLGHEGLIKTINRRKSTAYLELDLCGRRVTTRVGLAVL---
234 UniRef50_Q94AA3 AT3g09210/F3L24_8 n=6 Tax=r... 93 3e-18 1 23.4% 4:178 93:327 ---ESGPQWWAVRvlRGHET---AQILARALARQFPEMEFTVYAPSVQVKRkkNGSISVKPKPVFPGCIFIRCILNKEIHDSIRDVDGVGGFIGSKVgkPRPVDDSDLEAIFKQAKEAqeTKAKKKKLAAGSTVRVLSGTFAEFVGNLKKLNRKTAKATVGFTLFGKETLVEIDINEL---
235 UniRef50_Q6AIA2 Related to transcriptional ... 93 3e-18 1 15.2% 2:179 22:191 -DNETEGHWYAIRTKNKKEEVAK---------FNYQRQGYTVYLPLLRKTVHHARSTTEKLVAFFPGYLFLNLAPAEQNWTAIASTRGSLGALCF-GDSYIEIPGWVISDLKAREDKGLSILAkkENLTPGSVVTVNIPGLESVEAVVYSI-RGSENVDVLLNILSRQVKTTVSLDRIK--
236 UniRef50_Q1NMQ2 NGN n=3 Tax=delta proteobac... 93 4e-18 1 18.8% 9:178 10:171 --------WYAIRTKPHKEEMARQH---------YLNQQYTVYLPLMRVVRSHARRRQVVFRPVFPGYLFLRLNPETCDWAAIHATRGSIGPLRF-GEHYVPVPDWVIEGLQAREDEEGVIApqKEKLVPGCEVEVtkGFFCSFRG--------KENVEILMDILKRQVRTTVPLDRV---
237 UniRef50_UPI0001972DAA NusG antitermination factor... 92 6e-18 1 17.4% 9:180 2:175 --------WYVIQTTTGKEEELAGIVRRNVSHALYGS----CFSMKRELLKRLGGRWTAVTETMFPSYVFLETEQPERLFYELKRLPEYTRLLGDNEGCFIPIEKEEENflRRNEKETCVAGLTTLDLDEDGGIRKADGPLQFFLDKIVKLNLRKRFAVVELKVAGKEWRAMMGikDVER-
238 UniRef50_A3J1W0 Putative transcriptional re... 92 6e-18 1 17.0% 8:172 2:153 -------NWYALYTKPRNEQKVAQKLQA---------LGIIAYCPLVLSSKQWSDRKKKVLVPLLPSYVFVQIE--EQNRKDVFQVGGVVQYV-FWLGKPAIIKPNEIEALKQQLDSSIPVVHFetTWRSNETIQITEGVFKGQDAIVDKI--STNKVRLLLKSLNMYITIE---------
239 UniRef50_C8WIA4 NusG antitermination factor... 92 8e-18 1 16.0% 1:181 1:173 MPSRGRAR-YVLQVVPGRERAVAE----RVKALAGPELVRDCFALSYCILKKNQGVWRLLTETMFPGYLFVASDDIEAFEKTIKRSTAFARLLGAERRAFALRP--EEASFVHDFGGPSHVVGFSRGTIDNGRTIIDEGPLRGHVDRIKKIDRHKRIAYLDIGLLDQKQ-VRVGLEIVRKT
240 UniRef50_D1PRH1 Putative transcription term... 92 8e-18 1 19.6% 10:177 4:163 ---------YVLQVITGREKDICGRLRK---------AGIPAYCPRAVRQIRRGGRWQEQTYTLYPAYIFVQCERVVDVYYAVRREDGVLYWLGATRGTPEPLSADEEANILWLAGDGPQPVSKAVCRADGS-LDFTSGPLkeLEA-LRSVFRRERRATAVLPLHGKEHKINLSFEI----
241 UniRef50_UPI0001B49F58 putative LPS-related regula... 92 1e-17 1 15.9% 3:166 9:160 --KENASCWYAVYTAPRAEKKVKEQLDK---------IGIDNYLPLQPVIRMWNNRKKKIFIPVVPGCLFVYISSEEIA--QITSIHGVA-FLLKEKGQYVSIPEVQMETFRTMIERSHELVEfpTDFVPGSTVQVIRGQLQGLVAELVEC-QGNNKLLLRIEGLG---------------
242 UniRef50_B8IE36 NusG antitermination factor... 92 1e-17 1 20.7% 10:178 37:193 ---------YAASVAGHGEYRACEWLQQ---------AGFATLAprTAVVRQASSGKRLVRRPVFPGYAFVG-KRPEQSWRDILRVPGVRALVT-TGEAPTELPPW-MMKMLIAADEMGAYDRPRPQLAVGDKVRIRDELWQGLIGEVMRA-PEGRRIAVLLKAFGKKHVLSVDVDRL---
243 UniRef50_B7AH17 Putative uncharacterized pr... 91 1e-17 1 20.7% 7:180 8:170 ------RHWYAVYVRHNTEFRVESWLR---------EQGIEIYLPVQDVYREHAGKRIKVTKPVISGMLFVCLSRPE--LTIVEHAPNVHHFFSKRgnAPLIIPDQQMADFRFMVDLSDTSILMVNeiAPGTMVTVAKGSMQGIRGEMVKY-ESKYYIAVRLQELG-CALVSVPVSYVRR-
244 UniRef50_UPI000174528A NusG antitermination factor... 91 1e-17 1 26.1% 40:181 7:147 ---------------------------------------VETFCPRIRFQRSTPRGKVWFVEALFPSYFFARFVYSEA-HRAVKHTHNVIRIVGFGGD-PAPIPDLTIENLREEM-QGAELREVKYGVEVGDTVEVAEGPMRGLKGVVESLASGEQRVKLLLEFLGRQSLVEVQASKleKA
245 UniRef50_A9BF38 Transcription antiterminati... 90 3e-17 1 32.2% 63:180 231:351 --------------------------------------------------------------NLFPGYVFVEMMYIKETEELVSNLPYVSTIL-NIGGKPVKLNKNEVRFVLRVMGEerQVKEVRTDFELGEHVKIINGPFEYFTGKIKDFDLEKQEVQVVVTMFGRETTVTLSLGEIEK-
246 UniRef50_A4E6Y7 Putative uncharacterized pr... 89 7e-17 1 19.4% 2:176 22:195 -SQHGRVRWYLVHTPNGKERETCEKVRCIIPHNLMQD----AFVMQKEFWFKRDGAWSLQTKPMYKEYFFVATHDAAALDRALAQLSFGCRIAGSRERAYMPMPDDAQDWYRSVLDEDGVVRNSVARIEDG-VLHIEQGPLVGQEARVHKIDRRKRWCLVDvsSFREVLPLDVPIK-----
247 UniRef50_Q2RYZ3 Putative uncharacterized pr... 89 7e-17 1 18.4% 1:179 106:275 MSTSPDDnwRVFYTRARAEKKCETRLDER---------RIDVMVPKKTEVRQWSDRTKEITEPLFRNYLFARVDEKDRLR--VLRTNGIVRCVHFDG-EPARLREETVDRLQKAQAVPERLSTADLRPAVGETVTITGGplQGLTGKVLQ-HRGQTYLLVQVRAVRQAVKIEVAADWVQ--
248 UniRef50_Q1VSS9 Transcription activator or ... 88 8e-17 1 18.2% 1:170 1:156 MQKDAKKKWFVLYTKPRGEKKLSEQLNR---------SGIEAYCPTRTEVRVWSDRKKKVEMPVLPSMLLVKIE--NKQRAKALESPLAIRYL-FWNGKPSVVTQVEVDTLRSILGDSKFESHELDQLRPGQKLDMTELGFENIEGTVQYVN--KKECWVVLQGIGYVVK-----------
249 UniRef50_A9A583 NusG antitermination factor... 88 9e-17 1 15.1% 1:179 1:147 MSEEVKSHLFAIRTTGGQEKVVMRLLEAKANANQINIQ-------------------SVFWVNDLKGYVVIEAINPSDAYMAVEGVRHIRGQLRGE------LEFKDIEGYL-------VKKSTVSTLAVDNVVEITGGPFKGMKATITRIDSDKEEATVVLLDASYQLPVTVDANYLK--
250 UniRef50_Q7NAK3 NusG n=2 Tax=Mycoplasma gal... 88 1e-16 1 21.8% 1:179 2:265 MSKKSTAQWYIATTTNGNEDSVIKTLKAKVRALHFEDQILDCKVIKFRSVEevYKKYKITDTNKYPGYIYIKMEMNEAAWFAVRNTVNITGIVggKGAKpiVITPNAIIEMDRNLFNEreQVDEAIELKVGHMVDINSGDYSGLSGQISRII-DNDEYIVDVQILGKLVSVKLNKKQLK--
251 UniRef50_B8INV2 NusG antitermination factor... 88 1e-16 1 26.4% 4:181 3:178 ---DQAKTWFVVQTGPARERRVVELLAR---------EGADTWLPLFRVTTVRRGRKVDDFEKVFASYVFAGLdmRRRGTSVLFDCDHVLDVLGVD--RPLPFPADALQVlnRDETEEGRRRTEAAKIQVGEMRRIINGPFMSFFAEVEEVL-SNGIIKAGVRIFGRITPVEFTPDQLDAA
252 UniRef50_B7KSX1 Putative uncharacterized pr... 88 1e-16 1 19.0% 8:181 46:237 -------KWYVCTTAPSRELSAAASVRQalRGRREGETPFAAYVPCEFFWHRAIRsrREIQRPILRHYILVglAALRDRDREGRNVHGLAGILGAPGIGPLAMNGEGLRWLRAQGEdgATNRSASGTIQPGEDVRAGSGVFSGFLGKFIGTAEGGTVGVIALDMRSTSCEVRLPIEDVHRA
253 UniRef50_D1N7B2 Putative uncharacterized pr... 88 2e-16 1 15.2% 30:180 1:151 -----------------------------MVAQKLRNAGIACYLPVVPRAYMMHSTKVITEVPMFPGYLFLCLGRFEAADLKIREKKIVKIDLQFDEGREALLIDELHTLQRCEALAKTEPILINPGIRHGDKVLITSGSLAGLVTEVVRRDDAHDAIIVNVTLLGQHIEYRLPAEKLKK-
254 UniRef50_B0SHW0 Transcription antiterminato... 87 2e-16 1 20.1% 1:169 1:161 MSesEESAWYIVYTKPRAEKKLSELLRK---------YHIENYLPIRKERKKWTDRFKWIHVPVLPSYIFVRIVFWRD-KNKVLQLPGSVQFV-FHKGQPAIVEQNDLDVLEKGLQEYAESLKMNPelQKGKLVRIIDGSFVGKTMEIIKV---KNKTLVVCRIPGVET------------
255 UniRef50_A6X1C2 NusG antitermination factor... 87 2e-16 1 21.7% 5:179 47:215 ----DDSPWLVLQVMSGRELSVREALGKEN---------IEVLVPMkpKIRRQGREIPAKKQPVMNGYVLARCMISNECLAGLLSFENVVSILGGYET-PFLVSAEKVFVFRAKAEDGqdYEHFHRKFIGVKWARVADGPFAGCRAevSGGTKGNGLVVIEVSIMGRPVAMTVPIAILE--
256 UniRef50_Q7UWN7 Probable NusG-like protein-... 87 3e-16 1 22.9% 2:180 19:182 -EESLDSPWWLLYTKSRQEKAVIRKLR---------DAGVPHYAPMVkrFRSPAGRMRESFVPLFSTYVFLRGDDQARYEAIC------TGSVLKASEIVQVPDLIEDLQQIRSLIVMGVPLTIESQLQPGEHVRVKNGTFAGYEGTVIRRENET-RLLVFVRFMEQGVSVKLEDCQLEK-
257 UniRef50_C6QJC2 Putative uncharacterized pr... 87 3e-16 1 23.5% 9:178 3:183 --------WYAIRTNPQREFLLAGRYDENGEWrvLEKKGYdvFCPTETKFRkkKGRRVSIPvpMFCGYIFVGGRFS---WLELMAENYITAAVGFPdrRPAPISDYEMAKLREmlIPHRRSVNTHRAFRVGEMAAIAAGPFAHQVAQIAGLHGTKARVFLNLFNGTREVEVDLDMLDV---
258 UniRef50_A1RX84 NusG antitermination factor... 87 4e-16 1 16.8% 1:179 1:149 MAEKPPsrFYALRVTSGQEYNVAQLLYRRAASG-------------------KYKVYSILVVPGLKGMVFVESDALYEAQRLAYGLKHVRGVVRGA------VSLQEMEGLL-------KPKPLVDQLNVGDFVEIIRGPFTGMRGRIVGIDKSRNEVKVELAEAVFVLPVTINADDIK--
259 UniRef50_B8IEU5 Putative uncharacterized pr... 87 4e-16 1 26.3% 1:179 1:168 MDESRT--WHLVRTAPSMMGRALDTLK---------EQGIPTVVPRTVAVGHREGRPYLRRAQMFHRTVFVGVEGAADLDGKVPTARGVTRVLRNPTraPMTISGPDMAAFVAAIGITEKRKP--AGIAAGDRVVVQAGPFASFPAMVEEVLP-NERLKVAVQIFGRATPFECGHADVR--
260 UniRef50_C3RM78 NusG antitermination factor... 87 4e-16 1 15.7% 6:177 2:164 -----KDNWYVLFALVAKENKLCSVLRRK---------GLDAFIPKIEYYRR--DIKGNTLKMLFPGYIFVRSEmdNLLYELGEQRDGLIKQLKDDG--VTALRDEEIE-MFNKLLNSEGILEMSQAFIEDNKAKVIYGPLIHYQDHIVKIDKHNRIAILDIEFLNRHILAGLEIKS----
261 UniRef50_B1C1D4 Putative uncharacterized pr... 86 5e-16 1 15.6% 8:180 2:164 -------NWYVLYTLSHRTQRILGNLNKKKE--------LEAFIPSYEVC--HRYTKEITIKPMFNNYIFIKTMLNQelFNMKEDNNGLIRQLKNADT--SALTKKEIE-FFNLVLDSKHVVRLSHGYQENGITRVISGPLVAYENHIVKVDKHNCCAFLDLIFFDR--RIKLGIDILGK-
262 UniRef50_A6E8J5 Transcription antiterminato... 86 5e-16 1 18.8% 8:161 13:155 -------KWFAVYTRPRWEKKVEQQLKM---------QGITCYCPLRKVQSQWADRIKVVELPLFSSYVFVCIHPREEL--NVRLNIGVVNFVYYMGH-LAEIRHSVIEEIKSNLEkpDAEIVSMRDLEVGDRVRIKAGLMGEQEGKVLQVRGKNVLLVID--------------------
263 UniRef50_Q5LG31 Putative transcriptional re... 86 5e-16 1 18.9% 1:180 9:173 MTEKQSCHWYLAFTASRAEQRVKQELDQR---------KVRNYLPLRKITYQWQGRSREALCPQIARCVLIWTSLSDI-----RQLSGISGLIIPQNIWDYRVPEWQVESYQLLFSQMDTAVEWIPdlESATMVRVTGGPLTGLVGELDTSDTG-FRIRIRFHSMG-CFRVAVPEEWIEK-
264 UniRef50_B9YBN1 Putative uncharacterized pr... 86 6e-16 1 16.9% 9:180 3:169 --------WYFIETERFQEEQVKETLL---------NSQFDAFAPKKEMYFKKGDLTTLTLRFLFPGTVLIHDPASPPQFAkdRNQPGSEGIHREADAYFSLASDE--KETLEQLLNEKKILQFSTGIIRNKELHVLKGPLQGHEKEIQKIKRHQRLATLPIKLCGQTIPLILGLEVIEK-
265 UniRef50_UPI0001C34E8E NusG antitermination factor... 85 8e-16 1 14.7% 9:171 3:160 --------WYVLYCRPGQETEIIESLKQRLPKDALSEAffQC----ERLWRAGGGNWKLIRKEMFPGYVFLESEDSEYLSEKLEAYRGIVR-VMEEPGYLIPVYREEEERLRRLCGP-EHILRLSYGYRENGVNHVVEGPLKGMERQIVKADWHRRFAQIETAVGGKRTVI----------
266 UniRef50_A6L134 Putative transcriptional re... 85 8e-16 1 14.0% 1:179 1:174 MYSSEKMQWFAMRATYRRGMQIKGLLDQK---------GINSFIPMRYEIHLKNGHRRRELVPVIRDIVFVHTTQS-ELQRIKYGIPYFQYMMDIRNGEKIIVPDEQMRRFIAVAGTYDEQipDEVNLRKGTKVRITGGQFEGYEGVFVKVKGSrrRVVISLQGILALAMATLSPDLIE--
267 UniRef50_A6LGY4 Putative transcriptional re... 85 9e-16 1 16.3% 1:178 8:184 VEEKKQVRWFVMRAYKN-EKMAEDRLKDK-------EYGLEYFIPKHYAVKTYHGVKSTRLVPVIPSLVFVHASHSQITEFKKrnFLQFAMWKKSTGMEYITVPDDQMDSFIqyEKDTAYYKPDEIDVRKGTRVCIHGGKLDGVKGVFMRVKGKrrRVVVMLeiMGISAEVHPDLIEV---
268 UniRef50_D0I9V3 Putative uncharacterized pr... 85 1e-15 1 18.4% 8:181 5:165 -------RWYAVYTHFNEEKVLRDELLAK---------GYEVYLPERKLWETLGNRRRVTYEPLFKCHLFVRT--TPEGLKNVKQAQGFSHLVRY-GKYVATISESHIIKIKTILYYYEDATSVSNSNVEGLAVAVVNGPLKGMIGVLPAGEGERPIAM-EIGQLGYSVNVTVPMDTIFRT
269 UniRef50_B1ZWG3 NusG antitermination factor... 85 1e-15 1 17.0% 4:179 18:177 ---PANAVWLVCHTKPRCEKKFAAL---------MAAERFEHYLPLVDSVRKYRQQTKRFTKPLFPGYVFACVPNEKRARIFQQDL--LARAIDVDDERRFLRQLDDVRAIVASGYELTVLPL----LTRGRRVKIVGGPLHGLEGFVDDPSNPRG-VVLSVDVLQQGLLVKLPAENLQ--
270 UniRef50_C3RR25 NusG antitermination factor... 84 2e-15 1 15.0% 9:175 3:163 --------WYVARCKTGRTKKLVSTLNKQVNM--------NAFIPKSERCFGRGETAEFIVKEIYPDYVFIKSDLDQEAFDEqkTINGLVDLLEYKDTYPLT---SEEQSLLEKLLDNTDTIKHTKGVIVDRRFVPTDGPLVGLEDMIKKVDKYRRFATLDTEIFTGKLLVAIDY------
271 UniRef50_A7V9P1 Putative uncharacterized pr... 84 2e-15 1 17.5% 4:180 25:197 ---ETQKYWFAARTLSKQEFAVKKRIENLNLEEGID---VECYLPTRTVISQLKYRRKRSVVPVARGLIFIHA--TKQSACDIHNVYGVQVFYmfSTHSMLVVPDKQMQDFMFVMDLNPEGVCFDNelTVGKKVTVVKGEFSGIEG---EIATEANKTYVVIRITGVLvsIKVPKSYLKA-
272 UniRef50_A9SPI1 Predicted protein n=1 Tax=P... 84 2e-15 1 26.6% 9:177 119:326 --------WYMVSTPKKAEHEAAEQLHIQFAQM-FPGMKYEVLTPSIPSFRkkSGRYSDSRVRLYPGCLLIRCVMNRDVYNMIRSNLRIYNFFgsDMIIPSAVSIIEIEELFRKMEEAEAepPPPPTIEKGALIRINVGPFINHTGIVNYVDHENETVQLSVVIFGQSTDAELRIDE----
273 UniRef50_Q6L1X2 Hypothetical transcription ... 83 3e-15 1 16.6% 11:179 133:280 ----------IAKCTIGKELDTAVDLSAKAETDLKERLISN--------KNARNEILSIMSPYEIKGYIFIETMHVDRVEYLARTLRNFKGIISGT------VSMDEIEHYL-------TPKPAVSGLSLGDLVEIVGGPFKGERAKIMSIDASKEEVTVQLTESMVPIPVTVKAESIR--
274 UniRef50_B0MWZ3 Putative uncharacterized pr... 83 3e-15 1 16.7% 1:180 1:177 MSDKneECWYALKVFYNRVFELEKQLSQ---------EGVRSYIPLLHEDTVAGDKKIRKRKPAVSSLMFIRQslLELQDRMKASCPFMAYF-DRETKKPAVIPDREMELFMQITSADTSDLEyaIDYRSGDKVRVTGGPFKGAEGYIKRI-RGNRRLVVALEGIIAVATTYIPGRFLEK-
275 UniRef50_A7V7E7 Putative uncharacterized pr... 83 4e-15 1 18.9% 3:150 62:212 --EEDSPHWYALRTTYGREKKAYD---------YMTAKGITAFYPTTDTVKLIKGKRKIVTESRLPNIFFAyfVYDNVNLPFLRFYYRHVHVGRRIEKIPMIVPDYQMESLKIIcdNTIVSLIEVPKFEKGQLVRVIDGAFKGVIGRVAR-------------------------------
276 UniRef50_B8D5Q0 Putative transcription anti... 82 7e-15 1 16.7% 1:180 1:158 MSESQeaKIYAVKTTLGRELDTALIIGMRirARGEETSIGSIIIP-----------------PNVRGYVFIEVERLGELYKVISDIRYI------KAGRPIKVSYEEFEKLL-------KPKPVIEELNVGDEVEITRGPFRGMRARIAGIDRNKNMLTVNILEAAFTIPITIPGDYVKK-
277 UniRef50_A6L935 Putative transcriptional re... 82 8e-15 1 18.1% 3:179 35:218 --KSDQKHWYIAIVNNKSEKLCRDKLEKRIASQPEGEKDYEVYIASQKEMclPSGKRKQVDRIVFRSIVFIRCTDVLRRKEIVH-LPYIKRFmrSGGIRPVaiPDEQMVKLRRMLDDSEEPVIIDPRPLpgARVRINGGKLHGLEGNVLEVEDGNLNFVIRVDLLG-CAKVNITRDLLE--
278 UniRef50_A9NQH7 Putative uncharacterized pr... 82 9e-15 1 16.8% 8:156 80:242 -------QWWMLLVPRNSERLVAEDLSKAFPSE-FPDIEFQAYLPEIPSRRkkNGSYSESKKRMFPGYLFIRCPLNKEIHDFIRNTPRVRGFVgrQMIKPKPVPIAEMEETFRKVKEEQEAYDIEIQEekTDDDSIGQDLLEDLEGTDVRMKKDAN-------------------------
279 UniRef50_Q8VSS9 UpdY n=24 Tax=Bacteroides R... 82 1e-14 1 14.7% 1:163 1:159 MNNSINKSWYALRITYSRELAFKEYLDSR---------GVRNFLPMRYEYVFRGERKIRKLVPVVHNLVFVYATRSEV--DEMKSTVgiRYIMDRETRQPITIPEVQMRSFIAVAGNYDEQvpSVVSMKRGDRVRVTGGIFEGVEGEFVRIKGDR-RVVVSIQ------------------
280 UniRef50_B9Y881 Putative uncharacterized pr... 82 1e-14 1 17.3% 8:175 2:164 -------RWYFVEVEKHHEEDVLEL---------MKSSPFEAFLPKKQRYFKKQVLVTWVERLLFPGTIMITSDFPQAEFTKQFnhSDISQWIHLEEKEYFSLQEDE-RLFLNSLMNEQHVIPISTGFLNEKQLIVESGPLQGLESRIKKIDRHQRTAQVRFQICGQMMLLNLGL------
281 UniRef50_D1CTG7 Transcription antiterminato... 82 1e-14 1 22.8% 54:176 4:123 -----------------------------------------------------RAQHRTVCSAYFDCYLFVSLDIRQQRWPPINSTVGVRRLVMSE-HAPLPVPHGVVESLLAATDDEGFLHPKEL-LEPGQKIRVTNGPFTDQLGTLDYV-GRSGAVRILIDIMNRAVPIYIDRD-----
282 UniRef50_Q48MX6 Transcriptional activator R... 81 2e-14 1 18.6% 2:168 37:187 -EEEPKKEWYLVQCKSGQDSRAEENL---------TAQGYANFRPTINASSESRSVNTKHNSPLFPGYLFIHLSASD-NWAPVRSTKGILTIVKF-GGRAHAVRNEIIQDIKTRAE--------SLNYSHSSHSEKDSAPLDNRGSEISDILSAkeRTLLLVGFLQRE-------------
283 UniRef50_D0XNC5 NusG antitermination factor... 81 2e-14 1 21.0% 2:177 8:188 -DTKPAAPWFVVITHVNQEKLAKYQLERQGHAVYMP------MVPPSPRARMRNGVPPSV-RPMIPRYLFVQVDLDQPGWPAIYSTFGVSEVitGEGRRPRAIPTRFIEEIRAREVNGLVILPEARkfKKGDKLR-WHGPTADYEVVFQQM-VDGNRAEVVFTLMGVDSriSLPSDD----
284 UniRef50_C3RR26 Predicted protein n=2 Tax=B... 80 2e-14 1 14.3% 8:175 2:161 -------NWYVLYVFSNKTNKILSNLNQRKE--------LTAFIPKTEVF--HRQAKKKTTKDMFDNYIFVKSDLKQNDFNDLlkNDGLIKQL--ENAEVSALREKEIEFFNNILDKDNVARVSVGYQEEGKTI-ITEGPLLHYQDHIVRVMKHHCTAQLDLPFFDRKIILGVEL------
285 UniRef50_O27714 Transcription termination f... 80 2e-14 1 18.1% 3:179 12:162 --EDSKNSIYALKTSVGQEKNVARMLARKVRDSGIE--INAILVPE-----------------SLRGYILVESSSKIDMRNPAIRVPHLRGVVESKTEGEAEIDFEEVKRFL-------KPEPIISSIKKGSIVELISGPFKGERAKVIRIDESREEVVLELIEAAVPIPVTVKGDQIR--
286 UniRef50_D0D588 Putative NusG antiterminati... 80 2e-14 1 18.8% 3:172 39:207 --DRGEIAWYALLCRPQQERHAESWLAAR---------GVYAFHPVTSRRTRVRGKLREYERRYLPGYVFARFDGIPIPHRVLTS-PFLTGALCRSDGQWGVLGPKRLAALHEMRARDLRQEDERQEQkaGERAMFRAGPFEGMSCEVVEIDAAGG-VKVRFDLFGRENSVT---------
287 UniRef50_C5B0S5 Putative uncharacterized pr... 80 3e-14 1 22.0% 9:181 7:187 --------WLIVRAQLGRFSQVVEGLK---------SAGCPVFEARREIRVQTDGKPKVTNAPMMGRTLFVGVEEPEYA-CLLAGLDYVHGILCRggARPAMIPPKMMTEFADHITGHKKAGKGVQDfsVGDEVRISNGAFATFMAKIEGVDVKRGRYTVAVDVFGRPVPFEIAEESLEAA
288 UniRef50_C6I4Z2 UpcY n=5 Tax=Bacteroides Re... 80 4e-14 1 23.1% 38:180 2:142 -------------------------------------QEVDTFLPVQNRVIEREGKRIERERLLLPRMVFVHISRQE--MAAVRSTLNVYDFLrrSTGAPTCIPDAQMADFRYMLDYSQDQVILTGeiPKGTRVVVAKGDLQGLRGELVRYNN-KYHILVRIDMFG-SAMVTIPASYVRK-
289 UniRef50_C6ICX6 UpaY n=18 Tax=Bacteroides R... 80 4e-14 1 17.3% 1:179 1:168 MSQQQE-YWFAARTRKDQELTTRDALEK---------IGVEYFLPTQFVIRQLKYRRRRVEVPVIRNLIFVHA--TKEFACAIANEYGVRLFYmfDTKSMLIVPDKQMKDFMFVMndPAAVILNDDCFAVGTKVQVIKGDFCGVEGELASLS---NRTYVTIRIRGvsASVKVPKSYLR--
290 UniRef50_B6W2H1 Putative uncharacterized pr... 80 5e-14 1 17.6% 3:178 6:188 --DKDKILWYVMRVYKN-ENTAEDRLSN-------ETYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYYdfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEvkDKINIEKGKRVRVHGGPFDQVEGYFIKVAKKRGRQLVVidLLAVSAEVKPEYIQI---
291 UniRef50_C6A1F2 NusG transcription antiterm... 79 5e-14 1 19.0% 1:179 1:147 MVKMSESKIFAVRVTVGQEENTAKLIYSKAKTYSLP--IMAILSPSKVR-----------------GYIFVEATEKAAVDEVIRGIRHAKGTL------PGPISFIEIEHFL-------EEKPAVSGFEPGDIVELIAGPFKGEKAKVVRVDESKDEIVVELIGAIVPIPVTVRGEYVR--
292 UniRef50_Q8EUN7 Transcription antiterminati... 79 5e-14 1 22.7% 3:134 14:175 --KKDEAKWYIVTSINGNEDTVYKNIEDKVRAYDLGNVVQEMRLLKTREITirYKKTRIREINRFPGYIYIKMIMEDDAWYVIRNTFGVTGFVGSSGkkPIPMSDIEVANLFNPEMNQDIIINKTSDVFVEQTV-----------------------------------------------
293 UniRef50_UPI00003C8438 transcription antiterminati... 79 7e-14 1 17.2% 11:179 146:293 ----------IAKCTIGKELDIAIDLSNHAERDREERMAMN--------KNARNEVMAVMSPYEIKGYFFIETMHADRVDVLSKSIRGFRGFVSGD------IDISEIEKYL-------TPKPAVTGLEMGSLVEIVEGPFKGERAKITAIDAAKEEVTVQLIESMVPIPVTVKAEAIR--
294 UniRef50_A7UZ21 Putative uncharacterized pr... 79 7e-14 1 15.8% 9:179 10:175 --------WYAMRATYRREPDAMHLLKKENLG---------CFIPMQYKICIKKGKKVRALVPVVHNLLFVHARPSDVQ-RVKSQVTYLQYITDTRSGQKIIVPDGQMQRFIAVSGTYDDHlpDELNLSKGTKVRITGGEFEGQEGVFLKVKGARDR-RVVIEIQGvvAMATIHPDLIE--
295 UniRef50_B7QPX7 Putative uncharacterized pr... 79 7e-14 1 20.4% 20:181 49:217 -------------------RKVKGSGQrfVPELVLQKAGFEVFLPIKKEWSRVNreQKLKCRPAMEGWLFVGWAAGQARFHELMALDVVSG-VMGAGGQPVRISDAKVRFLMRKFGGGRLRRkePVRFSVGDLVRVDAGPFEGQTVSLLDVSGGSARAV--MTLLGKDVEVDLEQEFLTAA
296 UniRef50_B7C7N9 Putative uncharacterized pr... 79 7e-14 1 17.8% 5:173 2:162 ----NNEHWYVLLTIRSKEEEVCKYLN--------ENDGIYAFSPKMEFY--HRVSKQIQQRSLFGGYVFVVSKLSqeVDAIFKKFPLQSVFIhkYEEEVSALTDEEI-RILNMLLDDEKVLRMSYGELVNNKIHVTQGPLKNMDDYIVKYDKHNRLATLNLSFLNQIWKVGV--------
297 UniRef50_A3DNH9 LSU ribosomal protein L24A ... 78 9e-14 1 17.3% 1:179 1:152 MSIRRKTSFYAIRTTMGREIDVALVIESRIMDLVKQN--------------RDPGVKAVFVPPGVRGYVFLETSRLASIYRLISELKYV------KSGQPIKVSLDEVGRLV-------KPKPVIEMIKEGDIVEIVRGPFRGMKAQVISIDRNKNMVVLSILEAAFNVPITVPGDYVK--
298 UniRef50_A2BN62 Transcription antiterminato... 78 1e-13 1 17.2% 6:179 22:163 -----QPRLYAVRTVAGREIDVALIMEQRARDQNMP--IYAIIVP-----------------PQIKGYVIVETPAAFYATNAIQGIRYAKGVV------PGVLRYEDVERLL-------KPKAVIETLKPGDIVEIISGPFRGMKGQVVRVSPSKNEVVLNVLEVEYPLQITVPGDSVR--
299 UniRef50_B9QSZ2 Putative uncharacterized pr... 78 1e-13 1 18.5% 9:181 31:200 --------WIVVRSNPNCESRAAESL---------SAAGLIAWLPMLPVLRKNSRTRNekSRPLCTRYLFVALDRYkqSTSEVVVCDGVEKVLSfeENRPHIVPKAQMRViqCWNAITEGNLSKVKHFDIGAVFGLLADEFDGVTGTVTGYDEAKGIVEGLVPMFGREMAVKVAVDKVKAV
300 UniRef50_C7XGA2 Putative uncharacterized pr... 78 1e-13 1 20.9% 3:165 26:198 --DQEAVRWYVLttAGGGRDRikGLDAELSRRERRGEALFEYFSPSYVEARKVGGKMVNTKRPLLYNYVFVHAS-EDEIFRLKRTLpnFLPRVSSGGRSYFplSDREMDTLRWVAASYsvYVPDSGRLLKGDRVRITSGPFTDMEAEVV-VQPGGGHKDVMVRIL----------------
301 UniRef50_Q8AAK2 Putative transcriptional re... 78 1e-13 1 16.3% 3:180 10:182 --TEGRKAWYAVQTFYCKEEHLGKYLEKK---------GVNYFIPMRYIeeTLDGKKHRKLTPAVHNLLFIEKEFTeeLLERVKDCTIPFLLVrrSTRRCYEIPDCEMLEFRAVCDPNYkvDTVTAEARPGQAVRVIRGPFAGLEGKLTQYKKSY---YVVVTLATIGVMLHIPKWYCEK-
302 UniRef50_B0NP97 Putative uncharacterized pr... 78 1e-13 1 19.5% 6:179 13:180 -----KNPWYAVRTFNCQELKISDFLKERKKVH---------FVPMTYVEKEKEGKTRKMLVPVVHNLVFLQKNESRKATLAMLKECNvsVLCDKETKHPCEIPDKQMTEFRILCDPDFKDthEEAEAKPGKNVRIIHGPFAGITGKLHRARGGYYLIK---TLAGVGVMMRISRWYCE--
303 UniRef50_Q978E9 Transcription termination-a... 78 1e-13 1 17.8% 11:179 138:285 ----------ALKTTVGSEVQVATDLNNKAERDRDERSQGGEKQPSEVFA--------IMAPYEIKGYIFVETMHPDRISYLAKDIRGYKGMVSGK------IDLEEIAHYL-------TPKPAVSGLELGSLVELVEGPFKGEKAKIISIDSVKEEVTVQLVESMVPIPVTVKAESIR--
304 UniRef50_C3RM77 NusG antitermination factor... 77 2e-13 1 15.9% 8:177 3:167 -------NWYLIFAN---DNKINDLLLYFNNHPEMT-----AFVPKIEKLMKKDGKKVFAEVPMFPNYIFIESEFNSQEFylEKDMDSTMRIMQSDEQKVLSLANNE-KELLESLFNDDHLIIRSIGVIVDSKLIVQDGPLVGKEEMIKKIDRHKRVAFIG-DVFGKTMKVPLEVTS----
305 UniRef50_Q9Y9W3 Putative transcription anti... 77 3e-13 1 17.1% 1:181 1:149 MEGGVDARFYAILVTSGAEVNVATIIAERARALGL-------------------DIRSIIVPPRIKGYVILEAHDPGDVYDATRGLRHVKR------RRPLILKFEEVMKLVKPEVE-------IPALKPGQVVEIVAGAFKGMKARVIDVNQSKGQVTVSLLEPLFRATATIPIDEVRPV
306 UniRef50_Q5LF44 Putative transcriptional re... 77 3e-13 1 15.6% 8:148 27:164 -------NWYALRITYGRELALQEYL---------NSEGIENFIPMHYEYTIKNERRVRKLVPAVHNLVFVRSSRsdAIKESKGTTLPIRYIMDREYHRPIIVPDSQMRNFMAVSANYDESlpSELNIRKGTRVRITGGLFEGVEGEF---------------------------------
307 UniRef50_P96036 Putative transcription anti... 76 6e-13 1 17.9% 1:179 1:148 MEKPNMRNYYAIKVVGGQEINVALMLEERIKTNNI------------------KGIYAIIVPPNLKGYVVLEAEGLHIVKPLIAGIRNARGLAQG------LLPRDEILKIVS-------RKTVGPTVKPGDVVEVISGPFRGTQAQVIRVEEAKGEVVLNILESAFPLQVTVPLDQIK--
308 UniRef50_B9NP65 Putative uncharacterized pr... 76 6e-13 1 16.9% 3:179 6:213 --ESKELQWFACRVkvGGEFKAYRdcKRRVNGTglRRAGFEVFLPIKKVLRRKNreKALISQPLLVDWLFVGWPVGESRWHDLMELDVISG-VMGTGGHPIEFPAARVMSLMRqsSECRRYLKTGSEFAVGDTARVIAGPLDGVHVRV--VDVSGPTVKAALGMLGSEVVTEIRGDLLE--
309 UniRef50_Q8TX53 Transcription antiterminato... 76 7e-13 1 16.8% 1:179 1:154 MAETDSTKLYAVRVQAGREEATADMLVMRARRKVKEEGI-------------ETGLKAVIAPEELRGYVIIEVelTDELRDLIHDLPDTRGIVEK------PMDFEEIEHYFA-------PKPEAVEISEGDVVEILSGPFKGEKARVVSVDESRREITVELLEAPVPIPVTVKMDALR--
310 UniRef50_Q2NEV9 Putative transcription anti... 76 7e-13 1 17.6% 10:179 3:140 ---------YAMRVLIGQEKNVASLLAQSVKHED-------------------TGISAILSPESMKGYIFVESDKTLDMRHPALKVPNLRGLVEGD------VDFDELKSFLS-------PDQSIVNIEKGSIVELTSGPFKDEKAKVVRIDEAKEDVVLELIEAAVPIPVTVKGDQIR--
311 UniRef50_A6L7Z6 Putative transcriptional re... 75 8e-13 1 19.5% 5:163 7:161 ----DGNHWFALKVFYNKVFEIEESLKK---------DDIDCYFPCEDAVVMRNGVRKIIRKPIISSILFFHSTTLRAMEIQRQFTDKVILYTRDKELkpLIIPDREMNIFMLVTSSGEKGMEysTKFCRGERVRVIDGKFKGAEGYICRIKK-NSRLVVAIQ------------------
312 UniRef50_A6LD20 Putative transcriptional re... 75 8e-13 1 14.5% 1:179 1:176 MEYPLTDDWFVLrtRPN---------AKRPAYRLLEEKGIEIFTPMRWRLVERKGKRIREEVPLLHDLLFAHTTRTCMDPIVEEISTLQYRYLRGGYRKPMTVGHAEMNRFICAVHSDDSpvEELTPAMYGRMIRIEGGPLDGYEGRLLSIRGTrkRLIVEIPGL-LVAAVEVDPKYIR--
313 UniRef50_D1PI13 Putative transcription term... 75 1e-12 1 17.2% 2:181 43:220 -EKPTDAGWYVAVVRVNCETRIADSIR---INLNHNHVWFDYWIPKVKVVYikRSNKRKVKEKLFLS-TFIFCNVSPRQLDKIRFRSDVYKMLTMPgrKIYQIPDQVVANYRYFVENDEEPVTapVPLKKGIKVRVVAGSMKGVEAYVQSYNGKKAVIGSEIKYISGAT-LTISRNLLEVV
314 UniRef50_Q57818 Putative transcription anti... 75 1e-12 1 17.6% 10:179 3:140 ---------FAVRTMVGQEKNIAGLMASRAEKEQL-------------------DVYSILASESLKGYVLVEAETKGDVEELIKGMPRVRGIV------PGTIAIEEIEPLL-------TPKKIIENIEKGDVVEIIAGPFKGERAKVIRVDKHKEEVTLELENAAVPIPITLPVEGVK--
315 UniRef50_B0VET3 Putative uncharacterized pr... 75 1e-12 1 16.6% 5:179 21:179 ----DDRKWVVVHTKPRCEKKLADYAKQH---------QITYYLPQYTSKRVYQRRKVDVNKVLFPSYVFVGIDFKGKQELLISGYT--VNFLKVNAQKELIDELQAI----YYGRQKNVQMEPGLWLEKGLEVEIVNGPLKGIRGVVEDQSKLTE-VRLQVNILKQAVLVKVRTQDIK--
316 UniRef50_A7FC44 Transcriptional activator n... 75 1e-12 1 19.7% 7:128 2:115 ------KNWYLLSYKYGQVNRVQ---------FGLDRLGVNSFSPSIQVKKVRsgTIRLVNEPMFPTYLFVEFDIESIHTTTISSTLGVNYFVKF-GTEPKPIPLSLIHQLMNRSECSSQRNEEIDEI-----------------------------------------------------
317 UniRef50_B5IAH1 NusG antitermination factor... 75 2e-12 1 17.8% 11:179 133:270 ----------AVKTTIGQEVKVARDIGMKAKIHGWKE-IFSVLAP-----------------YNLKGYVFVETSRPDKVLSLIRGIKDAKGVVRGE------MHLEEIKHYLTPT-------PTIHRISVGDIVELVEGPFKGEHAKVIQIDEAKDEITVELFEAMVPIPITVKAEAVR--
318 UniRef50_D1JE94 Putative transcription anti... 74 2e-12 1 19.4% 10:179 5:145 ---------YAVKTTVNQELAVATMVEGALGEEGVKDHGIkiMVPEE-----------------LKGYLLVEASFPEALEQIIQSIPHARGLVKG------VMGLEEVEHFL-------TPKPSVTGILEGSIIEIVSGPFKGERARVKKVDEAHEEITIELFEAMVPIPVTVRGDSVR--
319 UniRef50_B3T614 Putative KOW motif protein ... 74 2e-12 1 15.7% 2:179 79:224 -EDEGISHLFAVRTTGGQEKIVMRLLEARIKMEKINIQ-------------------SVLLLSDLKGYVVVEARDVSAMFDAIQGIRHIRGQLRGE------LTYKEIDKYLI-------KKSTVSELAVENTVEIIGGPFKGMKATITRLELEKEEATVILLDATYELPVTVDANYLK--
320 UniRef50_B7UF78 Similar to transcriptional ... 74 2e-12 1 14.6% 8:165 3:141 -------NWYLACHQPGKETLYKAQLE-------LSRLHIDSFCPLIRLSRPRPDRprLIIEPLFSGYIFIQFDPEITHTTKLTALSSVSHFVKFGCD-IRPIPKTVIESLMKLPLCPTEQD-------------VIAGRFKEKIVAITRVSNKHERTVMFLALM----------------
321 UniRef50_B1C0R1 Putative uncharacterized pr... 74 2e-12 1 13.2% 9:175 7:167 --------WYVIH--------AKVDRGSKIVKFFNSQKGVDAFIPKIEKWHNVKSVKDYVIKDLYPDYVFVKSDMDNEAFNkfESIEGFGELLEYEGVYALKDTE---QDLMEKLFNGGHIIKRSIGNIVDKKLIVDTGPLLGLDDLVVKINRHHRVATLQTEFFDKKIMVPLEV------
322 UniRef50_C6IMS6 Putative uncharacterized pr... 73 3e-12 1 15.4% 4:159 40:190 ---KGGANWCYLFIHHTKVNAVNEKLKER----------YCTFIHKSVVYKRKNKRIAKDEKPTISGLVFVQGESDDIQSFLCENFFGLYLVKDCSTGKIAVIHNNVMQSFMQVSQVerFMPHTFDYYSSGNtvRITSGPLTGLEGYRIRISRDKCLVT----------------------
323 UniRef50_B5CYV1 Putative uncharacterized pr... 73 3e-12 1 16.0% 5:179 4:173 ----DKAKWFVMrtRSN---------AKIPAYQMLDDMGIENFTPKVTKIVTRNGKRERKELPFIHDLIFVHSSRTVIDPIVERVHTFQYRFLK--GREPMIVRDKDMASFKQAVESSRFppQDITPCMFKRKIRIIGGRLDGCEGYLLTVRGSKrrLLVELPML-ITAAVEVEPEYIQ--
324 UniRef50_A4EPJ2 Transcription antiterminati... 73 3e-12 1 20.9% 9:180 33:201 --------WFVLKVQPMKEFEVEMWL-------GQQEGVLEAWLPTNKAWrrGHRRKVQYRQKIAPGYVFACVERRIAWDLLQRRSNgvLGVVGYNG-RPLPVPEEQMRAMKKLPKIVQKIYAEAQSVkpGDKARIldGPMCDWVVDVTEVNG--GIAKILVPLLG-EREAQISMEQLER-
325 UniRef50_Q74M56 NEQ540 n=1 Tax=Nanoarchaeum... 72 8e-12 1 15.9% 10:179 18:155 ---------WIVKTAGGKEEIVADLIEAKAKKLG-------------------ANVYSIVIAPGIKGYIFVEADKYDTVNELVHDIKHVRKVL------PKPIEVKDIEKFI-------KAEPLVTKVNVGDIVEVIAGPLKGSRGKVVAFNENTGEVTIETLDSVIPLPVTVSIHDIK--
326 UniRef50_A0RUG2 Ribosomal protein L24A n=1 ... 72 9e-12 1 18.1% 53:179 14:127 ----------------------------------------------------KIDIQSVFVVDNLKGYVVVEANDPNAAYQATDGVRHIKGQLRGE------LDFKDIEGYL-------VKKSTVTSLEKDQTVEITGGPFKGMKASITRIDHEKEEATVVLLDASYQLPVTVDANYLQ--
327 UniRef50_A8Q761 Putative uncharacterized pr... 71 1e-11 1 11.7% 1:162 229:365 MPSVNDPGLWRIRCKRGRERTLVATVLRRALTRETSGRPLRIY--------------SAFCRDSLDGQIFVEARRADDVLDAFDGLAGAY----TTNTKPFLVPILEMADLLKLQKKNTEVP-------VGGWVRIKRGKYAGDLAQVLDVAENGEEVGVKL-------------------
328 UniRef50_D2EF56 NusG antitermination factor... 71 2e-11 1 14.7% 2:178 5:148 -ENNEESHFFIIRVTIGREMQALERLQSQLA--------------------RVNGIYSIVKPYSLKGYIIVEADSRESISNLIYNIKHIRGIMNKELSKDEALKTIE-------------KKKQNIDINIGDVVKVLSGPFKGETATVKAVNKEKEELTVMFLESAVPINVNIKISDV---
329 UniRef50_A8HQJ4 Global transcription factor... 71 2e-11 1 14.9% 2:162 164:299 -PTPNDPKLWLVTCKVGHEREAVVQLLQKCYTMAERGTPLRIM--------------SAVALDHLPGFIYVEAAKESHVMDAIRGLRTVY-----IGRGAKLVPLNEM------VDAVTVNKKAKDDMARDTWVRVRSGLYKDDLARVVEVDSVAGRAVVKL-------------------
330 UniRef50_Q4WP96 Transcription elongation fa... 70 2e-11 1 13.9% 5:162 239:371 ----DDPSIWGVRCKAGKEREVVFAIQKRIEERPPGSRK-----PIRIISAFERGG-------AMSGYIYVEARRQADVMEALEDMSNVY-----PRTKMILVPVREMPDLLR--------VQKSEELNPGGWVRIKRGKYQGDLAQIEEVDTNGLDVTVRL-------------------
331 UniRef50_A6UAQ8 Putative uncharacterized pr... 70 3e-11 1 13.9% 5:162 2:163 ----SRSRWYAIRTAPGYQRMAAVD-ERLPESRRMESigFDIFMPSFYKELKHHRTNEIIEkpFLVGYAFVNLPRLN--FEELRRVDGAVCFLRGANYGPLEFPSATIEALYFAEHERRQAFLYEQHCRKENE---RHEQIQHLRGQLRKILPKGRKARVSM-------------------
332 UniRef50_Q4PIC4 Transcription elongation fa... 70 3e-11 1 14.8% 1:162 299:436 MPSVEDPSLWGVPCKPGRERDIVMTLVRKAMAENFTSS------PM--------RIISAFCRDSIPGRVYVEARRADD---VVKACNGLAGAYARQTTSLHLIPISEMADLLKLQ-------KVQNEIQVGGWVRIKRGKYAGDLAQVLDVSENGEEVGLKM-------------------
333 UniRef50_Q984H9 Mlr7998 protein n=1 Tax=Mes... 70 4e-11 1 19.1% 28:179 20:194 ---------------------------EIVAERSIRDAGFECYYPRMRKEIIHHRTNVRIVrpLFTGYIFVALPSANGEY--LKDCDGLGRLLSYDggKPWQVPTGAVerIKRKLEGKTRRETIAMTFPEGQAIRVKQdmLAGFHGEVVSV-TGRGTVKSMIELFGRLVAAEFDADDIE--
334 UniRef50_P75049 Protein MG054 homolog n=2 T... 70 4e-11 1 18.8% 7:166 8:196 ------PQWYVAPVSVKDE-AVVRNLKAKVKALGFDNEILDVRVLKEREveDRYLKVKISEKNLLGRYIYIKMIYSEDAWRIIRNFPGITGIVGSSGRgpTPLDQADADNLEQMLKGISVNPKKRVLVTNTAIVEMDADKFDEKCQYILKHKQVKPEAIAQVNESG---------------
335 UniRef50_UPI00016B21AA transcription antiterminati... 70 5e-11 1 50.8% 118:180 12:74 ---------------------------------------------------------------------------------------------------------------------GVEEPKHQIDFEEGEVVSVIDGPFKGFDGTISEIDTVKGKIKVMVSMFGRDTPVELDALQVKK-
336 UniRef50_C9LF34 Putative transcriptional re... 69 5e-11 1 14.4% 27:158 48:183 --------------------------LKHIAQKLKADNCFPTFVHQSCKYIRNHDKVCKQLRPTISGLIFIQGEVKAVEAYFKERLPELHLACDYATRCVARIPHAVMQPFMKIAerIRFLLHPFEHYAGSQLVRITSGPMTGLEGYIIRIDRDRKLV-----------------------
337 UniRef50_C3Q0J2 Putative uncharacterized pr... 69 6e-11 1 15.7% 1:178 1:181 MDeeDKLHWYAMR-------DLKRRHAKLPAYKMFENLKVQCFTPMVHRLVVVGGKRVDQEVPFMQDLLFVK-DTREHLDAIVESTPKlyRYKLGVQHTPIIVPVADMERFIKAVEASDNppDEVTPEMRNRKIRIIGGQLDGYTGTLVTTRGSkkRLLVEltLLAASIEVEAEYIQL---
338 UniRef50_Q12UQ1 LSU ribosomal protein L26e ... 69 7e-11 1 17.7% 5:179 3:145 ----EDAAIFVVKTTANQERSVAAMLAQVAKKENL-------------------DIRSIIAPDELKGYVLLESSDSGAVEQAIQTVPHARTVVKGQS------TIAEIEHFL-------TPKPTVTGIVEGAIIEVTSGPFKGEKARVKRVDEGHEEITVELFDAVVPIPITIRGDTVR--
339 UniRef50_C9Y5P4 Transcriptional activator r... 69 7e-11 1 17.6% 8:138 10:135 -------KWYVLYCNS-------QDIQR--ISRRAEDIGVEVFCPRYIKVTPRTDCrrQEEKPLFPSYLFLRFDVNVVHTSTITSIPGAHGFVSF-GAAPCTVPESVITAirLLALNPDEDVFECRNISPDLLLKIQE-------------------------------------------
340 UniRef50_O80770 Putative transcription elon... 68 1e-10 1 14.6% 6:162 168:295 -----DPKLWLVKCAIGREREVAVCLMQKIVDRGSEFKI-----------------RSAIALDHLQNYVYIEADMEAHVKEAIKGMRNIY-----ANQKILLVPIKEMTAVLSVESKA-------IDLSRDSWVRMKLGIYKGDLAQVVDVDNVRKRVTVKL-------------------
341 UniRef50_B3JI43 Putative uncharacterized pr... 68 1e-10 1 16.9% 2:178 9:183 -EDLTRIQWFAMSAYKN-EKKAEEMLKGK--------DGLEYFIPKHYAVRVYHGVKSKRLVPVIPNLVFVHASRKQITDFKKknFLQFMMWEKSTGLKYIVVPDKQMESFIKIASQYEEnkPEEIDIRKGTHICIYGGKFNGVKGVFMRVKGKRRRRVVVmgIMGISVEVHPDLIEV---
342 UniRef50_C6JAQ8 Putative uncharacterized pr... 68 2e-10 1 19.6% 84:180 6:100 -----------------------------------------------------------------------------------RKVIGLTKLIG-TGDEIVPLVQEEID-LLMKIGTDKQLVEMSSGIIENDRVQILAGPLMGMEGNIRRIDRHKRTAYLEIEMFGRTVEMKGGLEIIRK-
343 UniRef50_O13936 Transcription elongation fa... 67 2e-10 1 12.7% 5:162 238:368 ----NDPNIWAVRCKIGKEKDIVFTIMRKAMDLQYTSSPLEII--------------SAFQRDSLVGYIYVEARKQSHVLDALNGVLNVY------TNNMILVPIKEMPDLL-------KVQKQVVELLPGAYVRIRRGKYAGDLAQVDNLSENGLTARVRI-------------------
344 UniRef50_D2VQ68 Predicted protein n=1 Tax=N... 67 3e-10 1 16.1% 2:162 117:257 -PTPEDPKLFLVKCKQGKEKevMTLLQKHFSVKHSPNKKDRLLITSALFIE------------GFKGKIYIEAQKEVHVRHA---IEGLSHLIYESGIKLVPL--KEMPDVLNVNQLSTKI----QDISVGKWVRVKRGTYKGDIGKVHDVDKARGYCVVVL-------------------
345 UniRef50_D1VYC4 Transcription termination/a... 67 4e-10 1 15.4% 4:172 28:194 ---DDDLPWYALRLFTLKTQQVIDYLEEH---------HLDYFIPMEYvvEDRKHRVQQKLRPVVRNLIFIKRTMSELSIRKILTEAPFKGSvsREDSQYYEIPSRQMFEFQAMCNPEIVMRQYLSelKVGTPVYVKYGPLKGLSGRLVRSNKKYFLLK-EIPGLGVMLKVS---------
346 UniRef50_B9XD13 NusG antitermination factor... 67 4e-10 1 17.4% 5:125 4:114 ----NSPAWYCARTKPKHEHIAAANLLRHAN--------VEVFNPRLRVEKATRRGVIRVSEPLFPCYIFVRCVI-EEKLNDIRYANGISTIVHFANRIPH-ISDSVVVELQEHFKEMREAIVDQ--------------------------------------------------------
347 UniRef50_Q5KNK1 Transcription elongation fa... 66 6e-10 1 15.7% 1:153 198:324 MPGVNDPSLWKVVVKSGREHAICASIFRKVFAQQYSANPIDVI--------------SVFCRDSIPGMIFIEARQSA---SVSAAVNGIVGIFMSRGVNLVPI--EEMAPLLKM-------KKKDVNLTPGMWVRMKRGKHAGDLAQVVDVDQ----------------------------
348 UniRef50_B9QXN0 Transcription termination f... 66 6e-10 1 17.8% 5:178 25:205 ----AKAEWVVIHTNPKCETRARDGLLGAGLLAFL---------PMEQIERRHGRGRKvvIRPMFPRYLFAGMDVKkqSVDQIRACDGVKGVLSFdtGAVARVAVSDLIKILELSHGTFEGRPVADglKEGAVVKLVKGSWCGQDLTVTGYDAAKERVIGELTGSAMRLAVTAPLDAV---
349 UniRef50_UPI0001BCE1C5 transcription antiterminati... 66 6e-10 1 34.4% 7:70 3:66 ------HKWYAIQTYAGSEMSVKRAIENLVVDHGIEEQLLEVVVPTEDVIEIKNGKQKINEESLYPGYAF---------------------------------------------------------------------------------------------------------------
350 UniRef50_Q9STN3 Putative transcription elon... 66 6e-10 1 10.8% 6:162 181:308 -----DPKLWMVKCAIGREREVAVCLMQKFIDRGADLQI-----------------RSVVALDHLKNFIYVEADKEAHVKEAIKGMRNIY-----ANQKILLVPIREMTDVLSVESKA-------IDLSRDTWVRMKIGTYKGDLAKVVDVDNVRQRVTVKL-------------------
351 UniRef50_Q6BZG0 Transcription elongation fa... 66 7e-10 1 13.2% 1:159 240:371 MPSINDPAIYAIRCTPGREKDLVRKLYEKKRTLARSN-------PLE--------ILTVFQRDSFKGYIYIEAKKPEAIERA------LTGMVNIYAKQRLLVPVREYPDLLKQVKSSDV------EIVPGIYVRITRGKYKNDLAIVDNLSENGLDVR----------------------
352 UniRef50_A4RZ64 Predicted protein n=2 Tax=O... 65 8e-10 1 12.1% 6:162 59:191 -----DPKLWLVTVKLGKERETVVCLMQKTINLAKQGKP-----PMQ--------ILSCIAQDHLKGYIYVEAEREDHVRKALQGMRHVYH------GKPVRLVP-----INEMVDSISVTTKEVSVVKVDSWVRMRTGVYKGDLAQVVDVNYADNQCTVKL-------------------
353 UniRef50_D1W4R5 Transcription termination/a... 65 9e-10 1 15.9% 2:171 23:190 -HEEDTLPWFAVRLFMAKPQLVMDYL---------TEQQLHYFIPMEYvvEDKDHHIRQQLRPVVRNLVFIKKSKPEKAIrlLMDAPFKSSVIRkdDSKYYEIPAKQMFEFQAMCNPEIAMRKFLSelKPGTPVYVKYGPLKGLSGRLVRSNKKYFLLK-EIPCMGVMLKV----------
354 UniRef50_Q1GG09 Putative uncharacterized pr... 65 9e-10 1 18.5% 9:181 3:188 --------WYLGRTTTRhePGAEKERGEFAVERQLRALGIEAHAPRRIEFKRVGKKRHaiTSAYLPGYIFAEIPAS----MFTRAIQ-CRGLSASLMAVPAQEVLHHVKPFIAKVKSENADAERIIefQPGEALDVLAGPFAERLVKFTRmhDSYPMIEAQIEILGRLTRVKIDPLDVRAA
355 UniRef50_C5VMP2 Transcription termination f... 65 9e-10 1 16.0% 4:172 13:179 ---DDGTPWYAVRLFT---------LKLEEVRTYFTSHGLECFVPEQYviEGHDGKPHSILRPVVRNLIFVKKPGEDISFQKiqEANYKISVVKkdSQEYALIPHDQMYEFRLMCNPEITMRKfeAQMKAGDEVLVKFGPLKGMIGRLVRSSKKYYLLK-EIPGIGVMLKVS---------
356 UniRef50_P36262 Transcription antiterminati... 65 2e-09 1 55.9% 113:180 1:68 ----------------------------------------------------------------------------------------------------------------NQVEAAVQRPVSSVFFEVGERVCVSDGPFASFNGIVKNVDEEKSRVHVEVVIFGRVTPVELAYNQVEK-
357 UniRef50_Q1QI72 Transcription antiterminati... 65 2e-09 1 20.7% 5:120 2:105 ----AERYWGACRTFTGREHLVRAKIEEMDRG---------AFLPTFVRSWIAGGKLSVAERPAVPGYVFFRA--SQDDWSPVQDIDGVIGVLAN-GGRAMRISNDDMASLVIGHAAGAH-------------------------------------------------------------
358 UniRef50_Q1GII5 Putative uncharacterized pr... 64 2e-09 1 19.4% 10:179 5:190 ---------YAINTTRGKEFAVRDDLKA---------MGVNPWVPVRLGSRYVKEKRSAVWYdyVPKLMF--AVIPAIIWRDVLEHKHVIgvKKSTGAVVPPVprRAVEAEYADAERARANSEYQCQFKPGQALELLCPPWEGFSATFAKVIKHAhkLRVELEIFGRVTPLDVDPDRVK--
359 UniRef50_D1XYZ0 Transcription termination/a... 64 2e-09 1 20.7% 4:172 14:180 ---DDGLSWYAVRLFT---------LRLKEVKAYFEALDYECFVPMQYviEKPEGGVKHELRPVTHNFIFVKQTMSEASfnVIRKVDDVTQF--------ALIPSKQMYDFRMMCNPekFLSEREAQMKAGDPVLVKYGAMKGMTGRLVRSNKKYYLLK-EVPGMGVMLKVS---------
360 UniRef50_Q9EUG2 Actx protein n=1 Tax=Escher... 64 2e-09 1 20.8% 8:108 2:95 -------KWYVLQFTTTRFAAVFKHLERLN---------FSYYCPMATEKYRRPDkyRERLTPLFPGYLFIQADFDEVHTTTITGLPHTQRFIAF-GGEPLAVPDDEV-------------------------------------------------------------------------
361 UniRef50_B6JZQ2 Transcription elongation fa... 64 2e-09 1 12.0% 5:162 183:313 ----NDPNIWAVRCKIGKEKDIVFSLMRKAMDLQYSGRPLDII--------------SAFQRDSLIGYIYIEARKQAHVLAALQGVVNVY------PQNMILVPIKEMPDLL-------KVQKKTVELLPGAYVRIRRGKYAGDLAQVDNLSENGLNARIRL-------------------
362 UniRef50_A7IAL6 Ribosomal protein L24 n=17 ... 63 3e-09 1 16.1% 8:181 24:168 -------RIFAIKTTSKQERTVADNILKAIETKATDIKVTSIIVPNE-----------------LQGYVLVETPEERNRIEQLVEMIAHARAVAKGQTTLAEVGHFLI------------PKPVVSGIDEGTIVELIAGPFKGEKAVVKRVDSAKEEITVELYESVVPIPITVRGDNVRVV
363 UniRef50_B8BT45 Predicted protein n=1 Tax=T... 63 3e-09 1 18.6% 5:165 76:258 ----SEPQWYLINCVAGIELDLLAQ-ARLVTKDFPPTDVEKIVVPVERHLRSHGDKKKVVDVKvyPGYVFCKIRLTEDVYETLQELELARSWMGTVNRkpLPLPDEEVKKFKgrTDSGEDLLAQYAGYEVGQMVKVLSGNFEGEDGTVRRLKDGQ----ICVRMF----------------
364 UniRef50_C7DH82 NusG antitermination factor... 63 4e-09 1 16.6% 10:172 3:133 ---------FVVKVTSGQENIAANILQSKLSKGDAP-------------------IYSIIVIEGLRGYIIVEAQDELACRNFITKERSIKGII------PKPMDPADVEKLIA-------TKSTAQDISRNDIVEFTSGPFKGYKAKVLKVDELKSDITVELMDVVVPIPIT---------
365 UniRef50_Q8ABS3 Putative transcriptional re... 62 6e-09 1 15.5% 31:159 54:187 ------------------------------VSKKLQTEQYRIFVHKSIVYKRGNKRIKKEEQATISGLVFIQGDANRIQKFLKENFFNLYLVKDCSTGEIAAIPDSVMQPFMRVSerIRFMPHSFDYYSVGnlVRITSGILSGLEGYRIRISRDKCLVT----------------------
366 UniRef50_A6LE17 Putative transcriptional re... 62 7e-09 1 14.4% 7:159 3:151 ------KKWYALKVFYNRFSEIKATLSR---------DGIESYIPMKTRSyqPDGEVVIRRVPLVAMLMFLRCD--DDYISSLNSILDEKAMvrPGTQIPASIPDEEMDMFImsMEDGFEQIPYDDNLVKneKYRVTGGEYAGVVGYYRRIKKNKRLVI----------------------
367 UniRef50_A3AP86 Putative uncharacterized pr... 62 7e-09 1 28.8% 102:181 305:388 -----------------------------------------------------------------------------------------------------PVEDSELMLmrQFKKPISKGGSNHNAFTPGASVHVLSGPFEGFTGSLLEVNRKNKKATLQLTLFGKESFVDLDFDQIEAV
368 UniRef50_A8T9L1 Putative uncharacterized pr... 62 7e-09 1 17.0% 7:112 2:102 ------KNWYLVYCN-------VKNSRRDVLIRFLNSFGVEVFNpyYKARKDRPGKFRKQTKSLFSNYMFIQFDCTKFSFSKFDNIEGISYFLRSSG-QIATIPEPLIENLR---------------------------------------------------------------------
369 UniRef50_B2CBC8 Transcription antiterminato... 61 1e-08 1 15.3% 8:138 3:128 -------EWYVLYCN----NQDVERITRRVEGLD-----VEVFCPRYIKVTPRKDCrrQEEKVLFPNYLFLCFDVNITHTSTITSIPGAHGFVSF-GSTPCTVPKSVITAirLMALNPDEDAIECRNIAPDLLAKIQE-------------------------------------------
370 UniRef50_B1L6L1 NusG antitermination factor... 61 2e-08 1 15.8% 3:179 2:147 --EQRQSLFFPVRVISGKEINIMRLLVSRVSSTG-------------------AKVRSIIFVPKFKNYLFVEAEREYEVRKL------IAGLSKLRLASSSPVPPQEIEDILSSETAG-------MEIEPGDIVKIIKGNFKGYRAVVIATPEGKSklTLKLLDIDRDWEVKMPVINVK--
371 UniRef50_UPI000197ADA0 hypothetical protein BACCOP... 61 2e-08 1 12.1% 3:159 34:185 --DSPTNSWCYLFVHHAKVETINEKLILK----------FKTFIHKSIAYKRGKSHVRKTERPTISGLIFIQGNSREIQNYLNQIAFDLYLVKDCSTKKTAIIPDRVMQPFMqnPHHIRFMPHSFDYYSPNHtiKITSGVLTGMEGYCIRIARDKCLVT----------------------
372 UniRef50_C1DYX5 Transcription elongation-nu... 60 3e-08 1 9.6% 6:162 238:370 -----DPKLWLVTVKQGKERETVVCLMQKAINLHKSGKGSMA-------------IKSACVQDHLKSYIYVEAERESDVKKALQGMRHVYH------SKPIKLVP-----ITEMVDSITVTKKKVENIQYQSWVRMRGGVYKGDLARVIDINYADNQCTVQL-------------------
373 UniRef50_Q2NTN8 Putative uncharacterized pr... 60 3e-08 1 18.0% 9:130 11:125 --------WYLLRFKATLFNMVFNHLAA---------SGVYYFCPMIETQYRRPDSvrKRLSPVFPGYLFVNLDFDHCHPQKLSAHRHIYGLINF-GQGPSPIDDAVIDLLMAKPHIVRKIIDAPRAWKE---------------------------------------------------
374 UniRef50_B3JEC4 Putative uncharacterized pr... 60 3e-08 1 13.1% 4:179 27:200 ---EKEQVWLPLQTVYNKELTVAAYLK---------EQGIEHYIPMTYELRdrEGECSHVLVPAIHNLIFIHCPY-DANwqFASEAPLPVYFLKKegNDYCTVSERDMQNFMHATNPDIQG----TRFIDSEKLrvRRGPLYGVTGKFLRY---GGRHYIAIEMPQSTALLKVSYTWCE--
375 UniRef50_D2MG88 Putative uncharacterized pr... 60 4e-08 1 17.1% 36:181 30:186 -----------------------------------DELGLAPYLPMEWKSVAarGRRREVQVPLLIGYLLlaGGLAHGRYGDVLATRGVRGLLHYAGSqpARLSDATVERLRAEERAADNKRQMRleWQPGDEVWAEILPGRSLLARISAEKAPRGRIAILleVLGRRAFA-VEPKQLQRV
376 UniRef50_A8UUU2 Transcription antiterminati... 59 6e-08 1 21.8% 9:178 2:195 --------WYVLKVRSGKEEALKELLGRDFEVLYPSRKKLNVYVNGKKRyrIRDGEVFTDneSPLRGYLFVKG-RYEDILSKTENLLDVVGFL-IMGGKVRTLTDEEVSDLQKRVEKGERLKTLLP--ERGMRVKVVSGEWTGAEGVIEEVYEDLS-LKLKLRLWDKTFTAILPLERV---
377 UniRef50_A4RYW5 Predicted protein n=2 Tax=O... 59 6e-08 1 22.0% 1:177 19:258 MSEAATGewYMLEVPETRENQAKAAILALNGTKLTRGQgvVAWVPrfYVAEEDAVGKSELeeMLQPGYVLVRCALTQELMDAFDDLRSVRGFATGGSSrpVVKTEADIEAEKAREQAKEVMRAERGDEADedRVEVHTGPFKGFKGHIVARNDDGS-VEATLAIFGRDTNVSLAADE----
378 UniRef50_A3TRT6 Putative secreted protein n... 59 8e-08 1 25.3% 100:178 361:434 ---------------------------------------------------------------------------------------------------PVPLP-----KITATPLPSTTVAVDPDPFSPGDTVKITAGQYLGLSAKVLKVDTVKNTVTVEVVVLGIKLPVVLPYSSV---
379 UniRef50_A8MDC8 Transcription termination a... 58 1e-07 1 14.9% 12:179 11:149 -----------VRVIAGQEYNVAAIIRTRLEL-------------MEKDKRKYYNVPSIVVPPNVQGQVYLETPHSYVAIDLSTGIKQYRGLMMGK------VPLTELMKMI----------KREIKVQINDVVEIITEPFRGFKAKVVDVDEKNNTVKLLLFDTATNIPVTLPIKSIR--
380 UniRef50_B5JIS7 Putative uncharacterized pr... 58 1e-07 1 26.9% 101:178 1:78 ----------------------------------------------------------------------------------------------------MVVEDEVVDLIKENSEDLMLSPAVDDSFQCGENVEVLEGPFQGMMGTVLQNLNEGSRVAILLTLLTSETKVTISRSHL---
381 UniRef50_C4QBT8 Suppressor of ty, putative ... 58 2e-07 1 11.4% 5:162 171:303 ----KDPNLWALRCKMGEEKATVLALMRKFIAYQFSDTPLQI--------------KSAFAKEGLKGYIYVEA---FKQTHVKQAIDGIT-ALRLSMYKQQLVPIEEMTEVVRVVKETGQ-------LKPDQWVRIKSGLYRDDLALVEYVEDAQNLVGLKL-------------------
382 UniRef50_UPI00016C0B0F transcription antiterminati... 57 3e-07 1 33.3% 5:58 2:55 ----SEAKWYVVHTYSGYENKVKVNIEKAIKNRNMQELIQKVEIPMHNEEEEKNGTTR---------------------------------------------------------------------------------------------------------------------------
383 UniRef50_A8ABQ4 NGN domain protein n=1 Tax=... 57 3e-07 1 18.0% 10:181 6:145 ---------FPVRTVSGREIDVALLIEERARAKNL-------------------DVKSVIVPPRIKGFVIVE---SPAHFVVAEAVRGIKYVRGGPGKK---ISLEEVLKMI-------KPVPIIETVEVGDIVELVAGVFKGVKARVEAKIPEKNELVLSIVEAAYPLQITVPADYVRPV
384 UniRef50_B8IRQ9 Putative uncharacterized pr... 57 3e-07 1 14.3% 3:128 51:164 --EPNPLRWHAAVTFPGCEVKVRDAMQLR---------RIDTVLPMVRFWRIRSRKRFVAERPLLARTVIFGLDHACQDIA---GIEGLERVVRGASVGWADLPEQDVYDLRLSILRGEFDATLRQDY-----------------------------------------------------
385 UniRef50_UPI0001743F0E transcription antiterminati... 57 4e-07 1 18.2% 6:82 15:90 -----EKKWYIIHTYSGYEKKVAADLEKRIESLDLTDRAFLELLAAF-FNKSDAGGVFNTNVKLLSAYTVISTGITNPILSC---------------------------------------------------------------------------------------------------
386 UniRef50_C4UKL3 Transcription antiterminati... 57 4e-07 1 16.4% 2:129 4:126 -EELNGQSWYLAQYITGGKNR-----EKLFGW--LCEQHITPWTPLTVRTIRRTDKINCIRkpLFPGYFFLKANLATQTVDNIRRHSAFCGFVMN-GPQIAPLRPLIVEGLMKCHPDPTLSPEALNELE----------------------------------------------------
387 UniRef50_B3CAR2 Putative uncharacterized pr... 57 4e-07 1 13.1% 3:124 22:137 --DKDKILWYVMRVYKN-ENTAEDRLSN-------ETYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYYdfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHF---------------------------------------------------------
388 UniRef50_A7V3C8 Putative uncharacterized pr... 57 4e-07 1 15.2% 1:79 8:77 MTDNDMMCWHALYTAPKSEHKLMQRLNA---------AGYTTYCPMQAVFVKWKGHTRKVITPLFSGCLFVAGNVSEVT------------------------------------------------------------------------------------------------------
389 UniRef50_C1FFC9 Predicted protein n=1 Tax=M... 56 5e-07 1 19.8% 5:135 315:476 ----NDVGWYMCEVPEGREQQAADKIDAIARTEKTEGEPITTWVPrfCVARSDAEGKTRieTLPFPGYVLVHMKLSQTTLNSLEEIYGVKGFarQTGERPRPVPAMQLETMMKMCDVRVVSDAEHAKITEALKRR----------------------------------------------
390 UniRef50_B0ZDY9 ActX n=5 Tax=Enterobacteria... 56 5e-07 1 16.8% 4:116 2:106 ---KGQKQFYLLQCSPHFHQSVLLQLSR---------SGIAYYNPVIRTFYKRRDcyRGQIMPMFPGYVFVLLDFEVVHPSCFTRMKNVYGLVSF-GEYPAEVPLSVINEVKEQEK-----------------------------------------------------------------
391 UniRef50_B5HX00 Putative uncharacterized pr... 56 5e-07 1 37.7% 124:176 2:54 ---------------------------------------------------------------------------------------------------------------------------PAPDIAVGASVTITDGPFATLRATVTEIDTPSQKVKGVIELFGRHAPVELSFT-----
392 UniRef50_C6J5U5 Predicted protein n=1 Tax=P... 56 6e-07 1 19.6% 10:157 5:168 ---------FAIQVMTGKENNVKKLMeaFARNESAQNWIKAVHTFTTTTRRLLGQGkkEIKRAIMPGYIFIEMnlPADVWHLIKSIPGVIKQFTGSGQVIGAEEFQKMLGLEPEEQQVEVAVPIQEQEAPgeKVQV-DEVEKNMKNALHEVNMAKTK------------------------
393 UniRef50_C3M8G1 Transcriptional activator a... 56 6e-07 1 10.5% 6:138 2:132 -----EKKWYLTCHKSGCSNLYKAQ-------QALIQIEVHSLSPSIQTWRQRLDRkrAVIEPLFKGYLFTCFDPEKIPTRKIEHCAGISHLVRFA-NTIVPIREAVMQEImcMNDETRTNHKITTSLKESQKEQIKN-------------------------------------------
394 UniRef50_Q7BQV7 Putative NusG-type transcri... 56 7e-07 1 18.9% 8:113 3:103 -------RWYLACHKAGKDNVFKAQ-------MTLERMNIMAFSPVMRAYRPrpGQLRPVMEQMFPGYLFIFFDTEIHHSSKIELCPGISHLVRFAG-EITPIRDAVVDDVMQ--------------------------------------------------------------------
395 UniRef50_Q6TFR9 ORF9 n=1 Tax=Erwinia amylov... 55 1e-06 1 22.9% 7:115 2:103 ------KNWYVLAFTSNKFGAVERFLKL---------NKIEFLCPMHEHSYSRPDkiRKSLVPTFPGYLFVYLDFNETHPEKLARFQYIYGLITFS-NAPMAVPEVTIQVIAYTC------------------------------------------------------------------
396 UniRef50_UPI0000382CEE COG0250: Transcription anti... 54 2e-06 1 38.7% 119:180 1:62 ----------------------------------------------------------------------------------------------------------------------EVQDFVETLFAIGDEVRITDGGFATFMAKVEKVDVKRGRYTVAVDVFGRPVPFEIAEESLEA-
397 UniRef50_D1PC69 Putative uncharacterized pr... 54 2e-06 1 16.5% 9:166 2:193 --------WFIVKTDVFSEQQSIDFLREK-----YNHIITDFYFPlrKTYKNENGEVKVRFVPVLQGMFFIRVQ-NERRLKKVLSPYGYFMYKGFEMerQSKIPDEDMETFVYFNDrsIVEKRYSDLVKENDTIRILSGPLAGRVGVVKQIKHKGKKDRHLLVRFG---------------
398 UniRef50_Q54017 AnfA1 n=2 Tax=Serratia ento... 52 1e-05 1 20.2% 6:134 2:130 -----KKKWYLIRCNYGKIDLGQKSLETYGLFEGFpsLEFEGFYLTFQKNFFRKG-----MVYFSPPYLFVRFDIDHIPISKIQHAIGVKGFVRFGGG-IKSIPDIVIGKIMKNDYLSGIDKDVIKLIRCENKV-----------------------------------------------
399 UniRef50_Q6VE90 Orf37 n=2 Tax=Pseudomonas s... 51 2e-05 1 23.6% 7:129 2:117 ------SNWYLINHNP----KAVQGIIFRIRALGAED----VYSPANLKITKRLDcvRTSETQLFPGYLFVKLNPEVLHTSIVLQVSGVKKFVSF-GGVLATISDCLIEAIKSSLLVRVDKKVTQIECR----------------------------------------------------
400 UniRef50_B5ZVK1 Putative uncharacterized pr... 51 2e-05 1 18.8% 9:136 29:156 --------WYAIRAAPGTQRMARhrVGESIIERNLRNEGISVYMPAFWYESIHHRTRKVIQrpLLVGYAFVNLE--NMNFEQVRDVDGVICFLRSEFG-PIRFSGDDLSVI------AAEELSRRQEFRRERITRI---------------------------------------------
401 UniRef50_Q92W20 Putative uncharacterized pr... 49 7e-05 1 15.9% 27:133 1:107 --------------------------MESIIERNCRKDGFDIFMPSFYTELRHHRTKQILQkpFLVGYGFVSLPRLN--FEELRRVDGVVCFLRGANYGPLEFPDGYHRGPVLRRSRATAGLPLQAALPEGDR------------------------------------------------
402 UniRef50_C7CEQ7 Putative uncharacterized pr... 48 1e-04 1 17.7% 103:181 13:91 ------------------------------------------------------------------------------------------------------LSDALARQSSAHVRPGRTNLTPLAGMQVGEEVRASSGLFSGFIGKFVGTAEGGAVGVISLEVMGSPFDYRLPIEDIQRV
403 UniRef50_Q6MDM7 Putative transcription anti... 48 1e-04 1 38.3% 8:54 3:49 -------KWYVVQVLSTHEKKVKKALEEHLELKGMSGEIEQILLPTENVSEVKK-------------------------------------------------------------------------------------------------------------------------------
404 UniRef50_Q48B18 Transcriptional regulator n... 48 1e-04 1 18.9% 3:129 70:195 --DLNMKNWRVLMHNS----SVYQSLITSIERLD-----VEVYSPESITYRKRPDRPSSVETklFPGYLLLRFDPEVTHTTTITALNGARGFVQFggGQACVMQDSTVEELKAVAMVRSNRPLDCIEFR----------------------------------------------------
405 UniRef50_A6NHU0 Putative uncharacterized pr... 48 2e-04 1 25.0% 93:172 204:274 --------------------------------------------------------------------------------------------LTPTGPSRMPRPDEEQEK---------DKEDQPQGLVPGGAVVVLSGPHRGLYGKVEGLDPDNVRAMVRLAVGSRVVTVS---------
406 UniRef50_C1N286 Predicted protein n=1 Tax=M... 46 7e-04 1 29.5% 134:177 422:464 -------------------------------------------------------------------------------------------------------------------------------------IEVQEGPFKGFKGYITG-NNTNGSVEARLLIFGRETSVTLAADE----
407 UniRef50_C7IY85 Os02g0772000 protein n=4 Ta... 60 4e-08 1 13.3% 5:162 180:307 ----KDPKLWMVKCAIGHERETAICLMQK--SIDTPDLQI----------------KSVLALDHLKNYIYVEAYKEAHVKEACKGVRNI-----FASRKVTLVPIREVADVLSVQSKS-------TDISINTWVRMKLGAYKGDLAKVVDVDDVHQKVTVKL-------------------
408 UniRef50_B9F3G9 Putative uncharacterized pr... 59 7e-08 1 13.3% 5:162 180:307 ----KDPKLWMVKCAIGHERETAICLMQK--SIDTPDLQI----------------KSVLALDHLKNYIYVEAYKEAHVKEACKGVRNI-----FASRKVTLVPIREVADVLSVQSKS-------TDISINTWVRMKLGAYKGDLAKVVDVDDVHQKVTVKL-------------------
409 UniRef50_A9S5X8 RNA polymerase II transcrip... 59 7e-08 1 12.0% 5:162 62:192 ----KDPKLWMVKCNLGHEREAAICLMQKYIDQDQINQPLLI--------------KSAIALDHLKGYLYIESEKEAYVRQACRGMRMIY------SQKVTLVPIKEMTDVVS-------VEKKLVEIDQDTWVRVKIGIYKGDLAKVVDVDHVRQRAQIKL-------------------
410 UniRef50_C4R370 Protein that forms a comple... 57 3e-07 1 13.7% 2:162 219:354 -PTVDDPGIWGVKVRLGKEKDVVRQILKKKLAREGTKNPLEIY--------------SAFQRDSFKGHVYIEARKAEAINDALKGNVNV-----FSNNSKFLVGIVEYKDLLRPVKSSDVK------LTRGSYVRVKNGKFKGDLAQVDEVLENGLEARLKL-------------------
411 UniRef50_A4RGW0 Putative uncharacterized pr... 57 3e-07 1 15.4% 5:160 201:334 ----DDPHIWAVRCKEGKEREVVWSIMKRIEQRMG----------TKEELSITSAFERGGTASVMKGYVYVEANRSTDIMVALDGLLNVY-----PRTKMLLVEIKDMPDLLR--------VQKTPELKVGDHVRLKRPpyAGDLAVVRNVTENGLEVQV---------------------
412 UniRef50_P27692 Transcription elongation fa... 56 5e-07 1 10.6% 12:162 290:416 -----------VRCRPGKEKELIRKLLKKKFNLD------------RAMGKKKLKILSIFQRDNYTGRIYIEAPKQSVIEKFCNGVPDIYI------SQKLLIPVQELPLLLKPNKSDDVA------LEEGSYVRIKRGIYKGDLAMVDQISENNLEVMLKI-------------------
413 UniRef50_B9HL78 Putative uncharacterized pr... 55 2e-06 1 12.4% 2:162 134:267 -PSAKDPTIWKVKCMVGRERHSAFCLMQKfkSLGTKLQIISAF-----------------SIDHVKGYIYIEADKQIDIIEACKGLCSIY------SSRMAPVPKNEVSHLLS-------IRKSCNQVSEGMWARVKNGNYKGDLAQIVAVNDVRKKATVKL-------------------
414 UniRef50_B9T6Z6 Suppressor of ty, putative ... 54 2e-06 1 13.9% 12:162 173:296 -----------VKCMVGRERHSAFCLMQKfkSLGTKLQIISAF-----------------SVDHVKGFVFIEADKQCDINEACKGLCSIY------STRVAPIPKNEVSHVLS-------VRSKSNAVREGMWARVKSGKYKGDLAQIVTVNDARKRATVKL-------------------
415 UniRef50_Q54K42 Transcription initiation fa... 53 5e-06 1 13.2% 12:162 131:257 -----------LKCRVGEEKLFVASMMQKMLNNRNSNNPNDHVL-----------IKSVMAPHHLSGYVYVEAEREVHVRQAIKGMTSLVSF------TPVITPLKDIIEVISAN-------KKNVDLQKGGWVRIRLGKYKADIGQIISYDPSKSRVTVKL-------------------
416 UniRef50_UPI00015B6054 PREDICTED: similar to GA204... 53 5e-06 1 10.1% 5:162 239:370 ----KDPNLWLVKCRIGEEMNTVLLLMRKFLTYQYTNSPLVI--------------KSAVAPKGIKGFIYIEAYKQVHVKAAIENVNNLK--LGFWKQQMVPL--NEMVDVLR--------VTSSINIKPNQWVRIKRGIYKDDLAQVDYIELAQNKVHLRL-------------------
417 UniRef50_O00267 Transcription elongation fa... 53 5e-06 1 15.3% 5:180 175:318 ----KDPNLWTVKCKIGEERATAISLMRKFIAYQFTDTPLQI--------------KSVVAPEHVKGYIYVEA---YKQTHVKQAIEGVGNllGYWNQQMVPI--KEMTDVL-------KVVKEVANLKPKSWVRLKRGIYKDDIAQVDYVEPSQN--TISLKMIPR-----IDYDRIKA-
418 UniRef50_Q6CC84 Transcription elongation fa... 53 6e-06 1 12.7% 5:162 175:306 ----NEPSIWGIRCKPGKEKELVRQCLRKKLSLQKSRNPLEIM--------------SVFQRDTFTGYIYMEARNQQAVTVALKGLVNVY------PQNMILVPIKEYVDLLRATKSAE------TELVPGAYVRLKRGKYGGDLAIVENLSENGLEVRLKL-------------------
419 UniRef50_Q4SB75 Chromosome undetermined SCA... 52 1e-05 1 14.2% 5:180 186:329 ----KDPNLWTVKCKIGEERATAIALMRKFIAYQFTDTPLQI--------------KSVVAPDHVKGYIYVEAYKQTHVKSAIEGIGNLR--MGLWNQQMVPI--KEMTDVL-------KVVKEVTNLKPKSWVRLKRGLYKDDIAQVDYVEPSQN--TISLKMIPR-----IDLDRIKA-
420 UniRef50_C9SF87 Transcription elongation fa... 52 1e-05 1 16.0% 1:162 213:352 MPSVDDPTIWAVRCKEGKEREVVFSIQKRIQERMG----------TKEEMAIISAFERGGTNSVMKGYIYVEAARSGDIMAALDGMLNVY-----PRSKLILVEIKDRPDLLR--------VTKTATLEPGAWVRLKRpkHAGDLGQVVDVTESGLEARVRF-------------------
421 UniRef50_Q2GQE5 Putative uncharacterized pr... 51 2e-05 1 15.3% 5:161 230:364 ----DDPSIWAVRCKEGKERDVIFSIMRRIEERAGGKDALSI-----TSAFERGGTNS-----VMKGYIYVEARRQNDIMIALDGVLDVY-----PRTKMVLVELKDMPDLLRVMK--------TPNLEPGAWVRLKKPayAGDLAQVLDVTENGLEARVR--------------------
422 UniRef50_B2WAZ3 Transcription elongation fa... 50 3e-05 1 13.0% 2:162 191:328 -PTVDDPSIWGCKCRPGKEREIIMAIQKRIDEKLRAGMGVQVYS---AFERGPSGPQS--------GFLYVEADSKQAVVELIEGIQNV-----FMGSGQFSIPPKERPDLLR--------KKKRAPLEVGKFVRMQRPpyKGDLAKVVEVSTNGLDCVVQL-------------------
423 UniRef50_Q9US64 Hypothetical nuclear protei... 50 3e-05 1 13.1% 7:143 1:110 ------PNIWAVRCKIGKEKDIVFTIMRKAMDLQYTSSPLEII--------------SAFQRDSLVGYIYVEARKQSHVLDALNGVLNVY------TNNMILVPIKEMPDLL-------KVQKQVVELLPGAYVRIRRGKYAG--------------------------------------
424 UniRef50_B7PNC8 Transcription elongation fa... 50 5e-05 1 12.7% 5:162 126:258 ----KDPNLWMVKCKIGEEKSTVLQMMRKFIAYQYSEEPLQI--------------RSVVAPEGLKGYIYIEA---YKHTHVKQVIQGV-GNLRIGLYQQTMVPIKEMTDVLRVTKE-------QAQLRPKQWVRLKRGIYRDDLAQVDYVDTAQSQVNLKL-------------------
425 UniRef50_B6KJY6 Supt5h protein, putative n=... 49 7e-05 1 13.7% 2:162 188:325 -PDITDPKLWMVKlkTGVEREVCISILNK--SFQMQEKGKDCEI------------YSCYASDDLKGYVYVEAFSQYAIKEALQGLRLIRTY-----GEIKMVPLEEMTAVFNSVRSRAPYIPQRNDF-----VRVKRGLYANDIAQIHQVEEQGMVVTVRL-------------------
426 UniRef50_B0EU05 Suppressor of ty, putative ... 48 1e-04 1 16.6% 10:166 119:245 ---------FAIRCKQGYEKDICMRIMKIWINQKDRIMhfSVFVPKEKT-----------------GIVYIEAMTERKFADACDGVRDLYI------NTIHALNDKQIEELL--------VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKLVPRFN---------------
427 UniRef50_C4LVU5 Transcription initiation fa... 48 1e-04 1 16.6% 10:166 119:245 ---------FAIRCKQGYEKDICMRIMKiiNQKDRTMHLFSVFVPKEKT-----------------GIVYIEAMTERKFADACDGVRDLYI------NTIHALNDKQIEELL--------VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKLVPRFN---------------
428 UniRef50_Q9V460 Transcription elongation fa... 48 2e-04 1 12.0% 5:162 212:344 ----KDPNLWMVKCRIGEEKATALLLMRKYLTYLNTDDPLQI--------------KSIIAPEGVKGYIYLEAYKQTHVKTCIDNV----GNLRMGKWKQEMVPIKEMTDVL-------KVVKEQVGLKVKQWVRLKRGLYKDDIAQVDYVDLAQNQVHLKL-------------------
429 UniRef50_Q5CWL0 5kows transcription initiat... 48 2e-04 1 11.8% 2:162 123:258 -PTSRDPKLWLVKvrAGLEKDICIALVQKAAECQKQGKELPIL--------------SAYVASSYRGYIYVEAEAPNFVNEALQGFTGVR------LSSIKIIPVKEMTRVF------SVDMQEKEQLMRESWVRVRSGIYGGDLAQIYEVDEHEANVILRL-------------------
430 UniRef50_A2ED41 KOW motif family protein n=... 47 3e-04 1 16.7% 12:179 151:288 -----------VKCKPGKELVVISYLYAKFAHSPSqnLTFAAYTPKIS-----------------SGFIYVEARTLADANTLCSELPFIMNL-----NRMKNLKYSEMAKAM-------TIPRTEVDFHPGNFVEIlsGYfkGDIGQVINININRNKVMVKL------IP-RIDYDRIE--
431 UniRef50_D1IDV9 Whole genome shotgun sequen... 47 3e-04 1 10.1% 5:162 132:262 ----KDPTIWKVKCMVGRERLSAFCLMQklQSLGTKLQIISAF-----------------SVEHVKGFIYIEADKQCDINEACKGLCSIY------TSRVAPVPKNEVTHLLS-------VRSKCNEISEGTWARMKNGKYKGDLAQIVVVSDAQKKATVKL-------------------
432 UniRef50_D0T981 Transcriptional regulator U... 47 3e-04 1 21.9% 93:165 14:90 --------------------------------------------------------------------------------------------VSSGGRSYFplSDREMETLRWVAASYsvYVPDSGHLLKGDRVRITSGPFADMEAEVV-VQPGGGHKDVMVRIL----------------
433 UniRef50_D1HH49 Whole genome shotgun sequen... 46 5e-04 1 14.7% 93:160 79:146 --------------------------------------------------------------------------------------------LAKSTEKPCPIVMRLKRWERKECKPNSLPVLHKMHVKVGDTVKIISGREKGRTGEISKIFRHNSTVVV---------------------
434 UniRef50_Q92917 G patch domain and KOW moti... 46 6e-04 1 25.0% 93:172 215:285 --------------------------------------------------------------------------------------------LTPTGPSRMPRPDEEQEK---------DKEDQPQGLVPGGAVVVLSGPHRGLYGKVEGLDPDNVRAMVRLAVGSRVVTVS---------
435 UniRef50_Q21338 Transcription elongation fa... 45 8e-04 1 11.2% 2:162 178:311 -PSTKDPNLWIVKCRMGEEKLVAMHLMRKCLAVEHTNEPFQI--------------KSVVVKEGLKGMIYIEAFKQSHVMSAIEGFSALNQF------TITMVPIKDMVDVL-------RVVKDIPQLKLGSYVRLKRTMYKDDLAVVDLVDIAQNRVNLKL-------------------
436 UniRef50_A1RRQ9 LSU ribosomal protein L24A ... 45 0.001 1 15.9% 10:179 9:146 ---------YSVSAVSRQEYNIVIVLKMRIESNKIP--IYSIVVPPEPF-----------------GILFIEGESLPAVSRAIYGVKHIKGIMRGVTNVEEVLRV-------------VRPTKPAVEIDINDEVEIIADVLKGSRGRVTFVDREKGIVRVELLDSAFPMPLDLRINEVK--
437 UniRef50_C5SIV6 Putative uncharacterized pr... 45 0.001 1 16.1% 9:176 23:173 --------WLIVTTYAKKEAVVLSQLK---------GIGYEGYRPMIAKRRKIAGQEAPVLVPlyPNYVFVRA-------LEGRSPLSLFGLQGLACVHERAVLDAVVQAHRAKEADGFLPFKNekAFRRGDRIKTLGGLLE----VVLSDPIDTNRCAALSSFMNGSSRLIVGLD-----
438 UniRef50_C2HWG3 Transcriptional activator R... 45 0.001 1 25.8% 112:177 62:126 ---------------------------------------------------------------------------------------------------------------LKQLDCEQLKHATKQLPEKGQTVRVARGQFAGIEAIYLEPDGDT-RSIMLVKMISQQVPMSIENTD----
439 UniRef50_C7J286 Os05g0506200 protein (Fragm... 44 0.002 1 17.3% 46:178 17:156 ---------------------------------------------TVNVLEGPFQGKQGVVKHLYMGILFIHNESESENsaQCSSCENVKKrfGNSDDNPIPMFSYEQNEQRDNERPYRSTREQL--FSIGEMLRIRKGPMKGYLCRVVRIF--RNDVTVKLDSLLKIVTVQAEFLSV---
440 UniRef50_B3L7U7 Transcription factor, putat... 44 0.002 1 12.9% 23:162 221:348 ----------------------KMWLIKLFKNGVERNIAMGIYYKYMKLKDNDFNIKGVYVSDNLKGYIYVEADSLYMLKRF------LLGFKFINLNEMTIVPVQELTSIFSMCHSKVIIP------KVNEYVRIKRGVYMNDIGQIFEVHEKGIYAIVRL-------------------
441 UniRef50_A5K1V0 Trancription factor, putati... 44 0.002 1 12.9% 23:162 227:354 ----------------------KMWLIKLFRNGVERNLAMGIYYKYMKLKDNDFNIKGVYVSDNLKGYIYVEADSLYMLKRF------LLGFKFINLNEITIVPVQELTSIFSMCHSKVIIP------KVNEYVRIKRGVYMNDIGQIFEVHEKGIYAIVRL-------------------
442 UniRef50_A9UZR3 Predicted protein n=1 Tax=M... 44 0.003 1 16.8% 70:170 441:536 ---------------------------------------------------------------------FVVGDRVIAYRGNLKNAFGVIETIREDGTVVLRVENQELRDLDRIPVPKEDLRKH---FRPADHVKVQRGRYEGQTGLVLEVND--QRVTVLIDLTMKQIE-----------
443 UniRef50_B8I2J4 NusG antitermination factor... 43 0.004 1 23.3% 8:80 3:70 -------NWFVFRVQIGEEYKACEFLNKLYDKEESVE-----FVPQVEVVTKNSQSIRKELTPTFPGYVFTGSILKEKTF-----------------------------------------------------------------------------------------------------
444 UniRef50_A6L4G6 Putative uncharacterized pr... 43 0.005 1 16.5% 67:181 159:276 ------------------------------------------------------------------GYLFVCAPLDELNLILAHLFPRQYLAKDRNSYSVAVIPHRQMEEFIysMPYNIedKPLEEYIQKKQKIRITGGVFQGKEGCIMRLHRNTKLVFA----FGNMT-VAISYLqfEKV
445 UniRef50_B0NND0 Putative uncharacterized pr... 43 0.005 1 15.9% 9:77 16:75 --------WCIVLTAPHAELNIQKKLEQ---------QGFITYVPTISVRRSWAGCIKEIHIPTIARCVFVYATKEE--------------------------------------------------------------------------------------------------------
446 UniRef50_Q8STZ8 Similarity to putative tran... 43 0.005 1 15.1% 1:159 74:194 VPKNTSPRLFIVRVKRGSEREILMRI--------IENDPKNVF--------------SIICKDGLKGYLYVEAFQKQHVVDALESLRGVSR------SRVSVVPQKEMIEAMTYHEQR----------ICGEWGRIRNGKYKNDLAKIIESDGEMVRIR----------------------
447 UniRef50_B7XII8 Transcription initiation pr... 43 0.006 1 15.7% 2:160 91:213 -PKMSDPLLFLVRVKIGKEKSIASKIAEHAKT-----------IPDITAILQKDG---------LKGYIYIESFKKSAVDEAVSKVKNVYK------NRIAAVPIAEMVDVLN----------SKKEYMINEYGRVKNGKYKGDLAQILENYEDSCQIRI---------------------
448 UniRef50_C5KNI1 Histidyl-tRNA synthetase, p... 43 0.006 1 13.4% 2:150 230:358 -PEPSDSKLFLVKCfiGHEREIITRLSTKYE--------------QFRKKGVKTGILSAFASDSLKGYIYIE----------GKSVNHIKRFVTgnTNSVKVVPATEMLGVFRSAQEAAKG--RFVPLKMGEWVRIKRHpySNDLAQVVE-------------------------------
449 UniRef50_Q79JX8 TraB n=17 Tax=root RepID=Q7... 42 0.007 1 15.7% 2:128 49:170 -SELHQRNWYLAQYIPAGKNR--EHL-----FSWLSEQHVLPWTPLILKKVRRTDkyRRHIHAVFPGYFFLKADPERHSFTHLRRHSAFLDFVKMAG-EIKTVREDIVQSLMKVYPDPALNPAAREEL-----------------------------------------------------
450 UniRef50_Q01WX6 Putative uncharacterized pr... 42 0.007 1 28.3% 126:178 25:76 -----------------------------------------------------------------------------------------------------------------------------VKPRAGQRVRIKGGALAGVEGVVIGFRQS-LRLILSITLLQRSVLLEIDRRLV---
451 UniRef50_D0N3F8 Transcription elongation fa... 42 0.008 1 19.0% 95:173 431:506 ----------------------------------------------------------------------------------------------NDTVRVMPLHEEIKDTILDF-----QLKQLMKYVKVGDHIKVVSGMYSGETGTVVAVDDSEgvAIVLVDSMAREIQVRV--------
452 UniRef50_A0D4Q4 Chromosome undetermined sca... 42 0.010 1 17.2% 6:162 138:268 -----DPKFWRVSCNKGKEQEAVTSIMFKHNHLIDTN-------PLEIV--------SVFALKKFPAAIFIEANFEQHVMRAIEGLTIVRQclVESEQCPNMFKPAEVEQI---------------DIEEGQWVRVRQhiYSGDLARVMQVDQERKLIKLKV-------------------
453 UniRef50_B8ICP2 NusG antitermination factor... 42 0.010 1 23.6% 4:75 35:97 ---DGDRRWYVVRIDPTRERKIREGLET---------AGFATCVPASSAVIEHRGRYRETRRRAVPGYLFVGADR----------------------------------------------------------------------------------------------------------
454 UniRef50_C3Z963 Putative uncharacterized pr... 41 0.012 1 25.6% 101:178 195:272 ----------------------------------------------------------------------------------------------------AVVRPTEDKNQRPLKPGETRKEEDTTGLVPGAHVLILAGPHRDMYGKVESLNAETARAVVSLALGGQTLDISENALQV---
455 UniRef50_C6KSV4 Trancription factor, putati... 41 0.012 1 12.9% 23:162 257:384 ----------------------KMWLIKLFKNNVERNLAIGIYHKFMKLKDNDFNIKGIYVSDNLKGYIYIEAD------SLYMLKKFLLGFKFINLNEISIVPIQELTSIFTMCHSKINIP------KVNEYVRIKRGLYINDIGQIYEIHEKGIYAIVRL-------------------
456 UniRef50_A7AM03 KOW motif family protein n=... 41 0.012 1 16.2% 52:162 188:286 ---------------------------------------------------RKLGIYSCFAPDEIKSFIYVEADTKSAIIDAFSDLRNL------NLSKLKMVPINEVSTIYAMESRQQTVPL------IGEYVRIKTGRYAGDLAQVHESDELNGTVVVKV-------------------
457 UniRef50_A9GHZ0 Putative uncharacterized pr... 41 0.013 1 32.7% 128:179 400:446 -------------------------------------------------------------------------------------------------------------------------------LEKGSRVRVRRGPFGDKIGVVSELDGRGG-ARVLLGLL----STRLELDDLE--
458 UniRef50_B7ZCC8 G patch domain and KOW moti... 41 0.014 1 26.5% 124:172 3:51 ---------------------------------------------------------------------------------------------------------------------------QPQGLMHGRAVVVLSGPYRGLYGKVEGLDPDNVRAMVRLAVGNRIVTVS---------
459 UniRef50_B3LCM7 Ribosomal protein l24, puta... 41 0.014 1 17.4% 70:161 4:89 ---------------------------------------------------------------------YVKYFMQAKQLDKRKRKYGNLDFLELSKELSIPFPLRE------RNQPKHLDLSKYLNIKVGDLVKVIYGPYKDREGLVLNINTKRNTVIVD--------------------
460 UniRef50_Q4DTT9 Transcription initiation pr... 41 0.016 1 11.8% 2:162 188:327 -PQDTDPRVFAVKCRPRM----ARLLVARIVNKCYAYRIGRNY----EKRKVDLGIISVFCLDHVKEYIYIEAHRKVFVENALNGLDGLFRY------KITLVNPSELMQMM-------ERRPSPEKLRVGSFVRLRQRQYRLDLAQVVEVHPISNQVTVKV-------------------
461 UniRef50_Q4MYL3 Transcription factor, putat... 41 0.024 1 11.7% 1:162 232:379 MPDLGDPKLWLVRTNR---QTADRNLAISIMNKSL----------RYQSLGKNLGIYSCFVPDGVTGYLYIEADNKTVVTEALSEFRQI------NLNTLKLVPINEMSNVFTTGALRCEVRSHIYYlrVGELVRVKFGRYSGDLGQVYESDENSSTVTLKL-------------------
462 UniRef50_C5Z0R7 Putative uncharacterized pr... 40 0.029 1 12.6% 60:178 495:620 -----------------------------------------------------------VVKHLYLGILFieSESENCGFFCAQscEKIRKGLGSSTTepTPMFSEPTYEQNEHRDTERprSTREQLFSVGQMLRIRKGPLKGYLCRVVRIF--RNDVTVKLDSLLKTVTVQADLLSV---
463 UniRef50_Q4FY88 Transcription elongation re... 40 0.029 1 10.5% 4:155 169:299 ---EDDPKVFAVKCRPRMSRVLVTRIVNKCYAYRVGRN--------YERKKVDLGIISVFALDHVKEYIYVEASRKRFVENVLNGLDGVFRF------NIAVVDPKELLQTM-------ETRPSTQKVRVGDYVRLRQRFYRGDLAQVTALHPDG--------------------------
464 UniRef50_B3C5U6 Putative uncharacterized pr... 40 0.033 1 13.3% 4:78 11:76 ---NETRNWYIVLTSPWKEKKIREDLDNK---------GIISHLPTTYVQYKWKEKIRKIQIPTVNRCIFIYATDSEI-------------------------------------------------------------------------------------------------------
465 UniRef50_UPI00016E26AA UPI00016E26AA related clust... 40 0.036 1 26.3% 116:172 232:288 -------------------------------------------------------------------------------------------------------------------PGDERVKEEELVMGPGSCVLVESGPHKDKYGKIEGVYPDNARVVVRLAIGGRTVDIS---------
466 UniRef50_Q11LV0 Putative uncharacterized pr... 40 0.039 1 16.2% 9:138 3:155 --------WYAIRTVPgrEYAVetSLGKDGRPRglSEAGYVHYMPAERRlrKHTDLWKARRFAMLVGYVFVKGPVDFRALEP---VPGVHSIVGICG-RPMEIDLLDILTLRSMEAIAEEKFDRDARVAR-KTIRIKS-------------------------------------------
467 UniRef50_A5BQJ5 Putative uncharacterized pr... 40 0.041 1 8.9% 62:162 451:538 -------------------------------------------------------------VDHVKGFIYIEADKQCDINEACKGLCSIY------TSRVAPVPKNEVTHLLSVRSKSIES-------SKGTWARMKNGKYKGNLAQIVVMSDAQKKATIKL-------------------
468 UniRef50_P60663 50S ribosomal protein L24P ... 40 0.044 1 24.4% 119:163 51:95 ----------------------------------------------------------------------------------------------------------------------EKLGIRNVPIKVGDVVRVERGNFRGKEGQVIDIDPKYYRVYLSLD------------------
469 UniRef50_Q90X38 G patch domain and KOW moti... 40 0.050 1 26.8% 116:171 239:294 -------------------------------------------------------------------------------------------------------------------GDEKGKEEEALVLGPGGCVQVLAGAHKDLYGKIEGVDPDNGRVVVKLAIGGKTVTI----------
470 UniRef50_A5UL77 50S ribosomal protein L24P ... 39 0.063 1 25.6% 123:161 38:76 --------------------------------------------------------------------------------------------------------------------------KRSLPIRKGDKVQVLRGDFKGHEGAVLGVDYGSYKITIE--------------------
471 UniRef50_B8BVN2 Predicted protein n=1 Tax=T... 39 0.073 1 10.6% 1:161 271:403 MPSVSDPNLWMFSCPTGKEQELVYQIMNKAVAFA---------------KRGRPLGITSVVAAQTKGKVYVESYSEPAVMEA---LQGVRGLMIYSAVK---VPISDMTTVMTVVPKKVPVKK-------NDWVRMTRGHFKGDLALVKHVRDSGLKCVIQ--------------------
472 UniRef50_B3RYJ9 Putative uncharacterized pr... 39 0.079 1 27.1% 106:164 224:282 ---------------------------------------------------------------------------------------------------------EEPERTSDVCFAAKMVTTISLGFARGVHVMVVAGPHADLYGKVEGIDGDNGRIFVALAI-----------------
473 UniRef50_A1RWS4 50S ribosomal protein L24P ... 39 0.081 1 24.3% 92:161 1:81 -------------------------------------------------------------------------------------------MVKGTSSKPGKVRKREVYDAPLHIRSKKIVAPLSAELqkGDRVLIVRGSFKGHEGKVTSVDVKKGRIHVE--------------------
474 UniRef50_B8L4E2 Putative DNA methylase n=1 ... 39 0.089 1 17.0% 23:163 886:1025 ----------------------AKTITRRGARNTKEEGFSKPEVVEREIKRRGLDPADYEVRKHFGGYVGVLKDAPDIAIKSQTPTAGNEGRGAQPTSKGDGAARTEIHRKIDQEFAENLEAIAEEGIGAGDTVKFRSGD-ETLAAEVMEIDNEQGTLQVRLE------------------
475 UniRef50_UPI0001926E74 PREDICTED: similar to predi... 39 0.091 1 21.8% 110:164 229:283 -------------------------------------------------------------------------------------------------------------RVRHIKGLSEEVKDNSIGYFPGCYVYIQNGPHKDLSGKIISVDEDTTRISVQLRI-----------------
consensus/100% .....................................................................................................................................................................................
consensus/90% ................................................................h.thhhh...............................h.......h...................st.h.h..t.h.t..s.h.................................
consensus/80% .......hahh.s..t.p..h...l.....................................hh.shlhlph.........h.th.th..hh.........l..t.h..hh...............h..sp.ltlhtG.hts..u.l.th..tt..hhl.h..................
consensus/70% ......Wahltsh.t.Etthht.l.t...........hthhhP.......htt.ht.h...hh.uYlhlpht.tpt.h.hhpth.tlhthlt..ttt.h.ls.pphtthh..............tht.GphVplhpGshts..u.l.php.tptphhl.l..ht....hth.......
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown